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 Abstract 
Staphylococcus aureus is a major cause of infections within hospitals. Its spread among patients 
in hospitals is one of the major problems that require urgent attention. Staphylococcus aureus has the 
ability to interact with other microorganisms such as the free-living amoebae Acanthamoeba which acts 
as a host for various pathogens. This interaction is highly complex and may be beneficial to one of them 
or both.    
The main aims of this project were to study the interactions of Acanthamoeba castellanii with 
methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus 
(MSSA), and to understand the molecular mechanisms involved. A large variety of molecules play a role 
in growth, function, migration and apoptosis. The role of Phosphoinositide 3-kinase (PI3K) in 
Acanthamoeba/bacteria interaction was studied through the use of inhibitors such as LY294002 and 
wortmannin, while the involvement of protein tyrosine kinase was studied through genistein and protein 
tyrosine phosphatase by sodium orthovandate (Na3VO4). The role of serine proteases of Acanthamoeba 
was investigated by using its inhibitor Phenylmethylsulfonyl fluoride (PMSF).  
The results showed that MRSA exhibited more invasive abilities towards Acanthamoeba, when 
compared with MSSA. In addition, inhibition of PI3K and tyrosine phosphatase subsequently resulted in 
the reduction of MRSA and MSSA invasion. However, PMSF increased bacterial uptake by 
Acanthamoeba.  Two dimensional gel electrophoresis was performed to separate and fractionate the 
Acanthamoeba conditioned medium and the Universal Protein Resource Uniprot database was used for 
the analysis and identification of protein for the forty three spots identified. 
This study further stresses the need for antimicrobial drugs that are effective without inflicting 
damage upon the host, as a result of the resistant nature of MRSA towards a variety of antibiotics. One 
possible method that can be used is Photodynaic Therapy, due to its effectiveness against microorganisms 
in a localised infected area, through the use of local combined photosensitizers and light.  
iv 
 
 
In addition, to simplify the interaction process, heat-killed fluorescein isothiocyanate-labelled 
(FITC)-labelled MRSA and MSSA were used. The findings suggest that trophozoites Acanthamoeba 
trophozoites uptake of MRSA was significantly higher than MSSA which may act as "vehicle" that 
facilitates the spread of MRSA to susceptible hosts.  
This study showed that photodynamic therapy had a significant impact on bacterial survival. 
Photosensitizers m-Tetra (hydroxyphenyl) chlorin (m-THPC) and psoralen were very effective in 
eradicating bacteria. In antimicrobial assays, natural product eugenol derivatives demonstrated significant 
inhibitory activity on the growth of MRSA and exhibited dose-dependent cytotoxic effects on 
Acanthamoeba trophozoites.  
Future work should continue to identify more molecular mechanisms of Acanthamoeba 
interaction with MRSA and finding new strategies for effective antimicrobial therapies. 
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1.1. Staphylococcus aureus  
Staphylococcus aureus (S. aureus) is the major pathogen within the genus Staphylococcus. It is 
coagulase positive Staphylococci which causes a wide range of infections in both humans and animals 
(Ruzauskas et al., 2015). S. aureus causes several diseases ranging from mild infections such as skin and 
soft tissue infections to potentially fatal infections such as endocarditis, bacteraemia and toxic shock 
syndrome. Depending on sensitivity to methicillin, there exist two types of S. aureus strains; the first 
strain is known as methicillin-sensitive S. aureus (MSSA) while the second strain is known as methicillin 
resistant S. aureus (MRSA) as they are resistant to methicillin and other β-lactam antibiotics. MRSA is 
also known as a ‘superbug’ due to its ability to resist many antibiotics (Okuma et al., 2002). This 
resistance to antibiotics makes infections caused by MRSA more difficult to treat among others. UK 
Office for National Statistics bulletin presented the number of deaths caused by MRSA between 1993 
and 2013 in England and Wales (Figure 1.1). It showed that the main cause of death is the presence of 
other underlying diseases rather than contracting MRSA at that time.  
Figures are based on deaths registered in each calendar year rather than those occurring in each 
year. Since the majority of deaths involving MRSA registered in 2012 also occurred in the same year, 
registration delays are likely to have no impact on the findings in this bulletin. Please see the section on 
registration delays for further information. Furthermore, due to its occasional rapid spread and 
destruction of human flesh in necrotising fasciitis, it is also called ‘flesh eating’ bacteria (Foster, 2004). 
The ability to produce penicillin-binding protein 2a (PBP2a) molecules (encoded by the mecA gene) 
which have low affinity to β-lactam antibiotics explains the resistance of MRSA to methicillin and other 
β-lactams (Berger-Bachi and Rohrer, 2002). People with compromised immune systems are commonly 
infected by this bacterium (Gordon and Lowy, 2008) and MRSA causes infections in both hospital and 
community settings (Singh et al., 2012).  
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 Number of deaths caused by MRSA between 1993 and 2013 in England and Wales. These Figure1.1.
patients were already ill before contracting MRSA and it is their existing illness rather than MRSA which 
may be the underlying cause of death (Office for National Statistics, 2013). 
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1.1.1. Staphylococcus aureus Colonisation 
Staphylococcus aureus is a pathogen, as well as a commensal organism. The main ecological 
niches for S. aureus are the anterior nares. Persistent nasal colonisation of S. aureus occurs in 
approximately 20% of individuals, and intermittent colonisation is observed in approximately 30% 
(Gordon and Lowy 2008). It has been found, however, that several other sites can be subject to S. aureus 
colonisation, including the gastrointestinal tract, the axillae and the groin. In the event of colonisation, for 
example through catheterisation, surgery, aspiration or shaving, or when the immunity of the host is 
compromised, bacteria may be introduced from this pool of colonies, in turn increasing the risk of 
infection (Wertheim et al., 2005). The colonising S. aureus strain is commonly responsible for 
subsequent infections (Ruzauskas et al., 2015). This was shown in the study by Von Eiff et al., 2001 in 
which they found that blood S. aureus isolates were identical to nasal isolates. There is a need to further 
investigate the underlying causes for S. aureus colonisation, due to its complexity and a gap in our 
current knowledge as to why the host must have contact with S. aureus and why in the event of this 
contact, S. aureus is able to adhere to cells of a host and evade immunity of the host (Wertheim et al., 
2005). 
1.1.2. Epidemiology and Prevalence of MRSA infection  
The epidemiology of MRSA infections is complicated and involves several routes of 
transmission. The carriers of MRSA are at a higher risk of developing infections, and they serve as 
potential reservoirs for the subsequent transmission of the organisms. There are increasing reports of 
outbreaks of MRSA colonisation and infection through skin contact as in the cases of gyms and locker 
rooms in the US; it is thought that around 53 million people carry MRSA (Archibald et al., 2008).  Some 
scientists have estimated that 25-30% of the world’s population carry MSSA bacteria (Islam et al., 2008). 
MRSA infected patients in intensive care units increased from 35.9% in 1992 to 64.4% in 2003. In 
Europe, MRSA infections increased from 16% to 24% between 1999 and 2004. It was further found that 
the MRSA strain was more prevalent in southern parts of Europe than in the northern parts. The highest 
prevalence was found in Portugal (54%) and Italy (43-58%), but the prevalence in Switzerland and the 
Netherlands was very low (2%). In the UK, MRSA causes almost half of hospital infections. MRSA’s 
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range is worldwide, with prevalence varying according to the type of clinical wards and geographical 
areas (Rello et al., 2007). The highest rates of MRSA occurrence (>50%) are reported in North and South 
America, Asia and Malta. Intermediate rates (25–50%) are reported in China, Australia, Africa and 
European countries such as Portugal (49%), Greece (40%), Italy (37%) and Romania (34%), Netherlands 
(5%) and Scandinavia (1%) (Stefani et al., 2012) (Figure 1.2). It is clear that the MRSA incidence is 
correlated with the management of antibiotic consumption in different countries. Between 2000 and 
2010, the consumption of antibiotics was amplified by 36% (from about 54 to 73 standard units). For 
example, Brazil, Russia, India, China, and South Africa accounted for 76% of this rise due to a 
significant variation in the number of MRSA infections. The overuse and misuse of antibiotics is more 
likely to happen in the developing compared with the developed countries. This is a significant factor in 
increasing antibiotic resistance. Therefore, researchers are more vigilant now to monitor and regulate 
antibiotic usage and it’s resistance. A wider partnership between countries to help policy makers for the 
monitoring of antibiotic consumption is essential to control antibiotic resistance (Thomas et al., 2014).  
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 The global map of the percentage of MRSA incidence. The darkest colour indicates high Figure1.2.
percentage (http://www.cddep.org).  
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1.1.3. Disease progression as a result of virulence factors 
Staphylococcus aureus has an extensive range of virulence factors; both secreted and structural 
products play a role in the pathogenesis of S. aureus infection (Patti et al., 1994). S. aureus expresses 
numerous surface proteins called Microbial Surface Components Recognising Adhesive Matrix 
Molecules (MSCRAMMs) which facilitate the adherence of connective tissue, such as fibrinogen, 
fibronectin and collagen, to the host tissue. Different strains of S. aureus have and express different 
arrays of MSCRAMMs, and so different strains cause particular kinds of infections (Patti et al., 1994). 
MSCRAMMs play an important role in the initiation of bone, joint and endovascular infections  (R J 
Gordon and Lowy, 2008).  
Staphylococcus aureus can grow efficiently when adhered to medical prosthetic devices, or host 
organisms. On prosthetic materials, S. aureus forms biofilms which appear as a thin slime layer. In this 
way, it may persist and as a result evade antimicrobials and other host defence mechanisms (Donlan and 
Costerton, 2002). This is the reason for infections occurring in prosthetic devices being almost impossible 
to eradicate, without removing the device completely. On the other hand, S. aureus can survive in 
epithelial cells following invasion. In vitro studies have shown that they are able to evade host defence 
mechanisms by forming Small Colony Variants (SCVs) (Patti et al., 2003). These may be the cause of 
infection persistence and recurrence, which has been found to be the case in endocarditis (Ogawa et al., 
1985). Furthermore, SCVs have been found to disguise themselves inside cells of a host without 
damaging the host cell significantly, and are less exposed to antibiotics. Being in host cells, they have the 
ability to proliferate and burst the cell, which in turn can lead to a recurrence of infection (Proctor and 
Peters, 1998). 
Aside from the aforementioned contributors to the evasion of the immune system of the host, S. 
aureus has been found to exhibit further characteristics enabling this evasion. One of the main 
mechanisms studied, is the production of an antiphagocytic microcapsule (O’Riordan and Lee, 2004). 
Being zwitterionic, this capsule is able to induce the formation of abscesses (Weidenmaier et al., 2010).  
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Infection is further caused by the binding of MSCRAMM protein A to the Fc portion of 
immunoglobulin (Foster, 2005). This can significantly reduce the chance of opsonisation occurring. 
Similarly, S. aureus can secrete extracellular adherence proteins and chemotaxis inhibitory proteins that 
inhibit chemotaxis and extravasation of neutrophils to the infection site (Foster, 2005). S. aureus also 
evade immunity of the host cell by producing leukocidins. This in turn results in the destruction of 
leukocytes, by forming cell membrane pores (Gladstone and Van Heyningen, 1957). This, in addition to 
the production of various enzymes including elastases, proteases and lipases, facilitate the destruction of 
host tissues and allow the metastasis of the infection to different sites. This can also induce a septic 
shock, through interaction with and activation of the immune system of the host and coagulation 
pathways. Contributors to this are α-toxin and Lipoteichoic acid  (Wang et al., 2007).  
Certain strains of S. aureus are also capable of producing ‘super antigens’. These can facilitate 
toxic shock syndrome and food poisoning (McCormick et al., 2001). They can further cause a septic 
syndrome through the induction of a ‘cytokine storm’. The capability of S. aureus to cause havoc in the 
cell is highlighted by the secretion of exfoliative toxins and epidermolysins. These can cause bullous 
impetigo and scalded skin syndrome (Prévost et al., 2003). The expression of staphylococcal virulence 
factors needs to be highly regulated in order to reduce high demands on metabolism and has a key role in 
pathogenesis (Figure 1.3). For example, MSCRAMM expression only occurs when needed in bacteria; 
i.e. during the log phase of growth, or replication. Secreted proteins, on the other hand, are produced in 
the stationary phase of growth. The early expression of MSCRAMMs contributes to colonisation in 
tissue, and the later secretion of toxins contributes to the spread of bacteria(Rachel J Gordon and Lowy, 
2008).  
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 Pathogenic factors of Staphylococcus aureus, with structural and secreted products both Figure1.3.
playing roles as virulence factors. A: Surface and secreted proteins. B and C: Cross-sections of the cell 
envelope (Gordon and Lowy, 2008).  
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The accessory gene regulator, agr, has a key role in regulation of the virulence of Staphylococcus 
(Yarwood and Schlievert, 2003). It is associated with some clinical syndromes; along with the 
‘staphylococcal accessory regulator’ and agr mutants have been found to be low in virulence (Cheung et 
al., 1992; Novick, 2003; Yarwood and Schlievert, 2003). A study has also shown that nasal carriers of S. 
aureus had the highest mortality rate compared with non-carriers (Wertheim et al., 2004). This was the 
case in patients who were hospitalised in a nonsurgical setting. There is still much required in the way of 
understanding how the host may contribute to staphylococcal disease. Colonisation was also found to 
confer immunity in those who have developed a staphylococcal infection, due to the infection being 
induced by a colonising strain (Wertheim et al., 2004). The occurrence of toxic shock syndrome can be 
reduced by antibodies. It was found that patients lacking antibodies of the toxins implicated during acute 
illness would almost certainly be subject to toxic shock syndrome (McCormick et al., 2001). Finally, one 
must note that different strains of S. aureus have differing abilities to produce biofilms, and also differing 
abilities to evade the immune response mechanisms of their host. Virulence factors can be compared with 
the resulting clonal type, but can also be unrelated to genetic factors.  
1.1.4. Hospital-acquired (HA)-MRSA: History and pathogenesis 
MRSA isolates were reported within a year of the discovery of methicillin in 1960 (Wu et al., 
1996). This resistance was observed in the penicillin-binding protein (PBP2A) encoding gene, mecA. 
This gene also confers a low affinity to β-lactam antibiotics. The genetic element ‘the staphylococcal 
cassette chromosome (SCCmec) encodes the mecA gene as well as recombinase genes within the cassette 
chromosome (ccrA/ccrB/ccrC). These regulate SCCmec transmission: horizontally, intra and inter-
species. SCCmec is absent in coagulase-negative staphylococcal species (Wu et al., 1996). Few lineages 
of MRSA have been the product of SCCmec transfer into successful clones of MSSA.  
Sequencing of a group of housekeeping genes (multilocus sequence typing), was used to 
demonstrate that MRSA clones are derived from 5 distinct groups of clonal complexes or related 
genotypes all arising from separate ancestral genotypes (Enright et al., 2002). It was found that isolates of 
MRSA were derived from sequence type (ST) 8-MSSA, which became ST250-MSSA following a point 
mutation. ST250-MSSA is believed to be the first SCCmec recipient yielding MRSA, and termed ST250-
11 
 
 
MRSA-I (Enright et al., 2002). Following this study, it was then identified by Crisostomo et al., in 2001, 
that there were other likely MSSA strain recipients in a separate group of isolates.  
Historically, HA-MRSA infections were the result of five major clones disseminated 
internationally, including the Brazilian, New York/Japan, Hungarian, Pediatric and the Iberian clones 
(Oliveira et al., 2002). As a result, drug resistant clones account for most HA-MRSA infections in 
various regions of the world, due to their global dissemination. An example of this dissemination is the 
spread of the Brazilian clone to other countries including Armenia, Chile, Portugal and Argentina 
(Oliveira et al., 2002). The ease of this HA-MRSA transmission and establishment of particular strains 
remains subject to investigation.  
One of the main issues faced today is the dominance of these strains in hospitals; commonly due 
to their antibiotic resistance. But aside from this, it has been also suggested that the increased virulence of 
clones has resulted in their enhanced colonisation of hosts, as well as their enhanced ease of transmission. 
Phage type 80/81 is an example of a clone that was responsible for the S. aureus pandemic of infections 
acquired in communities in the 1950s (Robinson et al., 2005). After 1960, it became much less common 
due to the introduction of methicillin. Phage type 80/81 encodes the Panton-Valentine leukocidin gene 
(PVL) and is related to the southwest Pacific (SWP) clone. The SWP clone encodes the SCCmec IV in 
addition to the PVL gene. Due to the similarity in genetics of these two strains, it would be expected that 
the SWP clone would be extremely efficient in the spread of disease. It has been found in the UK and is 
thought to be closely related to the epidemic strain (ST3-MRSA-II) found in hospitals (Robinson et al., 
2005). 
1.1.5. Community acquired (CA)-MRSA Infections 
Before 1990, it was rare for people who had no previous exposure to a health care setting to 
contract infection due to MRSA. Between 1989 and 1991, there was an outbreak of infections caused by 
CA-MRSA in Western Australia, among indigenous Australians, as well as members of neighbouring 
regions (MMWR Morb Mortal Wkly Rep 1999). During the 1990s, there was an aggressive outbreak of 
MRSA infections in the US, among individuals with no MRSA risk factors. During this time, four 
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children infected with CA-MRSA died in North Dakota and Minnesota between 1997 and 1999. Each 
reported case had associated sepsis from pulmonary abscesses or necrotizing pneumonia, and was fatal 
(MMWR Morb Mortal Wkly Rep 1999). It was subsequently found that the ST1 and PFGE strains (the 
MW2 strain) were the cause of these infections. Following this outbreak, CA-MRSA induced infection 
outbreaks in soft tissue and skin were reported; particularly in soldiers, prison inmates, men having same-
sex intercourse and football players (Lina et al., 1999). The ST8 and PFGE strains were found to be the 
cause of these outbreaks. Similar cases were also found to be the case internationally, additionally 
causing complications where S. aureus prevalence was low. Finally, cases were also found in which 
PFGE type USA300 caused the progression of pyomyositis and purpura fulminans with toxic shock 
syndrome (Lina et al., 1999; Vandenesch et al., 2003; Kravitz et al., 2005). 
1.1.6. Panton Valentine Leukocidin (PVL) as a determinant of Virulence  
PVL is a cytotoxin—one of the β-pore-forming toxins. It has been the subject of studies due to its 
occurrence alongside CA-MRSA infections. The epidemiological association between the two, however, 
is not common in isolates of HA-MRSA or MSSA. A study carried out in France involved 593 HA-
MRSA isolates, which were clear of PVL, however, PVL was found in all strains of CA-MRSA (Dufour 
et al., 2002). A separate study showed that PVL was present in all CA-MRSA isolates, carried out in a 
large and international sample group (Vandenesch et al., 2003). It has also been commonly found in both 
USA300 and USA400 (Saïd-Salim et al., 2005). A study also revealed that co-transcribed PVL genes 
lukS-PV and lukFPV, were present in strains of S. aureus from patients exhibiting various symptoms of 
disease (Lina et al., 1999). PVL has also been associated with 85% of strains from community-acquired 
pneumonia, in comparison with hospital-acquired pneumonia. PVL was also associated with strains 
causing skin infections such as furunculosis and cutaneous abscess, compared with superficial folliculitis. 
PVL was not observed in strains associated with infective endocarditis, toxic shock syndrome, or 
mediastinitis, although few strains were tested (Lina et al., 1999). Another study, in which the role of 
PVL was investigated in patients with MRSA-induced soft tissue and skin infections, alluded to the fact 
that PVL is a CA-MRSA virulence factor (Diep et al., 2004). PVL and other staphylococcal leukotoxins 
are secreted with S and F proteins (Menestrina et al., 2003). The S and F protein combination dictates the 
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erythrocytolytic, dermonecrotic and leukocytolytic properties of the toxin (Menestrina et al., 2003). PVL 
is made up of LukS-PV and LukF-PV. Four units of each form octameric b-barrel pores in leukocyte 
membranes, which contribute to cell lysis (Miles et al., 2002). As a result, neutrophils release cytokines 
and other inflammatory enzymes (Colin et al., 1994). Further, PVL can contribute to neutrophil apoptosis 
through interference in mitochondrial pathways, and at higher concentrations, can result in necrosis. It 
was also found that PVL was responsible for dermonecrosis in rabbits when injected intradermally 
(Genestier et al., 2005). As a result, the association between strains of PVL CA-MRSA and infections of 
soft tissue and skin can be somewhat justified, and PVL can further be suggested to be the cause of 
increased virulence in CA-MRSA.  
Contrastingly, studies have also compared the virulence of PVL-positive and PVL-negative 
strains of CA-MRSA in human polymorph nuclear cell lysis and did not find evidence of a difference in 
polymorph nuclear lysis (Saïd-Salim et al., 2005; Voyich et al., 2006). To further investigate this, PVL-
positive and PVL-negative strains with strong similarity in genetic backgrounds in mouse abscesses were 
compared against PVL mouse knockouts for USA300 and USA400 strains. Again, no difference was 
observed in mouse survival in the mouse models. PVL-negative strains were, however, the cause of 
abscesses of larger sizes in mice. The isogenic PVL strains USA300 and USA400 contrastingly displayed 
no difference in in vitro polymorphonuclear lysis. In light of these data, it was concluded that PVL could 
not be the soul determinant of disease in CA-MRSA strains (Labandeira-Rey et al., 2007). Further to this, 
a mouse pneumonia model was also studied. Non-CA-MRSA PVL-positive and PVL-negative strains 
were infected into mice. It was found that the PVL-positive strains gave rise to necrotizing pneumonia, 
while the PVL-negative strains showed a slight leukocytic effect. Severe tissue damage and mortality was 
seen to occur when PVL-negative mutants were complemented with plasmids containing the PVL 
operon. Further investigations in mice showed that LukS-PV and LukF-PV toxin exposure caused 
damage in mice lungs, as well as higher rates of mortality, which increased as the concentration of toxin 
increased. Another side effect was weight loss in mice (Labandeira-Rey et al., 2007). It is important to 
note that in these experiments, a non-MRSA strain was implemented. To counter this, a separate study 
showed that PVL was not responsible for mortality in mice, and it was in fact α-hemolysin (Bubeck 
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Wardenburg et al., 2007). This further suggested that there is little or no link between S. aureus virulence 
and PVL. To add to this, it was also documented that S. aureus secretes phenol-soluble modulins; which 
are often over expressed in strains of CA-MRSA when compared with their expression in HAMRSA 
strains. This can lead to the destruction of neutrophils, increase inflammation and further increase 
virulence in mice and bacteraemia models.  
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1.2. Acanthamoeba 
Acanthamoeba is a genus of Free-Living Amoeba (FLA), first described by Castellani in 1930, 
when he reported the presence of an amoeba in Cryptococcus pararoseus cultures (Burger et al., 1995). It 
is widely spread in the environment. Pathogenic Amoebae cause brain disease and death within days in 
monkeys and mice, and it first appeared in series of articles in Science (1958) and the Journal of 
Pathology (1959), written by Culbertson and collaborators. They first found and recognised amoebae 
accidentally in the lesions of animals that had died from inoculation with a tissue-culture fluid of 
trypsinised monkey kidney cells.  It was assumed that this was caused by an unknown monkey virus, but 
it was later known to be Acanthamoeba (Culbertson et al., 1958). Acanthamoeba species are bacteria-
eating (bacteriovores), but some are opportunistic pathogens as well (Whan et al., 2006). 
1.2.1. Ecology of Acanthamoeba 
Acanthamoeba spp. is the most widespread protozoan in the environment, which have been 
found from natural and man-made environments as well as in vegetables, mushrooms, cultured cells, fish, 
reptiles, birds and mammals. (De Jonckheere, 1991).Acanthamoeba is ubiquitous in nature as it is found 
in the soil and different types of natural environments such as seawater, ocean sediments, beaches, pond 
water, stagnant water, soil, mud, shoreline soils, fresh water lakes, streams, frozen swimming areas, 
saltwater lakes, river water and even the air (Marciano-Cabral and Cabral, 2003). 
In man-made environments, Acanthamoeba has been isolated from bottled mineral water, 
distilled water bottles, thermally polluted factory discharges, cooling towers of electric and nuclear power 
plants, jacuzzi tubs, hydrotherapy, ventilation ducts, humidifiers, air-conditioning units, sewage, compost 
and other sources (Marciano-Cabral and Cabral, 2003; Khan, 2009).  
In human beings, they have been isolated from nasal cavities, throats, intestines and infected 
tissues, which include cerebral tissues, lung tissues, skin wounds, cornea and contact lenses (De 
Jonckheere, 1991). 
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1.2.2. Life cycle 
The life cycle of Acanthamoeba consists of two stages: vegetative trophozoite, when 
Acanthamoeba is active, performs movement through actin polymerazation, phagocytosing and cellular 
division; dormant cyst, when it has rigid cell wall to survive undesirable conditions (Rondanelli, 1987). 
 Trophozoite stage 1.2.2.1.
When growth conditions are optimal,  such as the organism’s having sufficient food, a neutral 
pH, favourable temperatures and an osmolarity between 50-80 mOsmol/kg, the trophozoite stage starts   
(Band and Mohrlok, 1973). The trophozoite  feeds on bacteria and varies in size from 25 to 40 µm 
(Marciano-Cabral and Cabral 2003). Organelles typically found in higher eukaryotic cells have also been 
identified in Acanthamoeba, such as: the Golgi complex, the smooth and rough endoplasmic reticula, free 
ribosomes, digestive vacuoles, mitochondria, and microtubules (Marciano-Cabral and Cabral, 2003). It 
also has spiny surface projections called Acanthopodia, distinguishing it from other organisms (Figure 
1.4), prominent contractile vacuole in the cytoplasm that controls the water content of the cell, and a 
nucleus with a large central nucleolus. 
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 Acanthamoeba trophozoite under bright field microscope.  Figure1.4.
 
 
 
 
 
 
 
 
 
 
 
 
5μm  
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Acanthamoeba  has  generation time is in the range of 8-24 h for isolates belonging to different 
species (Khan, 2009). During this generation time, the cell passes through a series of discreet stages, 
collectively called the growth cycle.  Acanthamoeba reproduces asexually by binary fissions, resulting in 
two genetically identical daughter cells. Most of the cellular contents are synthesized continuously, so the 
cell mass gradually increases as the cell approaches division (Weisman, 1976). This is followed by cell 
division and involves two overlapping events in which the nucleus divides first, followed by cytokinesis 
i.e. division of the cytoplasm (Khan, 2009). 
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 Cyst stage 1.2.2.2.
The cyst stage occurs under adverse environmental and nutritional conditions, such as 
insufficient food, unfavourable hypo- or hyper-osmolarity, extreme temperatures or pH, high cell 
densities, and chemicals so Acanthamoeba transform from trophozoites into the cyst stage  by undergoing 
a process known as encystation (McClellan et al., 2001). The combination of encystation and 
morphological changes cease the cell growth and biochemical differences (Abjani et al., 2016). 
Decreased cellular levels of ribonucleac acid (RNA), protiens, triacyglycerides and glycogen  occur in the 
process of encystation, which results in decreased volume and dry weight (Khan, 2009). In addition, 
during encystation, cytoplasmic mass is reduced by the shedding of excess food, cytoplasmic fluid and 
volumes of solutes, and the trophozoite condenses itself into a double-walled cyst, with the wall serving 
only as a shell to help survive hostile conditions (Marciano-Cabral and Cabral, 2003; Dudley et al., 
2005). There is a diagramatic representation of the life cycle of Acanthamoeba (Figure 1.5). 
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 Diagram of the life cycle of Acanthamoeba under bright field microscopy. Figure1.5.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trophozoite form Cyst form 
2μm 2μm 
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1.2.3. Feeding of Acanthamoeba 
Environment microorganisms are the food source of Acanthamoeba (Weekers et al., 1993). 
There are contractile vacuoles in cytoplasm of Acanthamoeba trophozoite and acanthopodia, emerging on 
its surface, are used for capturing food particles like bacteria, as well as tiny organic particles. Its feeding 
is done by pinocytosis and phagocytosis. Pinocytosis is when cell is uptaking liquid particles when 
phagocytosis is a process of uptaking of solid particles. At temperatures of 30°C, Acanthamoeba 
performs both phagocytosis and pinocytosis for consumig food particles and liquid  (Figure 1.6) (Khan, 
2009). During the process of phagocytosis, plasma membrane surrounds each particle and specific 
receptors mediate attachment. Afterwards, particles are taken up and surrounded by membrane inside the 
cytoplasm, forming new  phagosomes. Following that, the phagosome combines with lysosomes 
containing hydrolytic enzymes, such as acid phosphatase, acid beta-glucosidase, n-acetyl 
glucosaminidase, alpha-glucosidase, acid beta-glucosidase etc. The outcome is formation of phago-
lysosome  ( Dudley, et al., 2005) leading to acid hydrolysis over a 30 min  period.  
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 Acanthamoeba displaying the bacterial interactions within the cytoplasm. (A) Acanthamoeba Figure1.6.
acting as a host for bacteria. (B) Acanthamoeba acting as ‘Trojan horse’ for bacteria transmission. (C) 
Acanthamoeba acting as predator of bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
Pathogenic bacteria Non-pathogenic 
bacteria 
1. Bacteria bind to Acanthamoeba 2. Bacteria taken  up  Acanthamoeba 
3. Vacuoles containing bacteria 
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1.2.4. Classification 
Identification of Acanthamoeba at the genus level is comparatively easy due to the occurrence of 
spiny superficial projections, named acanthopodia, on trophozoites. Nevertheless, using morphological 
criteria, identification of these amebae at the species level has been problematic. Acanthamoeba spp. 
have been positioned into three morphological groups (I, II, and III) based on cyst size and shape 
(Pussard and Pons, 2014). Species in group I were labelled on the basis of having a rigid cyst in 
comparison to that of species in the other groups. Species in group II were categorized as having a 
crinkly ectocyst and an endocyst which could be stellate, polygonal, triangular, or oval. Species in group 
III typically displayed a thin, smooth ectocyst and a round endocyst. However, classification of 
Acanthamoeba based on morphological characteristics of the cyst wall has been demonstrated as 
unreliable since cyst morphology can transform depending on environmental conditions (Daggett et al., 
1985). The genus Acanthamoeba was first established in 1931. The members of this genus were isolated 
very frequently from different environments. The taxonomical classification of the genus Acanthamoeba 
was confusing (Visvesvara, 1991). However, the traditional scheme of classification of Acanthamoeba 
based on ribosomal ribonucleic acid sequences is given below (Siddiqui and Khan, 2012). The discovery 
of progressive molecular techniques directed to the revolutionary work of the late Dr. T. Byers (Ohio 
University, USA) in the classification of the genus Acanthamoeba based on r-RNA gene sequences. 
Since life developed in the aquatic, most likely through self-replicating RNA as the genetic material or as 
a common ancestor and evolved into various forms, it is rational to investigate the evolutionary 
associations through r-RNA. Moreover, this is a highly accurate, consistent and instructive arrangement. 
Each base presents a single character providing a precise and various systematic. Based on r-RNA 
sequences (Figure 1.7), the genus Acanthamoeba is distributed into 20 different genotypes (T1–T20) 
(Adamska, 2016; Behera et al., 2016). Every genotype displays 5% or more sequence deviation among 
diverse genotypes. With the increasing research interests in the area of Acanthamoeba and the universal 
accessibility to cutting-edge molecular techniques, undoubtedly additional genotypes will be identified. 
These studies will help to clarify the role of Acanthamoeba in the ecosystem, bacterial symbiosis, as well 
as in causing primary and secondary human infections (Siddiqui and Khan, 2012). 
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Genotype Type Name of Acanthamoeba with Accession 
number 
Human disease association 
T1 A. castellanii V006 (U07400) Encephalitis 
T2 A. palestinensis (U07411) Keratitis, Encephalitis 
T3 A. griffin (S8137.1) Keratitis 
T4 A. castellanii 9GU (Af251938) Keratitis, Encephalitis 
T5 A. leticullata PD2S (U94741.1) Keratitis, Encephalitis 
T6 A sp. BR010 (JX683400.1) Keratitis 
T7 A. astronyxis (AF019064) NA 
T8 A. tubiashi (AF019065) NA 
T9 A comandoni (AF019066) NA 
T10 A. culbertsoni (CDCV409C) Keratitis, Encephalitis 
T11 A. sp. M-1 (HM778019.1) Keratitis 
T12 A. healyi (AF019070) Encephalitis 
T13 A. sp. UWC9 (AF132134) NA 
T14 A. sp. PN 15 (AF333607) NA 
T15 A. jacobsi AC080 (AY262361) Keratitis 
T16 A. sp. cvX (GQ380408) NA 
T17 A. sp. TSP07 (JF325889) NA 
T18 A. sp. CDC:V621 (KC822461) Encephalitis 
T19 A. sp. USP-AWW-A68 (KJ413084) NA 
T20 A. sp. OSU 04-020 (DQ451161) Keratitis, Encephalitis 
 
 Comparison of Acanthamoeba spp. Isolates with reference strains available in GenBank. Figure1.7.
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1.2.5. Human Infections 
Both pathogenic and non-pathogenic strains of Acanthamoeba spread widely in the environment 
and cause different infections such as Acanthamoeba keratitis and encephalitis. Approximately, 50-100% 
of healthy people have serum antibodies which are hostile to Acanthamoeba (Chappell et al., 2001). The 
following sections will describe some of the significant diseases caused by Acanthamoeba.  
 Acanthamoeba keratitis 1.2.5.1.
Acanthamoeba Keratitis (AK) is an eye infection, which is painful, progressive and sight-
threatening infection (Alsam et al., 2008). Although it is existing globally, Acanthamoeba keratitis (AK) 
is a rare condition. The first cases of ocular infection were identified in 1973 both in the UK and USA 
(Illingworth et al., 1995), but the first case of AK was described in 1974 (Naginton et al., 1974). AK was 
linked with five species of Acanthamoeba: Acanthamoeba castellanii, Acanthamoeba culbertsoni, 
Acanthamoeba hatchetii, Acanthamoeba polyphaga and Acanthamoeba rhysodes (Logar and Kraut, 
1997). It can arise in patients of any age, sex or race, but typically manifest in young, healthy adults. AK 
grows generally in contact lens wearers due to inadequate disinfection of contact lenses using non-sterile 
water, homemade saline solution, tap water, hard water, or splashing, swimming or bathing while 
wearing the contact lenses (Ibrahim et al 2007.). In non-lens users, it is related to trauma and exposure to 
contaminated water and soil (Dart et al., 2009). It causes permanent visual impairment or blindness. The 
initial stages of AK infections are not different from the signs and symptoms of other common eye 
diseases. Main symptoms of AK include: eye pain, redness, blurred vision, sensitivity to light, excessive 
tears etc. Without proper treatment, AK can cause loss of vision. As shown in pictures below (Figure 
1.8), the patient who suffered from AK, lost 80% of his vision in one month of infection (Alsam et al., 
2008). The treatment of AK is problematic due to its recurrence happens. Therapy usually includes a 
biguanide in combination with a diamidine. In vivo studies on rats demonstrated that miltefosine-
polyhexamethylene biguanide combination was highly effective for treatment of AK (Polat et al., 2014). 
Nevertheless, when available, confoscan and confocal scanning laser tomography (in vivo noninvasive 
screening tools) should be utilised before any type of corneal refractive surgery is carried out, so the 
latent protozoal infection can be diagnosed and treated (Al Kharousi and Wali, 2012). 
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A) Early epithelial 
infection 
 
 Eye infected with Acanthamoeba keratitis. (A) Slit lamp picture of early epithelial infection Figure1.8.
with Acanthamoeba keratitis exhibiting a dendritiform epithelial pattern. (B) Slit lamp picture after 6 
months of treatment with polyhexamethylene biguanide, propamidine- isethionate and neomycin. After 
the treatment the health condition of patient improved, but he lost 80% of his sight via corneal scarring. 
(C) Slit lamp picture displaying the affected area of the eye (Alsam et al., 2008).  
 
 
 
B) After 6 months of 
treatment 
C) The affected 
area of the eye 
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 Acanthamoeba Granulomatous Encephalitis (AGE) 1.2.5.2.
It is a serious infection of the brain and spinal cord that is typically caused by Acanthamoeba in 
persons with compromised immune system (Figure 1.9). The characteristic symptoms of AGE include 
headache, stiff neck, nausea, vomiting, tiredness, loss of balance and body control, seizure and 
hallucinations (Dudley, et al., 2005). Acanthamoeba species can produce multifocal, chronic and 
subacute granulomatous encephalitis, with trophozoites and cysts presented in central nervous system 
(CNS) (Gardner et al., 1991). Since haematogenous spread is a pre-requisite in AGE infection, the first 
line of defence is induced by complement initiation. Complement initiation occurs through the classical 
pathway triggered by antibody recognition of Acanthamoeba exterior antigens, the substitute pathway 
activated by C3 binding to the amoebic surface and mannose-binding lectin pathway triggered by 
Acanthamoeba surface saccharide configuration (Ferrante and Rowan-Kelly, 1983) Overall, these results 
display that the immune response of AGE is not clear. Additional studies are essential to categorize the 
factors that lead to this lethal infection. Since a high occurrence of Acanthamoeba antibodies is detected 
in both racially and ethnically diverse populations, it is not unexpected that this infection is typically 
limited to immunocompromised or debilitated patients (Pumidonming et al.). There is no effective 
treatment and neither a quick method to cure nor to diagnose this sickness. Existing therapeutic agents 
comprise a combination of ketoconazole, fluconazole, sulfadiazine, pentamidine isethionate, 
amphotericin B, azithromycin, itraconazole, or rifampicin that may be effective contrary to the central 
nervous system infections due to Acanthamoeba, but display severe side effects (Kaushal et al.). A 
fruitful result in a HIV-positive individual with AGE was detected following therapy with fluconazole 
and sulfadiazine (Seijo Martinez et al., 2000). Additional studies are required to determine the mode of 
action against Acanthamoeba and to develop new methods of application and treatment. Treated patients 
may evolve disabilities such as hearing loss and vision damage (Akpek et al., 2011). 
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           (A) Normal brain tissue        (B)Abscess formation         (C) After treatment 
 Regression of brain tissues in patients with AGE. (A) Magnetic resonance imaging (MRI) Figure1.9.
showing normal brain tissue. (B) MRI on day 44, showing multiple abscess formations with diameters of 
up to 20 mm. (C) MRI after 2 months, showing regression of abscess (Maritschnegg et al., 2011).  
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 Disseminated infections  1.2.5.3.
Disseminated infections affects skin, lungs, sinus and even the brain (Mortazavi et al. 2010). 
Disseminated Acanthamoeba infection is rare disease characterized by widespread granulomatous 
infiltration of the skin and extra-cerebral organs and usually occurs in immuno-compromised patients 
(Aichelburg et al. 2008).   
1.2.6. Pathogenesis of Acanthamoeba 
Environmental conditions factors as well as dependence factors upon host define pathogenesis of 
Acanthamoeba infections. The process through which amoebic killing starts include adhesion to the host 
cells, followed by phagocytosis through the secretion of extracellular proteases and the killing of the host 
cell. Pathogenic Acanthamoeba also possess greater adhesion properties, secreted cytotoxic products, 
invasion mechanisms and survival mechanisms than non-pathogenic Acanthamoeba (Alsam et al., 2003). 
The pathogenesis of Acanthamoeba can be described using two mechanisms: contact-dependent and 
contact-independent mechanisms. 
 Contact-dependent mechanisms 1.2.6.1.
1.2.6.1.1. Adhesion 
Essential step of infection is adhesion. It is an important microbial property that facilitates 
colonisation and persistence. Anti-adhesion therapies could be helpful in the treatment of diseases caused 
by Acanthamoeba. Adhesion in Acanthamoeba seems to be a necessary process in its pathogenesis and is 
mediated by adhesion-receptors. Adhesion to host cells of Acanthamoeba is used during initial step when 
proceeding to the deeper tissue and to avoid being cleared out during the onset of the disease (Alsam et 
al., 2005). A protein, known as Mannose Binding Protein (MBP) seems to play a role in adhesion of 
Acanthamoeba to the host. It is expressed on the surface of Acanthamoeba. Adhesion of Acanthamoeba 
leads to the next process, which is called phagocytosis (Alsam et al., 2005). 
1.2.6.1.2. Phagocytosis 
Phagocytosis is an actin-dependent process for Acanthamoeba because it leads to host cell 
damage. Although this process is associated with the uptake of food, it is still very important in 
30 
 
 
pathogenesis (Marciano-Cabral and Cabral, 2003). Acanthamoeba feed on bacteria using similar 
processes as outlined above (section 1.2.3).  
The bacteria uptake by Acanthamoeba is a receptor-dependent process and is performed by MBP 
which is expressed on the surface of Acanthamoeba (Allen and Dawidowicz, 1990). This protein is also 
involved in the early events of Acanthamoeba binding to the host cells which indicates its important role 
in infection (Morton et al., 1991; Yang et al., 1997; Alsam et al., 2003).  
Physiological actions of serine proteases are brought about by the proteinase-activated receptors 
(PAR’s) of host cells. These are responsible for bringing out cellular responses to infection, inflammation 
or injuries (Vu et al., 1991). The active role of PAR’s take place upon proteolytic cleavage of their N-
terminus by serine proteases. This cleavage displays the ligand domain of the receptors which combine to 
the cleaved receptor and activate it. 
1.2.6.1.3. Ecto-ATPase activities 
Ecto-ATPases (Ectoserine Triphosphate diphosphatase) are presented in plasma membranes. The 
active sites of Ecto-ATPase face the external environment which indicates that Ecto-ATPase may be 
involved in surface membrane interactions between parasites and their host cells. Ecto-ATPase are 
considered as necessary for safety from cytolytic effects of Adenosine triphosphate (ATP), cellular 
adhesion, the regulation of Ecto-kinase substrate concentration, the elimination of signalling and the 
environment involvement of signal conversion, showing that Ecto-ATPase may play crucial roles in the 
pathogenesis of Acanthamoeba (Sissons et al., 2004). 
 Contact-independent mechanisms 1.2.6.2.
Extracellular proteases of Acanthamoeba are one of the contact independent factors which target 
cells in close environment that leads to the death of the host cells as well as degradation of the epithelial 
basement membrane and underlying stromal matrix (Cao et al., 2008). 
Proteolytic enzymes or proteases are a group of enzymes which catalyze the degradation of 
peptide bonds. In parasitic protozoa the major pathogenicity determinants are proteases which damage 
the cell directly. There are three types of proteases present in Acanthamoeba such as extracellular serine 
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proteases, cysteine proteases and metalloproteases. Acanthamoeba proteases have been identified as 
harmful factors in AGE, AK and disseminated infections (Sissons et al., 2006a).  
To study Acanthamoeba extracellular proteases, zymography has been employed in several 
studies (Ferrante and Bates, 1988) where it has been found to contain elastase activity. It has been shown 
that elastase may play role in invasion of host tissue by destroying host protective barriers and tissues. 
They did not find any difference in levels of elastase between pathogenic and non-pathogenic strains, 
which suggests that it is not a virulence factor. It may play other important roles in Acathamoeba species. 
Cytopathic effects occur when the serine proteases of Acanthameoba have been involved in inducing host 
cell apoptosis (Garate et al., 2004). Proteases from T1 genotype of A. castellanii have been found to play 
an important role in overcoming blood brain barrier during AGE when increasing the permeability by 
45%. A 150 kD metalloprotease and 130 kD serine protease were found to be highly expressed in this 
strain and they were found to be capable of inhibiting collagen I and III, elastin, plasminogen, casein, and 
haemoglobin; but they failed to cause any cytotoxicity to Human Brain Microvascular Endothelial Cells 
(HBMEC) on their own (Alsam et al., 2005).  
Comparison of protease activity in pathogenic and non–pathogenic Acanthamoeba strains 
showed a significant difference. Pathogenic strains produce increased levels of protease activity and bring 
about higher levels of cytotoxicity. Extracellular proteases of pathogenic Acanthamoeba strains were 
found to be capable of disaggregating epithelial cells. One of the proteases identified was a 107 kDa 
serine protease (Lorenzo-Morales et al., 2005). 
1.2.7. Acanthamoeba used as a Trojan horse to carry MRSA  
Historically, Greeks constructed a huge wooden horse, and hid a select force of men inside. In 
biological setting, a Trojan horse can be pro-drug delivering cytotoxins to tumour cells, and endocytic 
pathway ferring nanoparticles across a cell membrane into a target cell or cell carrying a pathogen, across 
a biological barrier. In this case, the last mentioned example coincides with the case of Acanthameoba. 
Acanthamoeba is considered to be the Trojan horse of the microbial world which is crucial clinically and 
environmentally (Siddiqui et al., 2012). The presence of Acanthamoeba spp. in critically ill patients may 
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be advantageous to potentially pathogenic bacteria in urine, protecting them against antimicrobial drugs, 
disinfectants and host immunity. In this way, Acanthamoeba spp. may be a supply for pathogenic 
bacterial agents in severely ill patients or, as Khan et al described, a "Trojan horse for bacteria" (Santos et 
al., 2009). Acanthamoeba is a single-cell amoeba, which commonly eats and digests environmental 
bacteria. Inside Acanthamoeba, the pathogenic multi-drug resistant bacteria MRSA survive and replicate 
(Cardas et al., 2012). Acanthamoeba protects the pathogens; however, the bacteria survive and replicates 
inside Acanthamoeba instead of being digested (Alsam et al., 2005). In harsh conditions, Acanthamoeba 
is more likely to form cysts which act as a carrier for spreading MRSA. It was discovered that the 
pathogens become more virulent and more resistant to antibiotics if they first infect an amoeba and then 
emerge from it (Moon et al., 2011). It was also discovered that the amoebae and other protozoans help in 
persistence of MRSA in the hospital environment. The researchers found that in 24 hrs of its introduction, 
MRSA had infected around 50% of the amoebae in a sample (Saxena and Gomber, 2008). For MRSA, an 
amoeba acts like a site that helps it to become fitter and more pathogenic. 
Generally, bacteria need to follow certain molecular pathways in order to breakthrough a living cell. The 
same method takes place when the MRSA invades Acanthamoeba (Alsam et al., 2005). Thus it is 
essential to study the signalling pathways in order to identify the ones through which the MRSA invades 
the Acanthamoeba.  
1.3. The role of signalling proteins in Acanthamoeba and bacteria interaction  
1.3.1. The role of Protein tyrosine kinase and Protein tyrosine phosphatase: 
Tyrosine kinase, a subfamily of the protein kinase which is the protein that work as an "on" or 
"off" switch in many cellular functions by phosphorylating substrates at tyrosine, serine or threonine 
residues. These are mainly involved in cellular signal transduction. Tyrosine kinases consists of two 
major families: one is the trans-membrane receptor linked kinases and other one is cytoplasmic protein/ 
non-receptor proteins (Bhise et al., 2004). 
At the present time, approximately 2000 kinase proteins are known among which 90 protein 
tyrosine kinases are known to be found in human genome. Of the 90 protein tyrosine kinases, 58 are the 
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receptor tyrosine kinase (RTK) and 32 are cytoplasmic proteins. RTKs play crucial role in maintaining 
the cellular homeostasis; likewise in differentiation, cell survival, cell death and adhesion. There are three 
prominent domains in RTKs: one is the extracellular domain, required for the binding of specific ligand, 
a trans-membrane domain and an intracellular catalytic domain, which plays important role in activation 
of downstream signalling.  
Most of the RTKs are involved in the activation of two major pathways, phosphoinositide 3-
kinase (PI3K)/ AKT (Franke, 2008) and Rat sarcoma (Ras)/Mitogen-Activated Protein Kinase (MAPK) 
pathways, which play a pivotal roles in cell survival and cell proliferation. These receptors activate these 
two pathways through several signalling molecules (Kris et al., 2003; Navis et al., 2010). 
1.3.2. Phosphatidylinositol 3-kinase (PI3K): 
There are 15 kinase proteins in Phosphotidylinositol 3-Kinase and all of them have their own 
distinct substrates specificity, expression patterns and mode of actions. PI3 kinases mainly involved in 
the catalysing of the synthesis of phosphatidylinositol phosphate (PI), phosphatidylinositol-4,5-
bisphosphate (PIP2) and phosphatidylinositol-3,4,5-trisphosphate (PIP3). These three lipid derivatives are 
involved in the cellular physiological processes like cell growth, survival, differentiation, and chemotaxis  
(Katso et al., 2001).  
The PI3K/Akt pathway gets started with the activation of PI3K by RTKs (Figure 1.10). Activated 
PI3K phosphorylates the PIP2 (3'-hydroxyl group of phosphatidylinositol 4,5 diphosphate) in PIP3 binds 
to Phosphoinositide-dependent kinase-1 (PDK1) and Akt, resulting in the autophosphorylation of PDK1. 
Phosphorylated PDK1 transphosphorylates Akt protein along with various proteins (Engelman et al., 
2006; Franke, 2008). It is highlighted that the pathway branches below the node occupied by Akt to 
influence many cellular processes promoting other pathways such as cycle progression, cell growth, 
energy metabolism and resistance to apoptosis (Knowles et al., 2009).  
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 Signalling response of host to Acanthamoeba. Acanthamoeba causes cell cycle arrest through Figure1.10.
disruption of gene regulation, pRB phosphorylation modulation and as part of the PI3K pathway. 
Acanthamoeba also inhibit tight junctions through interference with zonula-1 and occluding proteins. 
MBP (Mannose-Binding Protein) binds at the membrane causing inhibition of E2F (a proliferation-
inducing transcription factor). PIP2 (phosphatidylinositol-4,5-bisphosphate) and PIP3 
(phosphatidylinositol-3,4,5-trisphosphate) are recruited following membrane protein activation, further 
recruiting the PH domain of Akt (protein kinase B). Kinases are essential in this pathway for signal 
transduction to give rise to apoptosis, cell proliferation, and angiogenesis (Khan, 2009). 
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The PI3K enzymes have prominent involvement in various patho-physiology which makes them 
important therapeutic targeting sites. PI3K serves as the major component of insulin signalling and 
moreover has prominent roles in inflammation and autoimmune disease, thrombosis, viral infection, and 
cancer.  
Protein tyrosine phosphatases are a cluster of enzymes that take away phosphate groups from 
phosphorylated tyrosine residues on proteins. Protein tyrosine (pTyr) phosphorylation is a common post-
translational adjustment that can generate novel recognition themes for protein interactions and cellular 
localization, affect protein steadiness, and manipulate enzyme function. As a result, sustaining a suitable 
level of protein tyrosine phosphorylation is crucial for a number of cellular functions. Tyrosine-specific 
protein phosphatases catalyse the elimination of a phosphate group bound to a tyrosine residue, by means 
of a cysteinyl-phosphate enzyme intermediate. These enzymes are essential regulatory ingredients in 
signal transmission pathways, and are important in the control of cell growth, proliferation, 
differentiation, transformation, and synaptic plasticity (Navis et al., 2010).   
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1.4. Antimicrobial agents and therapeutic strategies 
1.4.1. Photodynamic Therapy (PDT) 
 The principle of photodynamic therapy (PDT) 1.4.1.1.
Photodynamic therapy (PDT) is used to treat a wide range of medical conditions including 
malignant cancers and it is a non-invasive and minimally toxic treatment strategy (Moan and Peng, 
2003). PDT is a treatment that involves Photosensitizer (PS), light source and molecular oxygen within 
biological tissue. The wavelength of the light source needs to be fit for photosensitizer excitation and 
energy transfer to produce reactive oxygen species (ROS) such as radicals and singlet oxygen (Chen et 
al., 2002; Moan and Peng, 2003). The combination of these three components leads to the chemical 
destruction of the tissues that have taken up the photosensitizer and have been locally exposed to light 
(Figure 1.11).  Photosensitizers absorb the energy of light of specific wavelength, which excites the 
electrons from ground singlet stage (SO) to an excited singlet stage (SI). Photosensitizer can return to 
ground state through fluorescence or non-radioactive decay; it may change into intersystem crossing and 
enter excited triplet state (T1). Molecular oxygen is present in ground triplet state and so an energy 
transfer can occur between the triplet state of photosentiser and molecular oxygen; the energy transfer 
comes out in the generation of singlet oxygen (Tacelosky et al., 2012).  
 
  
37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Jablonski diagram depicting changes in molecular electronic states associated with Figure1.11.
photodynamic therapy (Tacelosky et al., 2012).  
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Photosensitizer molecules are usually excited from ground state to a short lived excited singlet 
state S1 and S2, on absorption of light. Following excitation, fast radiation less relaxation processes yield 
the excited triplet state T1 (Figure 1.10). It is considered there are two methods by which photosensitizers 
can act: 
a) The radical-type hypothesis: Electron transfer processes are increased on excitation of a 
photosensitizer molecule and results in reducing an electron and oxidizing hole.  
b) The singlet oxygen hypothesis: Singlet oxygen (
1
O2) is the cytotoxic agent responsible for the photo-
inactivation of the tissue.  The generation of 
1
O2 results from energy transfer upon the interaction of 
excited photosensitizers with the molecular oxygen. The interaction of singlet oxygen with intracellular 
targets subsequently leads to the damage of cell membranes, mitochondria, lysosomes and nuclei, 
inducing tissue necrosis (Ochsner, 1997; Chen et al., 2002).  
 Applications of Photodynamic Therapy 1.4.1.2.
One of the major PDT applications is the treatment of skin conditions notably, acne, psoriasis 
and also skin cancers. The PS can be applied topically and locally which is excited by a light source. In 
the local treatment of internal tissues, PS should be introduced to the targeted area first and then, light can 
be delivered using endoscope or fibre-optic catheter (Silva et al., 2006). PDT has also previously been 
used to kill pathogenic microorganisms in vitro, but its use to treat infections in animal models or patients 
has not, as yet, been developed (Hamblin and Hasan, 2004; Wu et al., 2006). PDT was also used to 
decontaminate blood and bone marrow samples before transfusion or transplant procedures (Boumédine 
and Roy, 2005). One study in Hong Kong confirmed that PDT was the tool to eradicate the rising 
incidence of multidrug-resistant (MDR) pathogens such as MRSA and extended-spectrum β-lactamase 
(ESBL)-producing Escherichia coli. The photodynamic inactivation (PDI) mediated by poly-L-lysine 
chlorine (e6) conjugate (pL-ce6) and toluidine blue O (TBO) showed a high efficacy against pathogens 
under investigation in a light- and drug dose-dependent matter. (Tang et al., 2007). 
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A great amount of photosensitizers have been assessed for possible clinical use. Numerous of 
these photosensitizers absorb light below 600 nm, thus restricting their therapeutic use to superficial 
lesions. The treatment of thicker tissue layers needs photosensitizers that absorb light above 600 nm. A 
huge number of photosensitizers with such a characteristic have been evolved in the last 20 years, and are 
presently being evaluated in clinical trials, largely for different cancers. The peculiarities of these 
photosensitizers to target lesions are still too low, current and future research is concentrated on 
technologies to unravel this problematic situation (Photosensitizers in Medicine, 2009). 
 Photodynamic inactivation (PDI) of bacteria 1.4.1.3.
There have been additional reports of bacteria being killed or inactivated by various 
combinations of PS and light, since many years have passed using PDT. It was discovered that there were 
fundamental differences in susceptibility to PDT between Gram (+) and Gram (-) bacteria. In the last 
decade, it has been found that, in general, neutral or anionic PS molecules are efficiently bound to and 
photodynamically inactivate Gram (+) bacteria, whereas they are bound only to the outer membrane of 
Gram (-) bacterial cells and do not inactivate them after illumination (Hamblin and Hasan, 2004). The 
cytoplasmic membrane of Gram (+) is surrounded by a porous layer of peptidoglycan and lipoteichoic 
acid that allows PS to cross and make it highly susceptible (Hamblin and Hasan, 2004). Whereas, the cell 
envelope of Gram (-) bacteria consists of an inner cytoplasmic membrane and an outer membrane, which 
are separated by the peptidoglycan-containing periplasm (Figure 1.12). In the outer membrane, several 
different proteins are present. Some of them function as pores to allow the passage of nutrients, whereas 
others have an enzymatic function or are involved in maintaining the structural integrity of the outer 
membrane and the shape of the bacteria. Therefore, the outer membrane forms a physical and functional 
barrier between the cell and its environment.  
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 The cell walls diagram of Gram (+) and Gram (-) bacteria (Jori et al., 2006). Figure1.12.
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Several scientific groups investigated  ways that would allow photodynamic inactivation (PDI) of 
Gram (-) species. Nitzan and co-workers conducted an experiment in which the permeability of the Gram 
(-) bacterial outer membrane was increased to  allow PS that are usually excluded from cell to penetrate 
to a location where the reactive oxygen species generated upon illumination could cause fatal damage by 
using the polycationic peptide polymyxin B nonapeptide (PMBN).  PMBN does not release 
lipopolysaccharide (LPS) from the cells, but ‘expands’ the outer leaflet of the membrane, allowing PS, 
such as deuteroporphyrin (DP), to penetrate and permitting the PDI of E. coli and P. aeruginosa 
(Ehrenberg et al., 1992). They demonstrated an interaction between PMBN and DP in solution, and 
speculated that this binding assisted the penetration. In another technique adopted by some groups was to 
use a PS molecule with an intrinsic positive charge. Wilson and co-workers used the phenothiazine 
Toluidine Blue O to carry out PDI on a wide range of both Gram (+) and Gram (-) bacteria. The growth 
phase of the bacteria did not make a large difference to their susceptibility to the PDI, though the 
presence of serum in the medium decreased killing. A scientific group in Italy has used cationic 
porphyrins [meso-tetra (N-methyl)-4- pyridylporphine tetraiodide and tetra-4-(N,N,N trimethylanilinium) 
porphine (Figure 1.13) to photoinactivate Gram (-) species, such as Vibrio anguillarum and E. coli  
(Wilson, 1992, 1993).  
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 Molecular structure of porphyrins.. A: meso-Tetra (N-methyl)-4- pyridylporphine tetraiodide. Figure1.13.
B: Tetra-4-(N,N,N trimethylanilinium) porphine (Wilson ., 1992 & 1993).  
 
 
 
 
A 
B 
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They deduced that washing the loosely-bound PS on the cells before illumination decreased the 
phototoxicity action of PS’s. They explained this finding by proposing that the first dose of light on the 
PS bound to the outside of the outer membrane causes initial limited photo damage that then allows the 
further penetration of the PS (Fuortes et al., 1996). The research group in the UK has used cationic 
phthalocyanines for PDI of Gram (-) bacteria (Minnock et al., 1996).  
An investigation on E.coli was performed in particular and the mechanism of uptake was studied. 
They found that incubation with zinc pyridiniumphthalocyanine (PPc) in the dark led to the increased 
sensitivity of the bacteria to hydrophobic antibiotics, such as erythromycin, (but not the hydrophilic). 
Incubation with PS also led to the increased uptake of radio-labeled protoporphyrin, a process that was 
reversed in the presence of up to 50 mM Mg
2+
 ions. These observations are consistent with the uptake of 
PPc proceeding through the self-promoted uptake pathway (Dahl et al., 1987, 1989). There are also 
reports of PDI of Gram (-) bacteria, clearly indicating that the PS does not have to penetrate the bacteria 
to be effective. Indeed, it does not even have to come into contact with the cells. According to this, if 
singlet oxygen can be generated in sufficient quantities near to the outer bacterial membrane, it will be 
able to diffuse into the cell and cause damage on vital structures (Dahl et al., 1989).    
         Since MRSA infection is resistant to different types of antibiotics, PDT treatment could be used as 
an alternative strategy to treat the infectious diseases caused by MRSA. According to studies, the 
antibody immunoglobulin G (IgG)-SnCe6 conjugate activated with red light eliminated MRSA bacteria. 
However, it worked only against a particular strain and at a particular growth phase. Therefore, antibody-
photosensitizer conjugate (Ab-SnCe6) was used, instead of IgG-SnCe6, due to its effectiveness on many 
strains of MRSA in all growth phases (Embleton et al., 2004). In contrast to PDT for cancer, where the 
PS is usually injected into the bloodstream and accumulates in the tumour, they believe that PDT for 
localised infections will be carried out by local delivery of the PS into the infected area by methods such 
as topical application, instillation, and interstitial injection or aerosol delivery. Therefore, the 
effectiveness of the treatment in destroying sufficient numbers of the disease-causing pathogens would be 
effective selectivity of the PS for the microbes, thus avoiding an unacceptable degree of PDT damage to 
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host tissue in the area of infection, and the avoidance of regrowth of the pathogens from a few survivors 
following the treatment (Hamblin et al., 2011a).  
Several chemical natural products with photosensitizing effects have been discovered, and some 
of these molecules are commercially obtainable. Various photoactive principles are natural compounds. 
Many reviews recently have concentrated on photodynamic therapy, its effects and applications, but less 
attention has been paid to plant extracts or compounds of natural origin investigated for their phototoxic 
activity to date.  
1.4.2. Natural products as antimicrobial agents 
 Psoralen  1.4.2.1.
Psoralea corylifolia, is a plant which has psoralen compound in its fruits. Psoralen (Figure 1.14) 
is a furanocoumarin which is the main active ingredient. A great number of biological properties are 
present in psoralen, such as preventing the proliferation of mucoepidermoid carcinoma, bladder 
carcinoma in vitro and mammary cancer cells (Liu et al., 2015). It has also been previously used to treat a 
number of conditions such as vitiligo, alopecia areata and tinea. In addition, recent studies have identified 
a number of different plants that contain psoralen derivatives which were discovered to possess 
interesting biological properties (Liu et al., 2015). Psoralen is a mutagen, and is utilized for this aim in 
molecular medicine research. Psoralen interpolates into the DNA and, on exposure to ultraviolet 
radiation, can form monoadducts and covalent interstrand cross-links (ICL) with thymines preferentially 
at 5'-TpA sites in the genome, stimulating apoptosis. Psoralen plus UVA (PUVA) therapy has shown 
considerable clinical efficacy (Wu et al., 2005). 
 Eugenol 1.4.2.2.
Eugenol is a phenolic compound that is present in clove oil, bay leaves, cinnamon and basil 
(Figure 1.15). It has many uses and one of the most important application in medicine is as an antiseptic 
as well as a local anaesthetic (Liang et al., 2015). A number of researchers have revealed the anti-
Candida biofilm potential of plant-derived chemicals such as flavonoids (Cao et al., 2008), and essential 
oils (Khan and Ahmad, 2012). Eugenol is the foremost active phenylpropanoid constituent of the 
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essential oil among various aromatic plants (De Vincenzi et al., 2000). The inhibitory activity of eugenol 
alone and in combination with fluconazole and amphotericin B in contrary to planktonic cells of Candida 
spp. has been earlier informed. Moreover, eugenol can mediate with the initial stages of biofilm 
formation, along with the viability of developed biofilm of Candida albicans (Khan and Ahmad, 2012). 
Various antimicrobial agents can affect the manifestation of staphylococcal exotoxins, and eugenol, an 
essential oil ingredient in plants, has been stated to have activity against both Gram-positive and Gram-
negative bacteria. It is crucial to study the effects of eugenol on the expression of the major exotoxins 
produced by both methicillin-sensitive and resistant S. aureus (De Vincenzi et al., 2000).  
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 Molecular structure of Psoralen (PSO). Figure1.14.
 
 
 
 
 
 
 
 Molecular structure of Eugenol. Figure1.15.
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Hypothesis and Aims 
The interaction of Acanthamoeba with MRSA and MSSA is distinct as some bacteria 
phagocytised by Acanthamoeba survive intracellularly. This has clinical and environmental importance 
as Acanthamoeba has some similar phagocytic activities with macrophages. The molecular mechanisms 
which play a role in Acanthamoeba phagocytosis still remain unclear despite numerous studies on 
Mannose-Binding Protein and its role in Acanthamoeba interactions. The overall aim of this part of the 
project was to study the role of protein tyrosine kinases, protein tyrosine phosphatase, and 
phosphatidylinositol-3 kinase (PI3K), which modulate a variety of cellular events, including growth, 
structure, function, migration and cell death was investigated.  
The overuse and misuse of antibiotics has led to the emergence of multi-drug resistant 
microorganisms such as MRSA. The subsequent constant demand for the exploration of novel strategies 
and antimicrobial agents for eradication is essential. To this end, photodynamic therapy was used as a 
novel promising approach against pathogenic bacteria which involves the usage of visible light, oxygen 
and a photosensitizer. The second aim of the present study was to demonstrate the ability of m-THPC and 
psoralen photosensitizers to bind to MRSA, MSSA and Acanthamoeba, and efficiently generate reactive 
oxygen species upon photostimulation.  
Finally, natural products have attracted much attention as additional and/or replacement of 
antibiotics. It is difficult, but vital, to develop treatments capable of eliminating pathogenic organisms. 
Eugenols have attracted much attention and were documented to have antimicrobial properties. It is 
hypothesized that they could be effective against pathogenic microorganisms that are resistant to 
conventional drugs. Here, the efficacy of eugenols on the microorganisms under investigation was 
studied. Four novel eugenols (EN1-EN4) were tested against the survival of Acanthamoeba castellanii 
genotype T4 and the clinical MRSA and MSSA isolates.      
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  Acanthamoeba interactions with Staphylococcus aureus Chapter 2.
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2.1. Background 
Staphylococcus is a genus of bacteria that can cause diseases in the human body, including 
superficial infections such as boils, abscesses, and wound infections. In addition, the microbes can also 
cause septicaemia, endocarditis and pneumonia, skin exfoliation and toxic food poisoning (Greenwood et 
al., 2007). Over 30 different species of Staphylococci can infect humans, but most infections are caused 
by methicillin-sensitive Staphylococcus aureus (MSSA) (Greenwood et al., 2007). The application of 
multiple antibiotics led to the emergence of methicillin-resistant Staphylococcus aureus (MRSA). 
Treatment is problematic because this microbe is sensitive to very few antibiotics. 
The genus Acanthamoeba consists of both pathogenic and non-pathogenic strains. Acanthamoeba 
can cause Acanthamoeba Granulomatous Encephalitis (AGE), a fatal central nervous system (CNS) 
infection (R J Gordon and Lowy, 2008) and Amoebic Keratitis (AK), a painful sight-threatening disease 
of the eyes. Acanthamoeba species also have been associated with cutaneous lesions and sinusitis in 
AIDS patients and other immune-compromised individuals (Marciano-Cabral and Cabral, 2003).  
In addition to its direct role in causing human and animal infections, it is now well established 
that Acanthamoeba acts as a host for various bacterial pathogens including Legionella pneumophila, 
Coxiella burnetii, Pseudomonas aeruginosa, Vibrio cholera, Helicobacter pylori, Listeria monocytogenes 
and Mycobacterium avium and may act as a vector to transmit these pathogens to susceptible hosts 
(Alsam et al., 2006). 
The feeding of Acanthamoeba on bacteria starts with the adhesion of bacteria to Acanthamoeba 
cell membrane. This leads to secondary processes such as phagocytosis and toxin secretion. The 
ecological significance of Acanthamoeba phagocytosis is in the uptake of food particles, such as bacterial 
and fungal cells. However, several studies have shown that phagocytosis plays an important role in the 
pathogenesis of Acanthamoeba (Niederkorn et al., 1999). This is shown by the use of cytochalasin D, 
cell-permeable and potent inhibitor of actin polymerization. It dislocates actin microfilaments and 
stimulates the p53-dependent pathways triggering detention of the cell cycle at the G1-S transition. 
cytochalasin D inhibited Acanthamoeba -mediated host cell death, confirming that actin-mediated 
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cytoskeletal rearrangements play an important role in Acanthamoeba phagocytosis. The molecular 
mechanisms associated with Acanthamoeba phagocytosis still remain unclear despite a few studies on 
mannose-binding protein and its role in Acanthamoeba interactions (Alsam et al., 2005; Khan, 2006). 
Bacteria, in general, need to follow certain molecular pathways in order to invade a living cell. Thus it is 
essential to study the signalling pathways of Acanthamoeba interaction with MRSA in order to identify 
the involvement of three major specific enzymatic pathways such as tyrosine kinase, PI3K, and tyrosine 
phosphatases.  
Tyrosine kinase is the subfamily of the protein kinases. These are the proteins which are mainly 
involved in the switching on and off the protein by phosphorylating substrates at its tyrosine residues. 
These proteins are mainly involved in cellular signal transduction. Tyrosine kinases compromise of two 
major families: the transmembrane receptor linked kinase family and the cytoplasmic protein/non-
receptor protein family (Bhise et al., 2004). Among the 90 tyrosine kinase proteins, 58 are receptor 
tyrosine kinases (RTKs) and 32 are cytoplasmic proteins. RTKs play crucial roles in maintaining the 
cellular homeostasis; likewise in differentiation, cell survival, cell death and adhesion (Robinson et al., 
2000). 
 PI3K is a big family of 15 kinase proteins, and all of them having their own distinct substrate 
specificity, expression patterns and mode of action. PI3K is involved in cellular physiological processes 
such as cell growth, survival, differentiation, and chemotaxis (Figure 2.1) (Katso et al., 2001). 
Assessment of PI3K’s role in various processes is done using either PI3K mutants or chemical inhibitors 
of PI3K, such as LY294002 and wortmannin. The use of LY294002, which specifically attaches to the 
ATP binding site of PI3K and thereby selectively inhibits its catalytic activity, showing PI3K is required 
for phagocytosis. PI3K is known to be involved in actin reorganisation; a process that is required for 
phagocytosis, and most likely affects phagocytosis via this route (Alsam et al., 2005).  
Acanthamoeba is known to promote host cell death via the apoptotic pathway. It has been shown 
using LY294002 that host apoptosis is induced by Acanthamoeba in a PI3K dependent mechanism 
(Siddiqui and Khan, 2012).  
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Figure 2.1. PI3K signalling pathway. Bacteria  bind with Acanthamoeba cell membrane receptor, such as 
RTK (Receptor Tyrosine Kinase) which activates PI3K. Activated PI3K phosphorylates PI(3,4)P (PIP2) to 
produce PI(3,4,5)P (PIP3). PIP3 in turn, recruits Phosphoinositide-dependent kinase (PDK1) to the 
Acanthamoeba cell membrane that phosphorylates and activates Akt (Planchon et al., 2008). 
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Tyrosine phosphatases, alkaline phosphatases and certain ATP-ases can be inhibited by sodium 
orthovanadate (Na3VO4). It contains a vanadate ion (VO4
3-
) that is similar in structure to phosphate ions, 
therefore acting as their analogue. It competes with phosphate ions to bind to the active sites of tyrosine 
protein phosphatases, but unlike phosphate ions, the binding is irreversible for most tyrosine protein 
phosphatases (Figure 2.2). Inhibition of tyrosine protein phosphatase in Acanthamoeba has been shown 
to enhance the phagocytosis of E. coli (Khan, 2006).  
  Tyrosine kinase protein could be inhibited by a specific drug, genistein (4,5,7-
Trihydroxyisoflavone). It is an isoflavone derivative and is a natural product obtained from plants. It has 
not yet been ascertained how genistein specifically blocks tyrosine kinases and not others, such as 
serine/threonine kinases (Alsam et al., 2005).  
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Figure 2.2. Tyrosine kinase–mediated signal for actin polymerisation in Acanthamoeba. The signal for 
actin polymerisation is given by an unidentified protein that is the target of phosphorylation/dephosphorylation 
by tyrosine protein kinases/phosphatases. Genistein, which is an inhibitor of tyrosine kinase, prevents 
activation of this protein and therefore stops the signal for actin polymerisation. Na3VO4, which is an inhibitor 
of tyrosine phosphatase, prevents dephosphorylation of the activated protein, thereby ensuring that actin 
polymerisation continues (Onsum et al., 2007).  
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2.2. Materials and Methods 
 
All the chemicals for this study were bought from Sigma Laboratories (Poole, Dorset, England), 
unless otherwise stated.  
2.2.1. Acanthamoeba culture 
For this study, Acanthamoeba castellanii protozoan was used. It is a clinical isolate (AF239303) 
from a keratitis patient kindly provided by Dr Maciver, University of Edinburgh. Acanthamoeba was 
cultured without shaking in a PYG [proteose peptone 0.75% (w/v), yeast extract 0.75% (w/v) and glucose 
1.5% (w/v)] medium. The PYG medium utilized for the growth of Acanthamoeba was obtained in T-75 
tissue culture flasks incubated at 30°C (Sissons et al., 2004).  
2.2.2. MSSA and MRSA strains cultures 
Two strains of each MRSA and MSSA were used in this project. MRSA and MSSA which had 
been isolated from blood samples of patients with septicaemia, kindly provided by Dr Tony Elston, 
Colchester NHS Trust Hospital. The bacterial isolates were grown weekly on Cysteine Lactose 
Electrolyte Deficient agar (CLED) plates. Prior to each experiment, bacteria were inoculated in a Luria-
Bertani (LB) medium and incubated at 37C overnight. For each bacterial strain, the optical density (OD) 
was measured at 595 nm. 
2.2.3. Invasion assays 
Invasion assays were performed to study the ability of bacteria to invade or be taken up by A. 
castellani. Acanthamoeba was cultured in 24-well plates to confluence (5 x 10
5
 amoebae or cells/well), 
followed by the addition of inhibitors and MRSA or MSSA (1 x 10
8
 CFU/mL) in a 0.5 mL final volume 
of Roswell Park Memorial Institute medium (RPMI). After 1 hr of incubation in RPMI, the wells were 
washed once with Phosphate Buffered Saline (PBS) and then vancomycin (100 µg/mL, final 
concentration) was added for 45 min to kill the extracellular bacteria. Acanthamoeba was washed with 
500 µL (PBS) and lysed with 0.5% SDS and then cultured onto CLED plates, incubated at 37°C   and 
bacterial colonies were counted. The proportion of intracellular bacteria was counted as follows: number 
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of bacteria recovered (CFU)/number of bacteria inoculated at the start of the experiment x 100 (Alsam et 
al., 2006). 
2.2.4. Labelling of MRSA and MSSA 
MRSA and MSSA strains were labelled with fluorescein isothiocyanate (FITC) by adopting 
previous methods (Alsam et al., 2005). MRSA and MSSA strains were grown in a shaker overnight at 
37°C in one litre LB broth [Bactotryptone 1 % (w/v), 0.5% yeast extract (w/v), 0.5% NaCl (w/v)]. The 
following day, the bacteria were heat-killed at 65°C for 30 min. Cultures were then centrifuged at 
10,000x g for 10 min and the pellet re-suspended in PBS. This process was repeated 3 times and finally 
the pellet was re-suspended in 1 mL PBS. The residue of MRSA and MSSA bacteria’s substances were 
incubated with FITC (1 mg) in a carbonate-bicarbonate buffer, pH 9.4 (0.2 M Na2CO3 (w/v) mixed with 
O.2M NaHCO3 (w/v) on a shaker for 30 min at room temperature in the dark. The cells were rinsed 4 
times as above to remove unbound FITC. Finally, the pellet was re-suspended in one mL PBS and stored 
at - 20°C in 0.5 mL aliquots each containing 3.5 x 10
7
 FITC-labelled MRSA and MSSA (Rohloff et al., 
1994). 
2.2.5. Phagocytosis Assays 
 Acanthamoeba uptake of FITC-labelled heat killed bacteria 2.2.5.1.
Acanthamoeba castellanii was incubated on sterile cover slips in 24-well plates in a PYG 
medium (5 x 10
5
 amoebae/mL PYG/well). Then plates were incubated for 17-20 h. The following day, 
cells were washed with PBS for 3 times to remove non-adherent A. castellanii and then incubated in 400 
µl PBS. Phagocytosis was initiated by adding 1.5 µl containing 10
5
 FITC-labelled MRSA and MSSA to 
each well. Plates were incubated for 25 min at room temperature in the dark to maintain the integrity of 
the bound FITC. Next, Acanthamoeba cells were washed with PBS for 3 times to remove any non-
adherent materials, this was followed by the addition of 400 µl of Trypan blue solution [final conc. 1%, 
(w/v)] for 5 min to quench the fluorescence of extracellular bacteria by binding to FITC-binding site and 
suppressing it. Finally, Acanthamoeba cells were gently washed with PBS for 5 times. A. castellanii was 
56 
 
 
fixed with 96% methanol at 20 °C for 15 min and observed under a fluorescent microscope (Alsam et al., 
2005).  
 Invasion of live bacteria inside Acanthamoeba  2.2.5.2.
A few colonies of each bacterium were inoculated into 10 mL LB medium and incubated at 
37 °C overnight. Next day, bacteria were centrifuged at 3000 RPM for 10 min and the pellets were 
washed two times with PBS. Following centrifugation and washing, the pellets were resuspended in 1 
mM (final concentration) Rose Bengal and incubated at 37 °C for 20 min. Next, 10
6
 Acanthamoeba 
trophozoites /mL were detached, centrifuged (3000 RPM for 3 min) and washed twice with PBS. Then, 
10,000 bacteria per Acanthamoeba were added in a final volume of 500 µL RPMI 1640 and incubated for 
1 h. Following 1 h of co-culture, cells were harvested by centrifugation (3000 RPM for 3 min). Then, the 
Acanthamoeba with bacteria were centrifuged and washed once with PBS. Cell suspensions with 
intracellular bacteria (10 µL) were pipetted on slides followed by coverslip application for 10 min at 
room temperature to allow the infected cells to settle and form a monolayer. The intracellular location of 
bacteria was assessed using the fluorescence microscope (Alsam et al., 2005). 
2.2.6. Determination of Phagocytic activity 
The percentage of Acanthamoeba engulfing bacteria was determined in order to quantify the 
phagocytic activity. Briefly, using a 20X objective, seven fields were randomLy selected. Within these 
fields, all Acanthamoeba, with or without bacteria, were counted and their percentage was determined as 
follows: % phagocytosis = Acanthamoeba engulfing bacteria / total Acanthamoeba x 100 
2.2.7. Statistical Analysis 
             The results are displayed graphically or tabulated with standard error representing the 
standard deviations of triplicate measurements. Differences are considered to be significant using the 
unpaired t-test with P < 0.05. 
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2.3.  Results 
2.3.1. Invasion assays  
To determine the molecular mechanisms associated with the engulfment of bacteria by 
Acanthamoeba, several pathways were studied using different inhibitors as mentioned in materials and 
methods. Two strains of each MRSA and MSSA were used in these experiments.  
 MRSA and MSSA Invasion Assays   2.3.1.1.
Genistein, LY294002, wortmannin and protein tyrosine phosphatase inhibitor, Na₃VO₄ were 
used. All inhibitors were dissolved in vehicles with non- cytotoxic  concentrations (Figure 2.3) 
Acanthamoeba T4 was pre-treated for 30 mins with these inhibitors before incubation with bacteria 
followed by incubation with MRSA1 for one hr. After this incubation, vancomycin was added to kill the 
extracellular bacteria, which were lysed and cultured as described in Methods. In general, use of the 
various inhibitors resulted in decrease of the level of invasion of MRSA1. The lowest level of MRSA1 
invasion was noticed when wortmannin was used (0.036% compared with the control 0.118%) (P<0.05 
using paired t-test, one-tail distribution). Na₃VO₄ reduced the bacterial invasion by 0.029% compared 
with T4 control (P<0.05 using paired t-test, one-tail distribution). LY294002 and genistein had minimal 
effect (0.014% and 0.015% reduction) (Figure 2.4A). Invasion experiments were repeated using MRSA2 
strain in which a similar result pattern was noticed as shown in Figure 2.4B. The lowest level of MRSA2 
invasion was noticed when wortmannin and Na₃VO₄ were used. In both cases the percentage was 
0.028% compared with the control 0.083% (P<0.05 using paired t-test, one-tail distribution). Minimal 
effect was noticed when genistein and LY294002 were used (0.052% and 0.063% respectively).   The 
lowest level of MSSA1 invasion was when protein tyrosine kinase inhibitor, genistein, was used: 0.042% 
in comparison with 0.135% the control sample (Figures 2.4C). Followed by Na₃VO₄, wortmanin and 
LY204002 (0.049%, 0.058% and 0.083% respectively) (P<0.05 using paired t-test, one-tail distribution). 
Simililarly, use of the various inhibitors resulted in decrease of the level of MSSA2 invasion. As 
indicated in Figure 2.4D, all inhibitors significantly reduced bacterial uptake by Acanthamoeba (P<0.05 
using paired t-test, one-tail distribution). This further confirmed the dependency of Acanthamoeba 
phagocytosis on intracellular signalling pathways. 
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Figure 2.3. Cytotoxic effects of vehicles (Methanol, Ethanol and DMSO) on Acanthamoeba T4. Genistein 
inhibitor was dissolved in DMSO (0.5%); PMSF in Methanol (5%); LY294002 in DMSO (0.5%); 
Wortmannin in Ethanol (5%); Na3VO4  in distilled water. Acanthamoeba was grown until confluence in 24 
well plates. All reagents with their final concentrations were added and incubated for 30 mins. The control 
wells were added RPMI. After incubation viability of cells were identified using Trupan Blue.   
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Figure 2.4. Effect of four inhibitors  on MRSA1 (A); MRSA2 (B); MSSA1 (C); MSSA2 (D); invasion in 
Acanthamoeba.  Acanthamoeba was cultured in 24-well plates and pretreated with inhibitors (100 μM of 
wortmannin, 100 μM of genistein, 100 μM of LY294002, and 100 μM of Na₃VO₄) for 30 mins before bacteria 
addition. After 1 hr of co-incubation, extracellular bacteria were killed. Acanthamoeba was washed, lysed and 
cultured onto CLED plates. The next day bacterial colonies (CFU) were counted. These results represent data 
of three independent experiments in duplicate. Error bars represent standard error. * p< 0.05 
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* 
* 
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D) 
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 Acanthamoeba engulfs heat-killed FITC-labelled MRSA and MSSA 2.3.1.3.
 
To simplify the phagocytosis process, assays were developed using heat-killed FITC-labelled 
MRSA and MSSA. The aim of using heat-killed bacteria was to identify the uptake of bacteria, excluding 
bacterial own invasion. Generally invasion process of bacteria inside the Acanthamoeba involves two 
processes in parallel. Bacteria is engulfed by Acanthamoeba as well as bacteria are penetrating 
themselves. To estimate and study the role of Acanthamoeba engulfment only by exclusion bacterial 
invasion gives the possibility to clarify phagocytosis process. In addition, we observed that trypan blue 
can be used to quench fluorescence of FITC (Figure 2.5). These bacteria were subsequently used in 
phagocytosis assays. It was observed that the Acanthamoeba uptake of MRSA was higher than the uptake 
of MSSA: 25 % and 14 % respectively (Figure 2.6) (P<0.05 using paired t-test, one-tail distribution).  
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(a) MRSA (FITC- labelled, under fluorescence 
microscope) 
 
 
(b) MSSA (FITC- labelled,  under fluorescence 
microscope) 
 
 
 
 
 
 
 
 
(c) MRSA (FITC- labelled, under light microscope) (d) MSSA (FITC- labelled, under light microscope) 
 
 
(e) MRSA (FITC- labelled followed by Trypan blue 
treatment, under light microscope) 
(f) MSSA (FITC- labelled followed by Trypan blue 
treatment, under light microscope) 
Figure 2.5. MRSA and MSSA strains were successfully labelled with fluorescein isothicyanate 
(FITC). A, C, & E are MRSA; B, D, & F are MSSA. Bacteria were grown overnight at 37°C in LB 
broth. The next day, bacteria were heat-killed at 65°C. Cultures were centrifuged at 10,000x g for 10 min. 
Bacteria were incubated with FITC on a shaker for 30 min at room temperature in the dark. The cells were 
rinsed 4 times to remove unbound FITC. Pellet was re-suspended in one mL PBS and stored at - 20°C. 
4μm 
4μm 4μm 
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(a) A. castellani under light microscope 
 
(b) A.castellanii + MSSA (FITC-labelled) followed by 
trypan blue treatment under fluorescent microscope. 
 
(c) A. castellanii with FITC labelled followed by 
trypan blue treatment under light microscope. 
 
(d) A. castellanii +MRSA (FITC-labelled) followed by 
trypan blue treatment under fluorescent microscope. 
 
(e) A.  castellanii with FITC labelled followed by 
trypan blue treatment under light microscope. 
 
Figure 2.6. Acanthamoeba castellani isolate phagocytosing FITC-labelled MRSA and MSSA. 
Acanthamoeba was incubated on sterile cover slips in 24-well plates in a PYG medium (5 x 10
5
 amoebae 
/well). Plates were incubated for 17-20 h. The next day, cells were washed. Phagocytosis was initiated by 
adding 1.5 µl containing 10
5
 FITC-labelled bacteria for 25 min. Next, Acanthamoeba cells were washed, and 
followed by the addition of Trypan blue to quench the fluorescence of extracellular bacteria. Finally, 
Acanthamoeba cells were gently washed and fixed with 96% methanol at 20 °C and observed under a 
fluorescent microscope       
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20μm 
20μm 
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 Invasion of live bacteria inside Acanthamoeba  2.3.1.4.
To visualize whether the bacteria invaded or were phagocytised by Acanthamoeba, Rose Bengal-
labelled MRSA and MSSA were used. As a result bacteria were able to invade or be engulfed by 
amoebae. Following 1 h co-culture at a multiplicity of infection of one cell: 10 bacteria, fluorescence 
microscopy showed that the MRSA presence in Acanthamoeba was higher than that of MSSA: 19 % and 
11 % respectively (Figure 2.7) (P<0.05 using paired t-test, one-tail distribution).  
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Figure 2.7. MRSA and MSSA labelled with Rose Bengal. MRSA under the light microscope alone (a), 
MRSA bacteria inside Acanthamoeba (b), under fluorescent microscope (c). Labelled with Rose Bengal 
MSSA under the light microscope alone (d), MSSA bacteria inside Acanthamoeba (e), and under fluorescent 
microscope (f). A few colonies of bacteria were inoculated in LB broth and incubated at 37 °C overnight. Next 
day, bacteria were centrifuged at 3000 RPM and pellets were re-suspended in 1 mM Rose Bengal and 
incubated at 37 °C for 20 min. Next, 10
6
 Acanthamoeba were detached, centrifuged and washed. Then, 10 
bacteria per Acanthamoeba were added and incubated for 1 h. Following 1 h of co-culture, cells were 
harvested and the Acanthamoeba with bacteria inside were centrifuged and washed. Cell suspensions with 
intracellular bacteria (10 µL) were pipetted on slides followed by coverslip application. The intracellular 
location of bacteria was assessed using the fluorescence microscope 
 
 
 
 
 
 
 
 
 
 
a )  b )  c )  
d )  e )  f )  
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2.3.2.  Phagocytic activity assays  
 
Phagocytic activity assays were performed in the presence of various chemical compounds 
including LY294002, inhibitor of phosphoinositide 3-kinases (PI3Ks); Na₃VO₄, inhibitor of protein 
tyrosine phosphatases and alkaline phosphatases; Genistein, tyrosine kinase inhibitor; and PMSF, serine 
protease inhibitor. All of the agents inhibited bacterial uptake. LY294002 had the greatest inhibiting 
effect , which reduced uptake by 88%, and least effective was PMSF which decreased bacterial uptake by 
53%. Na₃VO₄ and genistein reduced engulfing by 85% and 83% respectively (Figure 2.8). 
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Figure 2.8. Phagocytic activity of Acanthamoeba after treating with inhibitors: LY294002 (100µM), 
Na₃VO₄ (100µM), genistein (100µM) and PMSF (1mM). Data is representative of three independent 
experiments (P<0.05 using paired t-test, one-tail distribution). The percentage of Acanthamoeba engulfing 
bacteria was determined in order to quantify the phagocytic activity. Briefly, using a 20X objective, seven 
fields were randomLy selected. Within these fields, all Acanthamoeba, with or without bacteria, were counted 
and their percentage was determined as follows: % phagocytosis = Acanthamoeba engulfing bacteria / total 
Acanthamoeba x 100. 
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2.4. Discussion 
It is well known that Acanthamoeba acts as a host for several types of bacteria, and their ability 
to host bacterial pathogens, such as Legionella pneumophila, has gained specific attention. However, the 
detailed molecular mechanisms associated with Acathamoeba-bacteria interactions remain unclear. 
Acanthamoeba feeds on bacteria, but how these bacteria interact with Acanthamoeba needs to be 
elucidated. Here, MRSA and MSSA interactions with Acanthamoeba were studied. This might be the 
first study which focuses on Acanthamoeba and its interactions with MRSA and MSSA.   
Several lines of evidence suggest that PI3K plays an important role in host cell cytoskeletal 
remodelling processes, such as phagocytosis, pseudopod formation and trafficking (Wymann and Pirola, 
1998; Cox et al., 1999). For example, it has been shown that PI3K controls Rho-mediated changes in 
actin cytoskeleton in fibroblasts (Reif et al., 1996; Cantrell, 2001). Here it was observed that LY294002, 
a specific PI3K inhibitor, reduced Acanthamoeba invasion by MRSA and MSSA. This is in line with the 
findings of Alsam, et al (2006) who found that PI3K played an important role in Acanthamoeba 
interaction with E. coli. Similar results were found in the present study; LY294002 was used on 
Acanthamoeba and two strains of bacteria, MRSA and MSSA. The use of this inhibitor led to a reduction 
of the bacterial invasion of Acanthamoeba. 
Other commonly used inhibitors of PI3K include wortmannin. Wortmannin inhibits all PI3-
kinases but only at high concentrations at which it may affect PI3K-like enzymes, such as mTOR, MAP 
Kinase, PI4- kinases, and some other enzymes (Alsam et al., 2005). This inhibitor was also tested in the 
present study on Acanthamoeba and the bacterial strains: MRSA and MSSA which resulted in a 
significant inhibition of the PI3K pathways; a reduction of the number of bacteria that invaded the 
Acanthamoeba was noted in comparison with the control sample. 
Another inhibitor is Na₃VO₄ which is used to inhibit protein tyrosine phosophatase. It was found 
that Na₃VO₄ causes an increase in the Acanthamoeba uptake of  E.coli (Sissons et al., 2004; Alsam et al., 
2005). However, the present study used Na₃VO₄ to investigate the role of protein tyrosine phosphatase in 
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Acanthamoeba invasion by MRSA and MSSA which showed contradictory results. It was found that a 
significant reduction of the bacterial invasion was noted in comparison with the control sample. 
Phagocytosis plays an important role in the pathogenesis of Acanthamoeba (Palusinska-Szysz et 
al., 2014). Nevertheless, the detailed molecular mechanisms related to Acanthamoeba phagocytosis 
remain vague. In this study, we made use of FITC-, and Rose Bengal labelled MRSA and MSSA to study 
processes involved in the phagocytosis of Acanthamoeba. LY294002, inhibitor of phosphatidylinositol 3-
kinase, inhibited phagocytosis of macrophages (Cox et al., 1999). Pretreatment of Acanthamoeba with 
LY294002, resulted in reduction of bacteria (MRSA and MSSA) uptake by 88%. Na₃VO₄, protein 
tyrosine phosphatase inhibitor, decreased bacteria engulfment by 85%, genistein, protein tyrosine kinase 
inhibitor decreased by 83%. Among the inhibitors used the lowest inhibitory effect was of PMSF, serine 
protease inhibitor, which reduced phagocytosis by 53%. Overall our data shows that all these enzymes 
play role in phagocytosis. To conclude, these findings propose that particle uptake in Acanthamoeba is a 
multifarious process that could play a substantial role, both in food uptake as well as the pathogenesis of 
this protozoan. A comprehensive understanding of the molecular mechanisms related to this process 
might help identify therapeutic targets against this important pathogen. 
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 Extracellular Proteases of Acanthamoeba castellanii Chapter 3.
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3.1. Background 
  
3.1.1. Extracellular serine proteases  
Extracellular serine proteases are known for various roles in a variety of organisms. In higher 
eukaryotes, serine proteases are involved with the blood coagulation pathway (thrombin, etc.) and 
digestive enzymes (chymotrypsin, trypsin, etc.), and other functions (Gensberg et al., 1998; Thorburn et 
al., 2003; Wang et al., 2006; Kawabata and Muta, 2010). Extracellular serine proteases are believed to 
play a role in cell adhesion (Del Rosso et al., 2002). Phenylmethylsulfonyl fluoride (PMSF) is a serine 
protease inhibitor. PMSF binds irreversibly to the serine residue present in the active sites of serine 
proteases by replacing the hydrogen present in the hydroxyl group of serine’s side chain. PMSF does not 
bind to all the serine residues present in proteins, only to those present at the active site of serine 
proteases due to the hyperactive nature of these proteins. Serine proteases of Acanthamoeba are involved 
in various processes required for pathogenesis, such as making the Blood-brain barrier permeable and the 
encystment of cells (Figure 3.1) (Alsam et al., 2005; Dudley et al., 2008). Previous researches have 
shown that pathogenic strains of Acanthamoeba contain more serine proteases than non-pathogenic 
strains (Khan et al., 2000).  
Phagocytosis is one of the important factors that cause the pathogenesis of Acanthamoeba. The 
actual detailed mechanism responsible for the process of phagocytosis remains vague. In this study the 
role of extracellular serine proteases on Acanthamoeba phagocytosis was investigated.  
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 Acanthamoeba secretes serine proteases that target tight-junction proteins between cells. Figure 3.1.
Parasites contribute to corneal epithelial cell damage, leading to Acanthamoeba entry into the 
cornea(Lorenzo-Morales et al., 2015). 
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3.1.2 Proteomics and 2D gel electrophoresis 
Proteomics is defined as the qualitative and quantitative comparison of proteomes under different 
conditions to further unravel biological processes and study the structure and function of proteins. A 
proteome is a complete set of proteins expressed by the genetic makeup of an organism in a specific set 
of environmental conditions. The application of mass spectrometry (MS) for analysing proteomics is a 
powerful tool for characterising proteins (Cravatt et al., 2007). The classical method for analysing 
complex protein mixtures is the separation of the mixture by two dimensional gel electrophoresis of 
polyacrylamide (2D-PAGE) and the identification of proteins resolved by elution, digestion, and MS or 
tandem mass spectrometry (MS/MS) (Issaq and Veenstra, 2008). In contrast to the genome, the proteome 
of an organism is dynamic in nature due to post-translational protein-transcribed (Aebersold and Cravatt, 
2002) changes. In addition genomics and transcriptomics, proteomics is important because proteins 
represent actual functional molecules in cells (Wilkins et al., 2006). The identification of potential new 
drugs to treat diseases is one of the most promising developments to come from the study of human 
proteins (Abu-Farha et al., 2009). This is based on information proteomics gather to identify proteins 
associated with a disease that  computer software can then use as targets in the design of new drugs (Abu-
Farha et al., 2009). The entire set of proteins expressed by a genome, cell, tissue, or organism is a 
proteome (Andersen et al., 2005). 2D-PAGE is a method which utilizes to separate complex protein 
samples that applies isoelectric focusing (IEF) using immobilized pH-gradient (IPG) dry strips in the first 
dimension and sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) in the second 
dimension. The advantages of this method are: complete amount of proteins can be analysed at one time, 
high resolution of the protein by isoelectric point (pI) and molecular mass, comparison between resolved 
proteins spots for different conditions and use them for MS analysis. The disadvantages of this technique 
include difficulty detecting low molecular weight, as the time varies between the gels, the limited range 
(PI) proteins, and the unwieldy acidic, basic, and hydrophobic protein extremes (Aebersold and Cravatt, 
2002; Zhu et al., 2010). Recent studies have concluded that the key to improving recovery factors is 
hydrophobic proteins’ presence of urea and thiourea as a chaotropic agent in the cell lysate buffer 
(Chevallet et al., 1998; Rabilloud, 1998). 
74 
 
 
3.2. Materials and Methods 
 
All the chemicals for this study were bought from Sigma Laboratories (Poole, Dorset, England) 
unless otherwise stated.  
3.2.1. Acanthamoeba culture 
The clinical isolate of Acanthamoeba castellanii (ATCC 50492) was grown in tissue culture 
flasks in PYG medium as described in section 2.2.1. 
3.2.2. MSSA and MRSA strains cultures 
Two strains of each MRSA and MSSA were used in this project. MRSA and MSSA were grown 
as described in section 2.2.2. 
3.2.3. Invasion assays 
Invasion assays of MRSA and MSSA strains with Acanthamoeba T4 (ATCC 50492)  were 
performed as described in sections 2.2.3, 2.2.4 and 2.2.5. 
3.2.4. Acanthamoeba Conditioned Medium (CM) preparation 
 
            T-75 cell culture flask of Acanthamoeba was put on ice for 30 mins. Detached Acanthamoeba was 
collected and centrifuged for five min at 3000 RPM. The supernatant was discarded and the pellet was re-
suspended in the PYG medium and incubated at 30 °C overnight and the growth was observed. The next 
day supernatant was discarded and the pellet was re-suspended in RPMI. Additionally incubated 
overnight at 30 °C and centrifuged at 3000 x g for 5 mins. Finally, the supernatant (CM) was collected to 
be later purified.  
3.2.5. Acanthamoeba protein purification 
  The extracellular protein samples of Acanthamoeba were purified with modification to the 
methods reported (Cho et al., 2000). The precipitated debris was removed by centrifugation at 8500 x g 
for 15 mins. Acanthamoeba supernatant was concentrated with a concentrator GE healthcare Vivaspin 
20. The fractionated supernatant solution was dialysed against the 50 mM Tris-HCl buffer for 12 hrs at 4 
°C. The dialysate solutions were concentrated by lyophilisation then dissolved in 10 mL of 50 mM Tris-
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HCl (pH 7.5). The protein culture samples were applied to an ion exchange chromatography column 
using Diethylethanolamine (DEAE) Sepharose Fast Flow Flash chromatography (1.6 x 15cm), 
equilibrated with a 50 mM Tris-HCl (pH 7.5) buffer, and washed with the same buffer at a flow rate of 45 
mL/h. Fractions containing proteolytic activity were pooled, dialysed against distilled water at 4 °C, and 
lyophilised. The lyophilised preparation was re-dissolved in 50 mM Tris-HCl (pH 8.0) containing 1 M 
ammonium sulfate and applied to chromatography on Phenyl Sepharose CL-4B hydrophobic interaction 
chromatography (1.8 x 10 cm) equilibrated with the same buffer.  
Adsorbed proteins were eluted by using a linear gradient from 1 M to 0.1 M ammonium sulfate. The 
active fractions were pooled, dialyzed against distilled water at 4 °C, and lyophilized. The lyophilized 
preparation was resolved in 50 mM Tris-HCl (pH 8.0) and applied to a chromatography on Sephacryl S-
200 HR gel filtration (1.5 x 78 cm) equilibrated with the same buffer. Fractions (1.7 mL/fraction) of the 
eluate were collected and dialyzed against distilled water. Protein concentration was measured by the 
method of  Lowry et al. (1951) with bovine serum albumin (BSA) as the standard (Cho et al., 2000). 
3.2.6. Zymographic assays 
To study the effect of serine proteases on Acanthamoeba interaction with bacteria, zymographic 
assays were performed. Acanthamoeba CM was blended (1:1) with the sample buffer (0.5 M Tris, pH 
6.8), glycerol 0.11 M, 0.2 M of 10% SDS, 0.05% (w/v) bromophenol blue, and electrophoresed on SDS-
PAGE containing fish gelatine (4% w/v). After electrophoresis, the gels were soaked in 2% Triton x-100 
(w/v) solution for 60 mins, incubated in a developing buffer (50 mM Tris-Hcl, pH 7.5 containing 10 mM 
CACL2) at 37 °C overnight, and then washed and stained with Comassie Brilliant Blue. In the gel, the 
non-staining parts represent bands of gelatine digestion. In some experiments, samples were treated with 
PMSF (an inhibitor of serine proteases; 1 mM final concentration), which was found to be the most 
effective in inhibiting Acanthamoeba extracellular proteases (Alsam et al., 2005).  
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3.2.7. Two-dimensional (2-D) gel electrophoresis 
 First-dimensional gel IEF  3.2.7.1.
Immobiline 11 cm dry-gel strips with a pH range of 3 – 10 (GE Healthcare Bio-Sciences AB) 
were rehydrated in a dry-strip tray reswelling tray. The dried strip was rehydrated for 24 hrs at room 
temperature in 300 µl of a rehydration buffer (7 M urea, 2 M thiourea, 4 % CHAPS, protease inhibitor 
cocktail 1X, 20 mM DTT, 1 % ampholyte, Bromophenol Blue 0,1 %, 0.05 % SDS) containing 60 μg of 
the protein sample. The IPG strip was covered using ~3 mL immobiline dry-strip cover fluid, PlusOne 
(GE Healthcare Bio-Sciences AB). After rehydration, the IPG strip was gently rinsed with purite water to 
remove any crystallized urea. The strip subjected to isoelectric focusing was IPG Phor-cleaned with a 
cleaning solution Strip holder (GE Healthcare Bio-Sciences AB).The Ettan IPG Phor3 was switched on 
and connection with the IPG Phor3 control software was established. The IPG Phor mainfold was 
covered with 108 mL of Immobiline PlusOne dry-strip cover fluid and the rehydrated strips were then 
placed in individual lanes of the Ettan IPG strip holder (GE Healthcare Bio-Sciences AB) under the fluid 
using tweezers with the positive end towards the anode end of the main fold. Paper electrode wicks were 
placed between the IPG strips and the electrodes. The cathodic (negative) filter wick was rehydrated with 
150 µL of 100 mM DTT. The anodic (positive) filter wick was hydrated with 150 µL Purite water. 
The lid was closed and the IPG-Phor program was implemented according to the following 
schedule. (Görg et al., 1988, 1995, 2000). 
Step 1. 500 V 6 hrs  
Step 2. 1000 V 7 hrs 4 mins  
Step 3. 6000 V 2 hrs  
Step 4. 8000 V 2 hrs 22 mins  
Step 5. 200 V 1 hr  
 At the end of the programme, the computer was disconnected and IPG-Phor was stopped. The 
paper electrode wicks were removed with tweezers and discarded. The IPG strips were placed in a Petri 
dish, rinsed briefly with deionized water, labelled, and stored at -80
o 
C for later use.  
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 Equilibration of the IPG strips 3.2.7.2.
Before the second dimension gel run, the IPG strips comprising isoelectrically focused proteins 
were equilibrated and reduced. First, the strips were incubated for 15 mins with 10 mL of equilibration 
buffer containing 100 mg of DTT. After that strip was incubated for another 15 mins with 10 mL of the 
equilibration buffer containing 250 mg of iodoacetamide, incubation time was at room temperature for 
both steps. The IPG strips were equilibrated, the equilibration buffer first containing 1% DTT and then 
containing 4 % iodoacetamide for 15 mins each at room temperature. Running buffer for SDS-PAGE 
(stock solution SX): Tris 15g, glycine (G8898) 72g, SDS 5g, make up to 1000mL with distilled water. 
Adjust pH to 8.3 with HCI. Dilute to 1X with distilled water prior to use. IPG strips were rinsed with 1X 
running buffer before placing on the second-dimension gel (Amersham Biosciences).  
 Assembly and running of second-dimensional gel  3.2.7.3.
An agarose sealing solution was heated to liquid status. IPG strips were cut from each end up to 
0.6 cm, to a final length of 11 cm. A small square of felt paper electrode (2 x 3 cm of average thickness) 
was loaded with 10 µL of molecular weight marker and placed in the upper left corner of the gel. The 
IPG strip was placed in the well of 12 % SDS-PAGE gel with the acid side facing the glass plate of the 
hinge and sealed with the agarose solution, avoiding air bubbles. The electrophoresis tank was filled with 
0.5 L of the gel running buffer. The gel strips were removed from the casting assembly and cut off on the 
protein core unit tank. The central unit was lifted into the tank. The cover was mounted in the tank and 
the cable connected to the power PAC (Bio-Rad, Power Pac 1000). Electrophoresis was carried out first 
at 50 V for 30 mins and then at 150 V for approximately 2 – 3 hrs or until the bromo-phenol blue dye 
front had reached the lower end. The core unit was then removed from the tank and gels were removed 
from the clamps. The spacers were loosened and an edge of the glass plate was lifted with a spatula. Gel 
was placed in a gel glass container containing fixative solution. 
 Protein visualisation  3.2.7.4.
For visualization of protein spots a modified silver staining protocol was constructed (Yan et al., 
2000; Gromova and Celis, 2006). Gels were washed with 20 % methanol for 20 mins with changing the 
wash buffer thrice and then sensitized with 0.02 % sodium thiosulfate and washed with purite water 
78 
 
 
twice, each for 1 min. Staining was performed with 0.2 % silver nitrate solution for 20 mins followed by 
a careful wash twice with ultra-pure water for a maximum of 1 min each time. The gels were developed 
with sodium carbonate 6 % and 0.0004 sodium thiosulfate for 2-5 mins until spots appeared, and process 
was terminated by adding 12 % acetic acid and shaked  for 10 mins. The gels were stored in 12 % acetic 
acid at 4
 o
C. 
 Gel image capture and spot analysis  3.2.7.5.
The gels were scanned using the Epson scanner image III with LabScan 6.0 software. First, the 
scanner was calibrated and configured to use the transparent setting to 300 dpi with a blue filter. The 
surface scanner was cleaned with 70% ethanol and some purite water that was poured on the surface. The 
gel was placed directly into the scanner preview and air bubbles were smoothed out. Then, the scanning 
area of the gel was selected and scanned. Gel images were saved as MEL and TIF files. Gel scanned 
images were characterised with the software package Progenesis SameSpot (Nonlinear Dynamics 
Limited, UK). 
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3.3. Results 
3.3.1. Effect of Acanthamoeba serine proteases on bacterial uptake 
 
To determine the effect of Acanthamoeba extracellular proteases on bacterial uptake, 
Acanthamoeba was treated with PMSF, serine protease inhibitor. Although, the results vary for the two 
types of bacteria, MRSA and MSSA, it is evident that the percentages of bacteria uptake by 
Acanthamoeba has increased in the absence of extracellular serine proteases (Figure 3.2). The highest 
increase of invasion was in the MRSA1 strain where the presence of PMSF inhibitor increased the 
invasion by two-fold in comparison with the control sample 0.118 % and 0.215 respectively (P<0.05 
using paired t-test, one-tail distribution).   
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 Effect of serine protease inhibitor (1 mM of PMSF) on bacterial invasion in Acanthamoeba. Figure 3.2.
Acanthamoeba was cultured in 24-well plates and pretreated with inhibitors PMSF (final concentration 
1mM) for 30 mins before bacteria addition. After 1 hr of co-incubation, extracellular bacteria were killed. 
Acanthamoeba was washed, lysed and cultured onto CLED plates. The next day bacterial colonies (CFU) 
survived were counted. These results represent data of three independent experiments in duplicate. Error 
bars represent standard error. * p< 0.05  
 
 
 
 
 
 
 
 
 
 
 
 MRSA1                 MRSA2   MSSA1                   MSSA2 
* * 
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To visualize Acanthamoeba uptake of bacterial strains, heat-killed FITC-labelled of MRSA and 
MSSA were used. Acanthamoeba was pre-treated with PMSF (1mM), serine protease inhibitor before 
performing interaction assays with bacteria. From images taken, it is evident that the number of both 
types of bacteria has increased when inhibition of extracellular serine proteases carried out (Figure 3.3).   
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 Fluorescence of labelled MRSA without PMSF treatment (a), MRSA with PMSF treatment Figure 3.3.
(b), MSSA without PMSF treatment (c) and MSSA with PMSF treatment (d). Acanthamoeba was 
incubated on sterile cover slips in 24-well plates in a PYG medium (5 x 10
5
 amoebae /well). Plates were 
incubated for 17-20 h. The next day, cells were washed and pre-treated with 1mM PMSF. Phagocytosis 
was initiated by adding 1.5 µl containing 10
5
 FITC-labelled bacteria for 25 min. Next, Acanthamoeba 
cells were washed, and followed by the addition of Trypan blue to quench the fluorescence of 
extracellular bacteria. Finally, Acanthamoeba cells were gently washed and fixed with 96% methanol at 
20 °C and observed under a fluorescent microscope. 
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3.3.2. Zymographic assays 
The effect of serine protease inhibitor (PMSF) on expression level of T4 extracellular proteases is 
shown in (Figure 3.4) Acanthamoeba was incubated with and without the inhibitor in RPMI for 24h. 
Medium was collected, centrifuged and tested for the presence of proteases using zymography assays and 
fish gelatin as a substrate because Acanthamoeba produces little amount of extracellular serine proteases. 
Using 1 mM of PMSF was enough to inhibit the production of serine proteases totally. Analysis of 
proteases from keratitis-causing Acanthamoeba has shown that the presence of a 130 kDa protease was 
inhibited by PMSF. Two types of gel were used, one with fish gelatine and another without. The reason 
for using two different gels is to compare the sufficiency of conventional SDS gel to track bands from 
Zymographic gel. Gelatine was used since extracellular proteases degrade the compound allowing bands 
of degradation to be tracked on the gel. Further analysis with mass spectrometry was needed to determine  
the sequence and identity of the extracellular proteases. This would validate the findings and correlate 
with the existing proteins identified in databases. Using mass spectrometry at the School of Biological 
Sciences at Essex University was discussed however, that appeared to be too costly and therefore, it was 
decided to continue with the 2 D gel electrophoresis. Therefore, the 2 D gel electrophoresis was the only 
method used in this respect.  
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 A) Acanthamoeba T4 CM incubated with 1 mM of PMSF overnight at 30 °C. The non-Figure 3.4.
staining parts represent bands of gelatine digestion. B) Acanthamoeba T4 CM incubated with 1 mM 
of PMSF overnight at 30 °C without fish gelatine. Acanthamoeba CM was blended (1:1) with the 
sample buffer and electrophoresed on SDS-PAGE containing fish gelatine (4% w/v). After 
electrophoresis, the gels were soaked in 2% Triton solution for 60 mins, incubated in a developing buffer 
at 37 °C overnight, then washed and stained with Comassie Brilliant Blue. Samples were treated with 
PMSF, which was found to be the most effective in inhibiting Acanthamoeba extracellular proteases. 
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3.3.3. Two-dimensional gel analysis of serine protease inhibitor  
 
Acanthamoeba has been used in this study as a model, and the role of serine protease inhibitor (1 
mM of PMSF) has been investigated by two-dimensional gel electrophoresis followed by protein spot 
analysis.  
Qualitative and quantitative comparison of proteomes in Acanthamoeba CM under different 
conditions (with and without PMSF) was studied using 2D electrophoresis. It is the classical method for 
analysing complex protein mixtures by separation of the mixture and the identification of proteins 
resolved by elution, digestion, and mass spectrometry. In this method every spot is scattered according to 
its Molecular Weight and pH, which is very helpful in identifying the protein. 
The total proteome was separated by first-dimension isoelectric focusing on the basis of the 
proteins’ isoelectric points (pI). The isoelectrically focused proteins were then resolved by second-
dimension SDS-PAGE. Silver-stained protein spots in all cases challenged by 1 mM PMSF inhibitor 
(Figure 3.6) and an unchallenged control group which had 43 spots (Figure 3.5). Isoelectric point (pI) and 
molecular weight (MW) of 43 detected spots on 2-D gel were identified (Table 3.1). Gel images from all 
cases were then analysed using the Progenesis SameSpot software (Nonlinear Dynamics Limited), where 
the control untreated sample gel was used as a reference to find out differentially expressed proteins 
(Figure 3.7) (Table 3.2). Differentially expressed protein spots are circled with a blue colour. This data 
was used to gather preliminary results to discover the potential role of differential protein expression in 
response to a serine protease presence and the absence of a PMSF inhibitor. The PMSF inhibitor played 
an important role in inhibiting proteins (spots) in response to the serine protease. 
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 Representation of a reference image showing all differentially expressed spots circled with Figure 3.5.
the blue colour. The reference image used for image analysis that was carried out with Progenesis 
SameSpot software. Isoelectric points pI range is shown on the top, while the direction of second-
dimension SDS-PAGE is represented by an arrow on the left. 
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 Representative 2-D gel images of Acanthamoeba CM proteins untreated and treated with the Figure 3.6.
PMSF inhibitor of serine proteases. A1: untreated with 1 mM/mL of PMSF (0 – 100 kDa). A2: CM 
treated with 1 mM/mL of PMSF (0 – 100 kDa). B1: CM untreated with 1 mM/mL of PMSF (100 – 200 
kDa). B2: CM treated with 1 mM/mL of PMSF (100 – 200 kDa). In the first dimension, 50 µg total 
soluble CM was separated on immobiline IPG strips (11 cm, pH 3 – 10). IEF was performed on the IPG-
Phor unit. The second dimension was performed on 12% SDS-PAGE; gels were silver-stained and image 
B1 
B2 
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analysis was carried out with the Progenesis SameSpot software. M-molecular mass standards are shown 
on the right-hand side (kDa=kilo Daltons). 
Table 3.1 Specific protein spots identification. Isoelectric point (pI) and molecular weight (MW) of detected spots  
 
Spot number pI (pH) MW (kDa) 
107        5.6 90 
322 5.6 130 
351 5.5 133 
389 5.8 135 
682 5.9 120 
862 6.8 110 
1052 5.2 95 
1056 5.1 95 
1057 5.4 95 
1059 5.9 90 
1069 5.5 95 
1070 5.8 95 
1186 5.7 85 
1203 5.5 85 
1209 9 70 
1260 5 75 
1294 9.1 60 
1314 5.3 70 
1336 5.5 70 
1349 5.7 80 
1353 5.9 70 
1358 8.1 70 
1368 8 60 
1422 5.8 60 
1443 6.8 65 
1446 6.3 65 
1458 5.1 60 
1460 6.5 65 
1525 6 50 
1527 5.2 50 
1542 6.1 50 
1620 8.6 40 
1684 7 35 
1699 7 30 
1708 6.9 25 
1818 4.4 10 
1848 6 10 
1877 7.4 10 
1936 6.8 10 
1937 6.5 10 
1907 7.6 10 
2000 6 9 
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2022 6.1 9 
 
Table 3.2 Representation of spot numbers identified by the Progenesis SameSpot software. The spots up-
regulated (Spot+) or down-regulated (Spot-) in treated and untreated CM.  
 
Spot 
number 
(0 – 100) kDa 
Without inhibitor 
(0 – 100) kDa With 
inhibitor 
(100 – 200) kDa 
Without inhibitor 
(100 – 200) kDa With 
inhibitor 
107 Spot+ Spot+ Spot- Spot- 
322 Spot+ Spot- Spot+ Spot- 
351 Spot+ Spot- Spot+ Spot- 
389 Spot+ Spot- Spot+ Spot- 
682 Spot- Spot+ Spot+ Spot- 
862 Spot- Spot+ Spot- Spot- 
1052 Spot- Spot+ Spot- Spot- 
1056 Spot- Spot+ Spot- Spot- 
1057 Spot- Spot+ Spot- Spot- 
1059 Spot+ Spot+ Spot- Spot- 
1069 Spot+ Spot+ Spot- Spot- 
1070 Spot+ Spot+ Spot- Spot- 
1186 Spot+ Spot+ Spot- Spot- 
1203 Spot+ Spot+ Spot- Spot- 
1209 Spot- Spot- Spot- Spot- 
1260 Spot- Spot- Spot- Spot- 
1294 Spot- Spot- Spot+ Spot- 
1314 Spot+ Spot+ Spot - Spot- 
1336 Spot+ Spot+ Spot- Spot- 
1349 Spot+ Spot+ Spot+ Spot- 
1353 Spot+ Spot+ Spot- Spot- 
1358 Spot- Spot+ Spot- Spot- 
1368 Spot+ Spot- Spot+ Spot- 
1422 Spot+ Spot+ Spot- Spot+ 
1443 Spot+ Spot+ Spot+ Spot+ 
1446 Spot+ Spot+ Spot+ Spot+ 
1458 Spot+ Spot+ Spot- Spot- 
1460 Spot+ Spot+ Spot+ Spot- 
1525 Spot+ Spot+ Spot- Spot+ 
1527 Spot+ Spot+ Spot- Spot- 
1542 Spot+ Spot+ Spot- Spot+ 
1620 Spot- Spot+ Spot+ Spot- 
1684 Spot+ Spot+ Spot+ Spot- 
1699 Spot+ Spot- Spot+ Spot+ 
1708 Spot- Spot- Spot+ Spot- 
1818 Spot- Spot- Spot- Spot+ 
1848 Spot- Spot+ Spot- Spot- 
1877 Spot+ Spot+ Spot+ Spot- 
1936 Spot- Spot+ Spot- Spot- 
1937 Spot- Spot+ Spot- Spot- 
1907 Spot- Spot+ Spot+ Spot- 
2000 Spot- Spot- Spot+ Spot- 
2022 Spot+ Spot- Spot- Spot- 
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 3D representations of spots identified by the Progenesis SameSpot software. The results show  Figure 3.7.
spots up-regulated or down-regulated in treated and untreated CM stimulated with 1 Mm PMSF. 
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3.4. Discussion 
 
Analysis of proteases from keratitis-causing Acanthamoeba shows that the presence of a 130 kDa 
protease was inhibited by PMSF, which is known to inhibit serine proteases involved in the degradation 
of the extracellular matrix required for structural and functional maintenance of brain tissue. Thus it has a 
role in permeabilising the blood-brain barrier (Sissons, Alsam, Stins, et al., 2006). It is interesting that 
inhibition of serine proteases increased MRSA and MSSA uptake by Acanthamoeba. This is the first 
report to investigate this phenomenon, but it should be studied further.  
On addition of 1 mM PMSF in these experiments, 130 kDa band representing serine proteases 
inhibited, indicating inhibition of serine proteases. This data supports work by Alsam et al. (2005), in 
which it was demonstrated that PMSF addition abolished permeability changes due to serine proteases. 
However, the role of serine proteases in Acanthamoeba interactions with MRSA and MSSA are yet to be 
investigated. 
Phagocytosis is one of the most important factors that cause the pathogenesis of Acanthamoeba 
(Palusinska-Szysz et al., 2014). The actual detailed mechanisms responsible for the process of 
phagocytosis remain vague. This study explores and describes these mechanisms by studying FITC-
labelled bacteria phagocytised by Acanthamoeba. Those heat-killed FITC-labelled MRSA and MSSA 
bacteria were noticed inside the Acanthamoeba at 25% and 14%, respectively. Previous studies (Bowers 
and Olszewski, 1983) showed that Acanthamoeba uses two distinct pathways to uptake particles: 
pinocytosis and phagocytosis. The former is for the uptake of fluid particles and the latter is for the 
uptake of solid particles. The phagocytosis is receptor-mediated. The phagocytosis in Acanthamoeba is a 
complex process which might play an important role in both food uptake and the pathogenesis of this 
protozoan. Identifying the molecular mechanisms associated with phagocytosis may help identify 
therapeutic targets against this serious pathogen (Alsam  et al., 2005). 
In an effort to investigate the expression of novel proteins, treated and untreated Acanthamoeba 
CM was investigated. Two-dimensional gel electrophoresis is employed to obtain preliminary data about 
potential differential protein expression. 2-D is considered one of the most powerful tools for protein 
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separation and fractionation since its introduction in 1975 (Görg et al., 2000). The method has been 
improved over time to become a more robust tool for proteome analysis. At the same time, the robustness 
of 2-D is limited to samples with low complexity and subcellular fractions. Other limitations of 2-D 
include reproducibility, difficulty in separation of low molecular weight, and hydrophobic proteins. The 
method has a limited dynamic range (Issaq and Veenstra, 2008; Magdeldin et al., 2012), however it has 
yielded many novel proteins and discoveries in protein chemistry. In this study, 2-D was used to separate 
and fractionate the whole Acanthamoeba CM (treated and untreated) stimulated with 1mM PMSF 
inhibitor. 
Protein spots in the gels were made visible through silver staining and analysed by the 
Progenesis SameSpot software, as previously used in a number of studies (Amiour et al., 2012; Brasier et 
al., 2012; Brioschi et al., 2013). Results obtained from this analysis were used as preliminary data to 
identify differences among treated and untreated Acanthamoeba CM treated with 1 mM PMSF inhibitor.  
The results of this proteomic analysis revealed the resolution of a number of polypeptide spots. Forty 
three protein spots resolved at a given pI and molecular weights were identified. 
The protein search engine Uniprot was used for the analysis of the protein identity for a number 
of the forty three spots identified. This revealed potential useful results. For example, the polypeptide 
spot number 389 correlates with the receptor tyrosine-protein kinase erbB-2, which has a pI of ~5.8 and a 
MW of ~135 kDa.  The spot number 1260 could be related to the serine/threonine-protein kinase Nek11, 
which has a pI of ~5 and a MW of ~75 kDa. The spot number 351 with a pI of ~5.5 and a MW of ~133 
kDa (serine protease) could be related to the cell adhesion molecule, where oral immunisation reduced 
the severity of the corneal infection by modulating MMP-2 and MMP-3 expression (Siddiqui and Khan, 
2012). The spot number 322 played a role in the parasite adhesion to the host cell as a primary step and 
was mediated by a pI of 5.6 and MW of 130 kDa mannose binding protein (MBP) expressed on the 
surface of Acanthamoeba, which was spot number 351 (Alsam, Sissons, Jayasekera, et al., 2005). Finally, 
two superoxide dismutases have been identified in Acanthamoeba: an iron superoxide dismutase, which 
is spot number 1525 with a pI of 6 and an MW of ~50 kDa, and a copper-zinc superoxide dismutase, 
which is spot number 1699 with a pI of 7 and an MW of ~38 kDa (Siddiqui and Khan, 2012). 
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Acanthamoeba predominantly secrete serine proteases (Mitro et al., 1994; Leher et al., 1998; Khan et al., 
2000, 2001) of varying molecular weight: 12, 40, 42, 55, 70, 85, 97, 107, 130, 133, and 230 kDa 
reviewed in (Khan, 2006), all sensitive to the PMSF serine protease inhibitor.  
Further analysis of mass spectrometry is needed to identify the sequence and identity of the 
places of differentially regulated polypeptides.  
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 Photosensitizers as potential antimicrobial agents for Chapter 4.
Photodynamic Therapy applications 
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4.1. Background 
Acanthamoeba are free-living protozoa widely distributed in the environment and recognised as 
amebic agents of fatal encephalitis and amoebic keratitis, especially in humans with a compromised 
immune system (Marciano-Cabral and Cabral, 2003; Schuster and Visvesvara, 2004). Unfortunately, 
appropriate antimicrobial therapy for these infections is still lacking research and patient recovery is often 
problematic (Schuster and Visvesvara, 2004). Acanthamoeba protects and assists various bacteria in their 
dissemination in the environment, including MRSA (Cardas et al., 2012). Intracellular survival and 
growth of bacteria within Acanthamoeba can affect bacteria, making them more pathogenic to humans 
and more resistant to extracellular hazards such as antimicrobials and disinfectants (Adékambi et al., 
2006; Ohno et al., 2008). 
Staphylococcus aureus is the most common bacterium isolated from both community-acquired 
and nosocomial infections. S. aureus is known to rapidly develop resistance to antibiotics (Wright, 2003; 
Deurenberg and Stobberingh, 2009). Staphylococcal disease has increased in many countries, in both 
healthcare and community settings. Currently, MRSA accounts for more than half of nosocomial S. 
aureus infections in most countries (Jean and Hsueh, 2011). Due to limited therapeutic strategies, 
staphylococcal infections are often difficult to treat. Therefore, there is a need to develop alternative 
therapeutic methods for the treatment and prevention of MRSA infections. 
Because of the decreased number of antibiotics that can be used to treat MRSA infections, the 
need for new antimicrobial treatments has led to the investigation of photodynamic therapy (PDT). PDT 
is a treatment that utilizes a drug, called a photosensitizer or photosensitizing agent, and a specific type of 
light. When photosensitizers are exposed to a particular wavelength of light, they synthesize a form of 
oxygen that eradicates proximate cells (Hamblin et al., 2011b). Basically, PDT involves treatment of the 
microorganisms with a chemical activated by light, known as a photosensitizer (PS). When the cells to be 
killed are pathogenic microorganisms the procedure is termed photodynamic inactivation (PDI) 
(O’Riordan et al., 2006). The PS has no antimicrobial activity, after exposure to light of a wavelength 
that is capable of absorption; the PS undergoes a transition from a lower-energy "ground state" to a 
higher energy "triplet". In the triplet state, the PS can react with substrate molecules to produce free 
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radicals and free or molecular oxygen ions, resulting in the generation of singlet oxygen (Ochsner, 1997; 
Redmond and GamLin, 1999). Antimicrobial PDI may be a new approach to killing or eliminating 
pathogens that are infecting tissue. All studies that have examined the killing of antibiotic resistant 
bacteria by PDI have found them to be equally as susceptible as their native counterparts or even more 
susceptible (Tang et al., 2007). Moreover it has not as yet been possible to artificially induce resistance to 
PDI in any microbes where it has been tested (Lauro et al., 2002). 
4.1.1. Foscan 
Foscan contains temoporfin (meta-tetrahydroxy phenyl chlorin, m-THPC), a photosensitising 
agent that is activated with non-thermal light at 652 nm several days after intravenous administration. It 
has an oncolytic effect, intended for palliative photodynamic treatment of head and neck squamous cell 
carcinoma lesions in patients not curable with surgery and/or radiotherapy. The therapeutic effect is 
mediated through the generation of Reactive Oxygen Species (ROS), a process dependent on the 
intracellular interaction of temoporfin with light and oxygen. m-THPC is a second generation 
photosensitizer, approved in the EU in 2001 for the diagnosis and management of head and neck cancers. 
It is the one of greatest powerful photosensitizer categorized by a low required light amount and reduced 
skin photosensitivity as compared to other PS (Figure 4.1).  
In this study we tested a chlorin PS m-THPC, which is known as non-toxic to human cells 
compound .It has been shown to have antimicrobial efficacy against Enterococci (Ossmann et al., 2015). 
The effect of chlorin m-THPC was studied with bacteria under three various conditions: a) PS in absence 
of light in order to establish the chemical toxicity of m-THPC alone; b) in the presence of only 
internalised (intracellular) PS and blue light to determine its ability to penetrate the cell membrane and 
cause biological damage; and c) in the presence of extracellular m-THPC without internalisation and blue 
light. 
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 The chemical structure of meta- Tetra (hydroxyphenyl) chlorin Figure 4.1.
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4.1.2. Psoralens 
 
Psoralens are a class of planar aromatic molecules that can bind reversibly to single-stranded and 
double-stranded nucleic acids by intercalation (Figure 4.2). Psoralen illumination with long-wavelength 
ultraviolet light (UVA light, 320 – 400 nm), intercalated psoralens form mono adducts and interstrand 
crosslinks with RNA and DNA. In the absence of repair, the psoralen-modified genomes of viruses and 
bacteria are inactivated because transcription and replication cannot occur. Optimal amounts of psoralen 
and UVA illumination create sufficient nucleic acid alterations to overwhelm cellular repair capability. 
Additionally, it is reported to be preserved upon UVA illumination with psoralen (Abonnenc et al., 
2015). Another report, described an improved PCT process with psoralen derivatives application (Liu et 
al., 2015). Different concentrations of psoralens have been used and synthesized to optimise aqueous 
solubility, cellular permeability, enhanced nucleic acid intercalative binding, and increased photo-
reactivity with nucleic acids. Therefore, psoralen was exploited in this study to explore its inactivation 
potential against Acanthamoeba and bacteria with blue light illumination with the range of wavelength 
which is non-toxic to cells. Acanthamoeba and bacteria found to be inactivated with combination of 
psoralen and 12.5 J/ cm
2
 of blue light, significantly. 
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 Chemical structure of Psoralen Figure 4.2.
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4.2. Materials and Methods 
4.2.1. PDT/PDI protocols for bacteria  
 Dark toxicity 4.2.1.1.
 
For the determination of the dark toxicity of m-THPC, MRSA and MSSA bacteria were 
incubated with and without the highest concentration used under investigation of PS, in order to examine 
the chemical toxicity of the drug without the light. A single type of bacteria was inoculated into the 
assigned wells in the dark with m-THPC (10 µg/mL concentration) in a 24-well plate, then wrapped with 
aluminum foil and incubated for 24 h at 37 °C. Bacteria were cultured on CLED agars and were allowed 
to stand for 20 h in the incubator at 37 °C. Then they were enumerated and the survival ratios of bacteria 
were calculated as a percentage of control (bacteria without, PS). 
 Time course effect of the intracellular/internalized (m-THPC) only on MRSA and 4.2.1.2.
MSSA strains with light exposure 
m-THPC was prepared in RPMI 1640 in a brown glass vial for each bacterial strain. Bacteria 
MRSA1&2 and MSSA1&2 strains (2 µg/mL, 4 µg/mL, and 6 µg/mL) with OD 0.22 5 x 10
6
, (5 x 10
8
 
cfu/mL) were added separately to the above solution of m-THPC sample in the dark. The bacteria strains 
with m-THPC were added in Eppendorf tubes containing 500 µl RPMI in triplicate for each strain. In the 
meantime, bacteria without m-THPC were added as above and assigned as control samples. The bacterial 
samples with and without m-THPC were wrapped with aluminium foil and incubated at 37°C for 
MRSA1&2 and MSSA1&2 were incubated with PS (m-THPC) in RPMI 1640 (5 µg/mL) for 2 h, 6 h, 24 
h. The samples were agitated gently after one hr to distribute the m-THPC. The bacteria were then 
centrifuged and washed with RPMI media after each incubation time and taken into 24-well plates. The 
24-well plates were placed on top of a glass plate which was laid over the LumiSource
TM
 light (PCI 
Biotech, Norway) source as above and light irradiation was applied for 30 min., corresponding to a total 
light dose of 12.5 J/cm
2
. Once irradiated, the bacteria were cultured/counted after 2 h incubation of light 
exposure on agar plates. The numbers of viable bacteria with and without m-THPC and light treatment 
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were calculated and the results were presented as Log10 the number of bacteria with (+) m-THPC and 
without (-) m-THPC (bacteria without PS and exposed to light).  
The experiment was repeated and bacteria were incubated with m-THPC for several incubation 
periods (2 h, 4 h, 6 h, and 24 h) before light exposure. The bacteria were exposed to the blue light as 
above then cultured on agar plates after 2h of light exposure. 
 The phototoxic/PDI effect of in presence of extracellular (m-THPC) on MRSA1 and 4.2.1.3.
MSSA1 strains with light exposure (short incubation) 
m-THPC were prepared in RPMI 1640 (2 µg/mL) in a brown glass vial for each bacterial strains. 
Bacterial strains (MRSA1 and MSSA1) were incubated with m-THPC for 2 min. in 24 well plates. The 
plate was irradiated for 2 min., corresponding to a total light dose of 0.8 J/ cm
2
 with LumiSource
TM
 light 
in the presence of the extracellular m-THPC. Once irradiated, the bacteria were incubated for 24 h after 
light exposure at 37 °C. The bacteria then cultured on agar plates, as described above and the number of 
the percentages of viable bacteria were calculated against the control (bacteria without the m-THPC, and 
without light exposure).  
 Determination of minimum inhibitory concentration (MIC) of m THPC for MRSA. 4.2.1.4.
MRSA were incubated with and without a range of m-THPC concentration (0.2, 0.4, 0.6, 0.8, 1 
µg/mL) for 2 min. at 37 °C in the dark. The 24-well plates were placed on top of a glass plate which was 
laid over the LumiSource
TM
 light (PCI Biotech, Norway) source and light irradiation was carried out for 2 
min., corresponding to a total light dose of 0.8 J/cm
2
. Once irradiated, the bacterial samples with and 
without m-THPC were wrapped with aluminum foil and incubated for 24 h after light exposure at 37°C. 
The bacteria were cultured onto agar plates, as described above. The surviving bacteria with and without 
m-THPC and light treatment were calculated. The ratio between the numbers of viable bacteria and m-
THPC concentration doses were displayed as a chart and the MIC value was determined. The MIC value 
is the concentration of m-THPC that eliminated MRSA1 bacteria totally after 24 h of light exposure.   
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4.2.2. Phototoxicity/PDI effect of m-THPC on Acanthamoeba  
Acanthamoeba were incubated for 24 h in 24-well plates until reaching a confluent state. Next, 
the well plates were washed once with PBS. After washing, wells (in triplicates) containing 
Acanthamoeba were incubated with different concentrations of m-THPC (2, 4, 6 µg/mL) in RPMI 1640 
were added and plates were incubated at 30 °C for 1h. Wells also incubated with Acanthamoeba without 
PS in the same plate to see the effect of blue light only on Acanthamoeba. Additional plate with 
Acanthamoeba only without PS or light were incubated in the same way and assigned as control (CRTL). 
The excess of m-THPC was discarded and the well plates with Acanthamoeba were washed with PBS. 
The well plates were exposed to blue light for 20 min. (8 J/cm
2
), then were incubated overnight at 30 °C. 
Trypan blue (0.4 % concentration) was added and Acanthamoeba were counted. The experiment was 
repeated for longer incubation times (5 h and 14 h) instead of 1h with m-THPC (5 µg/mL). 
Acanthamoeba viability was calculated as the percentage of the control (Acanthamoeba only, without m-
THPC or blue light but incubated at 30 °C for 1 h, 5 h, or 14 h). 
 Phototoxicity/PDI effect of m-THPC on Acanthamoeba with the bacteria inside 4.2.2.1.
 
Acanthamoeba were incubated for 24 hrs in 24-well plates until reaching a confluent state. Next, the well 
plates were washed once with PBS. After washing, 5 x 10
6
 bacteria were added for 1h. The well plates 
were washed again with PBS. Vancomycin (100 µg/mL, final concentration) was added for 45 min. to 
kill the extracellular bacteria. Wells containing Acanthamoeba with the intracellular/engulfed bacteria 
were incubated with/without m-THPC (2, 4, 6 µg/mL) for 1h, then repeated for longer 5h, or 14h 
with/without m-THPC (5µg/mL) at 30°C. The plates were exposed to blue light for 20 min (8 J/cm
2
) and 
treated as above. Control (CRTL) Acanthamoeba with the intracellular/engulfed MRSA were considered 
and incubated in separate a plate without PS or light exposure.  
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 Phototoxicity/PDI effect of m-THPC on the intracellular/engulfed MRSA bacteria 4.2.2.2.
inside Acanthamoeba. 
 
The intracellular MRSA within Acanthamoeba for the above plates, which incubated with/without m-
THPC and with/without light exposure, were all examined. Acanthamoeba with the engulfed MRSA 
were lysed and (20 µl) of bacteria were taken on agar plate and counted as was explained in the 
experimental sections for bacteria.   
 
 Effect of psoralen on Acanthamoeba and the bacteria inside Acanthamoeba 4.2.2.3.
 
Methods were similar to section 4.2.2.1 but instead of m-THPC, psoralen was used with various 
concentrations (100, 200, 300, 400, 512, 768 µg/mL). 
4.2.3. Irradiation light source 
 
Light irradiation for PDT was carried out using a LumiSource
TM
 lamp (Biotech), which had been 
turned on 30 min prior to use. The light source (Figure 4.3) contains a bank of four light tubes, emitting 
blue light with a peak at 420 nm and reflectors designed to provide homogenous illumination of the 
treatment area. The 24-well plates were placed on the removable glass plate on top of the light source for 
30 min and covered with a dark sheet to shield against any other forms of present light. This light field 
was approximately 14 cm x 32 cm. 
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 LumiSourceTM (PCI Biotech) lamp used for irradiation. Figure 4.3.
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4.3. Results 
4.3.1. PDT assays 
 
The effect of PDT on bacteria was examined using m-THPC drug as potential antimicrobial agent 
by three different sets of conditions. Firstly, the chemical toxicity of m-THPC uptake was determent after 
range of incubation periods between 2 h-24 h in the dark, without light exposure. Secondly, PDT effect of 
the internalized / intracellular m-THP only on bacteria strains after time-course incubation periods 
between 2h-24h, then exposed to blue light with energy level of 12.5 J/cm
2
 (blue light for 30 min), in the 
absence of extracellular m-THPC. Thirdly, PDT effects of extracellular m-THPC on bacteria were 
investigated after very short incubation time (couple of min) then exposure to low energy level of 0.8 
J/cm
2 
(blue light for 2 min) in the presence of m-THPC. Number of viable bacteria was calculated after 
24 h of light exposure.      
 m-THPC Effect on MRSA and MSSA in the absence of blue light 4.3.1.1.
 
To determine the dark toxicity of m-THPC on MRSA and MSSA strains without exposure to 
light, the experiment was carried out with m-THPC the highest concentration used for the phototoxicity 
(10 μg/mL). The results show the percentage of bacteria that survived after 24 h of incubation with the m-
THPC in comparison to the control (bacteria without m-THPC) for each strain (Figure 4.4). In general, 
the chart showed an insignificant decrease in the number of bacteria with the PS (m-THPC) in the dark. 
The number of MRSA were even increased in the dark with PS slightly after 2 h and 4 h incubation. This 
indicated that m-THPC was not chemically toxic by itself for bacteria without light exposure.  
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   Dark toxicity of m-THPC incubated with bacterial strains alone for 24 h in RPMI media, Figure 4.4.
plates wrapped with aluminum foil to avoid light exposure at 37 °C. Bacteria strains were washed and 
cultured on agar gel for determining the chemical toxicity. These results represent selected data of three 
independent experiments in duplicate. Error bars represent standard error (P>0.5). The standard error (SE) 
is ±1. 
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 Time-course effect of the intracellular / internalised (m-THPC) only on MRSA and 4.3.1.2.
MSSA strains with light exposure 
 
The phototoxicity of m-THPC with a concentration of 5 μg /mL on MRSA and MSSA strains 
was examined during the time course experiments. Bacteria were incubated for several periods of time (2 
h, 4 h, 6 h, and 24 h) and exposed to blue light 12.5 J/ cm
2
 (wavelength band between 405 – 420 nm) in 
the absence of extracellular PS. The viabilities of bacteria were determined after 2 h of light exposure. 
The PS, m-THPC exhibited over 99 % reductions at that concentration for both MRSA and MSSA strains 
in each incubation period. Bacteria without m-THPC and exposed to light (control) also suffered 
significant reductions but continued the growth after light exposure (during 24 h). (Figure 4.5, A and B) 
The intracellular m-THPC molecules could not completely eradicate the bacteria 100%, bacteria growth 
was visible after several hrs of light exposure up to 24h. PDT using the above set of conditions showed a 
similar effect on both MRSA strains and MSSA strains; the viable bacteria were approximately less than 
0.1% in both strains after the time-course of incubation with the PS between 2 h-24 h, (Figure 4.5 A, B).  
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 PDT/Phototoxicity of intracellular/internalized m-THPC on MRSA1 and MRSA2 (A), , Figure 4.5.
MSSA1 and MSSA2 (B) with light exposure. m-THPC (5 μg/mL) incubated with bacteria of original 
number without light or PS (control, 5 x 10
6
) in RPMI medium for 2 h, 6 h, and 24 h at 37 °C, in the dark. 
The excess m-THPC was discarded and washed twice. Bacteria were exposed to blue light (12.5 J / cm
2
 
for 30 min.), then they were cultured after 2 h of the light exposure onto agar gel to calculate the viable 
bacteria. Data were analysed by t-test which showed (**P<0.0005).  
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 Phototoxic/PDI effect in presence of extracellular m-THPC on bacterial strains  4.3.1.3.
 
The following experiments attempted to determine whether the PS (m-THPC) was required to 
penetrate the cell membrane of bacteria in order to cause the damage, or bacteria eradication can occur 
without the internalisation. The results were relatively comparable for both strains; PDT effect was 
greater on MSSA than MRSA, where a total eradication of MSSA was accomplished at a lower 
concentration than the required one for MRSA strain.  
            The data (Figure 4.6) represents the experimental investigation of the phototoxicity of m-THPC 
on MRSA1 and MSSA1 bacteria during both PS and light exposure for very short incubation time. It 
showed the viabilities of bacteria after PS for a short period of time (2 min ) and with light energy (2 min, 
0.8 J/cm
2
) in the presence of m-THPC with a range of concentrations between 0.2 – 0.8μg/mL. Under the 
above set of conditions, MSSA1 showed better destruction than MRSA1 when bacteria cultured onto 
agar gel immediately after light exposure or after 24 h. MRSA1 survival was approximately 25 % using 
the concentrations of 0.2-0.6 μg/mL, while the total eradication was achieved with 0.8 μg/mL, Figure 4.6 
(A). However, a complete elimination of MSSA1 and MRSA1 was recorded after 24 h light exposure 
with concentration less than 0.2 μg/mL for MSSA1 and 0.8 μg/mL for MRSA1(Figure 4.7). The MIC 
values for MRSA bacteria were determined at the above set of conditions (2 min incubation with m-
THPC, 2 min of light exposure, and culturing to examine the bacterial survival after 24 h) using the range 
of concentrations between 0.2-1 μg/mL and 0.2 μg/mL (Figure 4.6). Bacteria growth from both strains 
did not continue after 24 h incubation under those conditions. Therefore, the MIC values of m-THPC 
were considered to be 0.8 J/cm
2 
for MRSA and less than 0.2 μg/mL for MSSA1 (Figures 4.7 and 4.8).  
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 PDT/Phototoxicity in the presence of extracellular PS under light exposure (A) for MRSA1 Figure 4.6.
and (B) for MSSA1: Bacteria were incubated with various concentrations of m-THPC at 37 °C, then 
exposed to blue light (0.8 J/cm
2
, 2 min ) Bacteria then cultured/counted either immediately, 2 h, or after 
24 h on agar gel and number of viable bacteria were calculated. (CRTL) represents the control for bacteria 
without light or PS, (CRTL+BL) represents bacteria exposed to light only without PS. (**P < 0.0005). 
 
 
 
1.0E+00
1.0E+01
1.0E+02
1.0E+03
1.0E+04
1.0E+05
1.0E+06
1.0E+07
CRTL CRTL+BL 0.2 0.4 0.6 0.8
L
o
g
1
0
 N
o
 o
f 
v
ia
b
le
 b
a
ct
er
ia
  
m-THPC Concentration (μg/mL) 
(A) Dose dependant study in presence of extracellular m-THPC 
the phototoxic/PDI effect on MRSA/2 min.  
Immed counting after light
2h counting after light
24h counting after light
1.0E+00
1.0E+01
1.0E+02
1.0E+03
1.0E+04
1.0E+05
1.0E+06
1.0E+07
CRTL CRTL+BL 0.2 0.4 0.6 0.8
L
o
g
1
0
 o
f 
v
ia
b
le
 b
a
ct
er
ia
  
m-THPC μg/mL 
 (B) Dose dependant study in presence of extracellular m-THPC; 
the phototoxic/PDI effect on MSSA/2 min. 
Immed counting after light
2h counting after light
24h counting after light
112 
 
 
 
  
 Determination of MIC upon PDT treatment with presence of the PS for short Figure 4.7.
incubation time and short light exposure; MRSA1 incubated with various concentrations of 
m-THPC for 2 min at 37 °C, then exposed to blue light (0.8 J, 2 min.) in the presence of m-
THPC. MRSA bacteria were cultured after 24 h from light exposure to measure MIC value (**P 
< 0.0005).  
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 The immediate effect of blue light on bacteria without PS  4.3.1.4.
 
The experiment investigated the effect of blue light on MRSA and MSSA bacteria in the absence 
of PS m-THPC immediately after light exposure. It was found that blue light has a significant effect on 
bacteria. There were only 1% of both MRSA1 and MSSA1 bacteria surviving after exposure to blue light 
for 30 min (12.5 J), and cultured on agar gel, immediately. It was clear from the experimental data above, 
there were reductions of viable bacteria for both strains. The control (bacteria without m-THPC) which 
was exposed to light for 2 min (0.8 J/cm
2
) was also considerably reduced, (Figure 4.8). It is worth 
recording that a prolonged light exposure time from 2 min to 30 min did affect the number of bacteria 
survived, on one hand. On the other hand, bacteria continued to grow to further after 24 h after light 
exposure.  
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 The effect of blue light alone on bacteria. The percentages of bacterial strains (MRSA, MSSA) Figure 4.8.
survival after exposure to light for 2 min. (0.8 J) as the percentages of the original number of bacteria used without 
light, then cultured immediately afterwards (**P<0.0005).  
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 Phototoxicity of m-THPC on Acanthamoeba  4.3.1.5.
 
          This experimental section explores the effect of PDT on Acanthamoeba trophozoites. PDT 
investigation was carried out first with incubating Acanthamoeba trophozoites with m-THPC with a 
range of concentrations (2 μg/mL, 4 μg/mL, 6 μg/mL) for one hr and exposed to blue light for 20 min 
(8.3 J/cm
2
). The viability of Acanthamoeba trophozoites with or without m-THPC but exposed to the 
light were calculated after 24 h from their exposure to the light, againest the control (Acanthamoeba 
trophozoites that did not expose to light or m-THPC), (Figure 4.9 A). The blue light reduced the number 
of Acanthamoeba trophozoites to 78% without the PS effect. Further reduction of Acanthamoeba 
trophozoites were achieved with the range of m-THPC concentrations used and blue light together for 1 
h, decreasing the numbers of Acanthamoeba trophozoites to 57%, 42%, and 36%, respectevely. When the 
experement was repeated with prolonging the incubation time for 5h and 14h, the number of 
Acanthamoeba trophozoites diminished to approximately 21% and 9.7%, respectively, (Figure 4.10, B). 
Whereas, the number of Acanthamoeba trophozoites incubated without PS for 5 h and 14 h and exposed 
then to blue light only were also reduced to 67 % and 83 %, respectively.  
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 PDT/Phototoxicity of PS m-THPC on (A) Acanthamoeba (Ac) Acanthamoeba incubated with Figure 4.9.
m-THPC and exposed to light for 1 h. (B) Acanthamoeba incubated with m-THPC (2 μg/mL, 4 μg/mL, 6 
μg/mL) and exposed to light for 5 h and 14 h. The medium was discarded and Acanthamoeba was washed with 
PBS then exposed to light for 20 min (8.3 J/cm
2
). The viability of Acanthamoeba was examined with trypan blue 
after 24 h of light exposure and the percentage was determined against CRTL (control: Acanthamoeba was not 
exposed to PDT). This result is a mean of three independent experiments in duplicate. Error bars represent standard 
error (**P<0.005).  
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 PDT Effect of m-THPC on Acanthamoeba with the intracellular/ingulfed bacteria 4.3.1.6.
 
Acanthamoeba with the intracellular/engulf MRSA were also examined with three different 
concentrations of m-THPC (2, 4, 6 μg/mL) for 1 h, then exposed to light for 20 min (8.3 J/cm2). There 
were significant reduction in the number of Acanthamoeba incubated with PS for 1 h, elevated with 
raising the dose of PS from 2 - 6 μg/mL. Acanthamoeba with MRSA reduced to a range between 50% - 
31 %, applying the above concentration. Therefore, IC50 (the concentration that eradicate Acanthamoeba 
with MRSA by 50 % would be approximatly 2 μg/mL, (Figure 4.10, A). It’s worth noticing, the blue 
light alone eliminated around around 36% of Acanthamoeba with intracellular bacteria. The phototoxic 
effects of m-THPC with light exposure of 8.3 J/cm
2 
on the viability of Acanthamoeba with engulfed 
bacteria were examined with increasing the incubation period to 5 h, then lysis after 24 h of light 
exposure. The phototoxicity of PS demonstrated higher reduction of around 80 %. A substantial effect 
has been found when longer incubation periods up to 14 h were applied on Acanthamoeba with engulfed 
bacteria. Acanthamoeba with intracellular/engulfed bacteria were reduced significantly by 93 % to reach 
approximately 7 % of the number of Acanthamoeba with engulfed MRSA (were not exposed to light and 
PS). Acanthamoeba with bacteria exposed to blue light, also decreased by approximately 44 % and 21 % 
without m-THPC incubation, (Figure 4.11, B).     
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 PDT effect on Acanthamoeba with the intracellular/engulfed MRSA. (A) The effect of m-Figure 4.10.
THPC concentrations  (2 μg/mL, 4 μg/mL, 6 μg/mL) for 1h on Acanthamoeba with the intracellular/engulfed 
MRSA.  (B) Time-course effect on Acanthamoeba with the intracellular/engulfed MRSA incubated with/without 
5 μg/mL m-THPC for 5 and 14h. Acanthamoeba was incubated with MRSA1 [10 x 106] for 1h. The excess of 
bacteria was discarded and the membrane - associated bacteria were killed by vancomycin. Acanthamoeba with 
the intracellular/engulfed MRSA were incubated with or without m-THPC. The excess m-THPC was discarded. 
Acanthamoeba with the bacteria inside were washed and exposed to light for 20 min. (8.3 J/cm
2
), The viability 
of Acanthamoeba was examined with trypan blue (0.4 %)  after 24 h of light exposure and the percentage was 
determined against CRTL (control: Acanthamoeba with the intracellular/engulfed MRSA were not exposed to 
PDT). This result is a mean of three independent experiments in duplicate. Error bars represent standard error 
(**P<0.005). 
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 The effect of m-THPC on the engulfed bacteria within Acanthamoeba 4.3.1.7.
 
The role of Acanthamoeba in protecting bacteria against the PDI effect was also examined. 
Therefore, the viability of MRSA bacteria that invaded Acanthamoeba and subjected to PDT was 
inspected. Acanthamoeba were lysed and bacteria were cultured on agar gel after 24 h of light exposure 
and calculated. The viabilities of bacteria were reduced to 40.5 %, 26 % and 24 % for m-THPC 
concentrations applied (2, 4, 6 μg/mL) after 1h incubation and culturing after 24 h of light exposure, 
(Figure 4.11, A). Blue light alone reduced the number of intracellular bacteria by more than 45 %.    
The engulfed MRSA bacteria strain inside Acanthamobea were diminished completely with 
longer incubation periods. There were no bacteria survived inside Acanthamoeba after PDT treatment (m-
THPC, 5 μg/mL and blue light of 8.3 J/cm2) for 5 h or 14 h, then cultured after 24 h of light exposure 
(Figure 4.11, B). 
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 PDI/Phototoxicity of MRSA inside Acanthamoeba incubated with m-THPC (A) The effect of Figure 4.11.
m-THPC concentrans (2 μg/mL, 4 μg/mL, 6 μg/mL) for 1 h and (B) Time-course effect on the 
intracellular/engulfed MRSA incubated with/without 5 μg/mL m-THPC for 5 h and 14 h and exposed to blue light 
(8.3  J/cm
2
). The results were calculated after 24 h of light exposure as percentages of bacteria with/without PS 
against the percentage of control (bacteria without PS or light exposure). The results are the mean of three 
independent experiments performed in duplicate. Error bars represent standard error (**P<0.0005). 
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 Effect of psoralen on Acanthamoeba and bacteria inside Acanthamoeba  4.3.1.8.
 
The effects of three different concentrations (100, 200 and 300 μg/mL) of psoralen on 
Acanthamoeba in the presence and absence of blue light were investigated. Blue light itself without 
psoralen was able to reduce the number of Acanthamoeba by 19 %. On the other hand, psoralen itself had 
dose dependent growth inhibitory effects against Acanthamoeba. 768 µg/mL of psoralen concentration 
eradicated 100% of trophozoites (IC100). 300 µg/mL of psoralen without exposure to blue light reduced 
the number of Acanthamoeba by 23%. When the same concentration is used with blue light exposure, 
100% reduction of Acanthamoeba number was found (Figure 4.12). 
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 Effects of psoralen (100 – 300 μg/mL) on Acanthamoeba in the presence of Ps with and Figure 4.12.
without blue light exposure. Acanthamoeba was incubated for 24 h and exposed to blue light (12.5 J, 30 
min). Every result is a mean of three independent experiments performed in duplicate. Error bars 
represent standard error (*P<0.05). 
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 Effect of psoralen (Ps) on MRSA and MSSA bacteria 4.3.1.9.
 
Bacteria with a starting number of 5 x 10
6
 colonies were incubated with various concentrations of 
psoralen for 24 h at 37 °C, then exposed to blue light (12.5 J, 30 min) in the presence and absence of 
psoralen, then cultured after 30 min of light exposure. The phototoxic effect on MSSA is much higher 
than that on MRSA under the same conditions (30 min incubation, 12.5 J) in the presence and absence of 
psoralen with a range of 100 – 768 μg/mL). The lowest concentration required to reach total destruction 
of both bacteria was 768 μg/mL with light exposure, while the concentration of 768 μg/mL was not 
enough to cause total damage of both bacteria without light exposure after 24 hrs (Figure 4.13). 
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 Comparison of PDT/Phototoxicity of MRSA (A and B) and MSSA (C and D) in the presence and Figure 4.13.
absence of the psoralen with and without light exposure. This result is a mean of three independent experiments 
in duplicate. Error bars represent standard error; (**P<0.005).  
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The effect of psoralen was tested against intracellular bacteria inside Acanthamoeba with blue 
light exposure. Invaded, untreated bacteria were accepted as a control. This was achieved by lyses of 
Acanthamoeba and culturing the lysate on plates. Another control was the intracellular bacteria exposed 
to blue light alone and intracellular bacteria exposed to psoralen alone. Blue light alone was able to 
reduce the number of intracellular bacteria by more than 70%. Moreover psoralen alone decreased the 
number of intracellular bacteria by more than 80%. 768 μg/mL of Ps with blue light exposure was lethal 
for both types of bacteria used in this study (Figure 4.14). 
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 PDT/Phototoxicity of intracellular MRSA and MSSA in the presence and absence Figure 4.14.
of Ps (768 μg/mL ) with and without light exposure. Intracellular/engulfed MRSA and MSSA were incubated 
with/without 768 μg/mL (psoralen) for 24 h and exposed to blue light for 30 min (8.3  J/cm2). The results were 
calculated as percentage of bacteria with/without PS against the percentage of controls (bacteria without PS or 
light exposure). The results were the mean of three independent experiments performed in duplicate. Error bars 
represent standard error (***P<0.0005). 
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4.4. Discussion 
 
All the available evidence suggests that multi-antibiotic resistant strains are as easily killed by 
PDT as native strains and that bacteria will not readily develop resistance to PDT (Maisch, 2007; Maisch 
et al., 2011). It is known that Gram-negative bacteria are resistant to PDT, and commonly used PS will 
readily lead to phototoxicity in Gram-positive species. PS bearing a cationic charge or agents that 
increase the permeability of the outer membrane will increase the efficacy for killing Gram-negative 
organisms (Jori et al., 2006; Rello et al., 2007). Treatment of localised infections with PDT requires 
selectivity of the PS for microbes over host cells, delivery of the PS into the infected area, and the ability 
to effectively illuminate the infected lesion (Dahl et al. 1987; Dahl et al. 1989; Dai et al. 2009). When the 
cells to be killed are pathogenic microorganisms the procedure is termed photodynamic inactivation 
(PDI) (O’Riordan et al., 2006). 
This study explored the potential of one of the most powerful chlorins as antimicrobial PS agent, 
(m-THPC) with four hydroxy groups on four phenyl rings, which is considered a neutral compound. The 
effect of chlorin (m-THPC) on bacteria was examined under three sets of conditions: a) in the presence of 
a PS and absence of light, in order to establish the chemical toxicity of m-THPC; b) in the presence of 
only internalised (intracellular) PS and blue light to determine its ability to penetrate the cell membrane 
and cause biological damage; and c) in the presence of extracellular m-THPC and blue light without 
internalisation for very short incubation period and very short light exposure. The PS (m-THPC) proved 
to be not chemically toxic to the bacteria by itself at a concentration of at least twice the employed 
concentrations for the phototoxicity. The effect of m-THPC on MRSA and MSSA colonies was 
negligible in the dark without blue light irradiation. The chemical toxicity has a clinical relevance to any 
PS, taking into account the goal is to reduce the damage to the bacteria host (High-Throughput Screening 
Methods in Toxicity Testing, 2013). The PDT effect was significant on all four bacterial strains. m-THPC 
was capable of eliminating over 99 % of MRSA and MSSA bacteria after light irradiation after two hrs of 
light exposure. Nevertheless, in the second set of conditions, where the PS was eliminated during the 
light exposure, bacterial growth was visible after several hrs. This is likely due to the uptake of the PS 
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during the incubation time (up to 24 hrs) was not sufficiently yielding enough ROS to maintain the 
damage. These observations were reported for other PS that had penetration difficulties through bacterial 
cell membranes (Gomes et al., 2013). In some cases, the combination of charged groups with certain 
porphyrine/chlorin derivatives resulted in increased cell recognition and water solubility, which improved 
cell membrane penetration (Nitzan et al., 1992). In the third set of conditions, both MRSA and MSSA 
were exposed to very low concentrations of PS (m-THPC), following low-light energy exposure for a 
very short time to confer total and lasting destruction. This could be owing to the nature of PDT/PDI, 
where the initial damage was not the PS itself but the ROS moieties. Production of ROS could exert the 
desired damage in the cell membrane, which allowed the rest of the PS to pass through, as previously 
reported (Jori et al., 2006).  
There was a positive dose-dependent response of m-THPC phototoxic effects on both MRSA and 
MSSA, which was supported by several studies regarding PDT/PDI and different bacteria using a variety 
of PS (Di Poto et al., 2009). The study of phototoxicity also sought to identify the MIC of the PS (m-
THPC), which is sufficient to eradicate all bacteria after 24 h PDT application. The value of MIC for this 
compound on MRSA was found to be 0.8 μg/mL. This concentration achieved total eradication of 
bacteria after 24 h in the presence of PS after very short incubation time (couple of min.) and during very 
short light exposure. PDT efficacy in MSSA was much greater than MRSA, it required a concentration of 
less than 0.2 μg/mL to cause total destruction in MSSA. Therefore, MIC value for MSSA would be under 
the lowest concentration of the chosen range. The third set of conditions would consider ideal 
requirements as PDI concern, where in clinical field low concentration of PS and its short application are 
essential to avoid light sensitivity in human bodies that sometimes persists for days after PDT (Dai et al. 
2009).      
Following the work of (Elman et al., 2003) on the use of high intensity light to treat acne, this 
study explores the use of blue light alone, without PS, to eradicate bacteria. Blue light had a significant 
effect on both MRSA and MSSA strains of bacteria, where about only 10% of the bacteria remained 
viable after exposure to blue light. The bacterial elimination by blue light alone, which has a wavelength 
range between 405 – 430 nm, can be attributed to the endogenous phorphyrins. Bacteria are known to 
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secrete amounts of endogenous heme precursors, such as uropophyrinogen, coproporphyrinogen, 
protoporphyrinogen, and protoporphyrin IX (Frankenberg et al., 2003), which can be photochemically 
activated upon light exposure corresponding to the wavelength range of blue light. It’s worth noticing the 
short lived effect of blue light didn’t eradicate totally the bacteria after 24 h. This was clear from the 
control of all the experiments which contained bacteria without PS but exposed to blue light. Initially, the 
bacteria was reduced significantly after light exposure, then continued to grow back to a certain level in 
each case.    
The experiments also investigated the effect of m-THPC on Acanthamoeba and the bacteria 
inside Acanthamoeba. One of the goals was to investigate whether Acanthamoeba might protect the 
bacteria inside them against the phototoxicity/PDI. One study with a similar scope  (Chen et al., 2008), 
concluded that Acanthamoeba keratitis is affected by photodynamic therapy when a PS was used. This 
study used a different PS than m-THPC, and found similar results, i.e. Acanthamoeba were reduced by 
approximately 20% upon internalized m-THPC with blue light exposure. Another finding was that the 
longer the period of PS incubation (1, 5, and 14 h), the higher the efficacy of the phototoxicity/PDI owing 
to the increased of m-THPC uptake by the tough Acanthamoeba cell membrane (Chen et al., 2008). 
PDT/PDI effect on bacteria inside Acanthamoeba was examined and the results showed that there were 
reductons in the survival of the intracellular bacteria by 28 % - 44 %, with increasing m-THPC dosage 
from 2 μg/mL – 6 μg/mL after one-hr application. Nevertheless, bacteria inside Acanthamoeba were 
totally eliminated when m-THPC applied for longer periods (5h and 14h) on Acanthamoeba with 
engulfed bacteria. Therefore, we can confirm the substantial efficacy of PDI in preventing Acanthamoeba 
of shielding the intracellular bacteria inside and allowing their growth. The experiments investigated the 
effect of psoralen on Acanthamoeba and bacteria inside Acanthamoeba. There was positive dose-
dependent response of psoralen phototoxic effects on Acanthamoeba, MRSA, and MSSA, which was 
supported by several studies regarding PDT and different bacteria using a variety of PS (Wainwright, 
2009). The study of phototoxicity also sought to identify the MIC of the psoralen, which was sufficient to 
eradicate all bacteria after 24 h. The value of MIC for this compound on Acanthamoeba with light 
exposure was 300 μg/mL. This concentration achieved total eradication of bacteria after 24 h. The MIC 
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value with blue light for MRSA and MSSA was 768 μg/mL. However, the MIC value for MRSA and 
MSSA without blue light probably was over the highest concentration of the chosen range. One of the 
goals was to investigate whether Acanthamoeba might protect the bacteria inside them against 
phototoxicity. One study with a similar scope was that of (Solheim, 2008), who concluded that 
Acanthamoeba keratitis and bacteria were affected when psoralen was used. This study used psoralen and 
examined its effect on bacteria inside Acanthamoeba. The results show that there was a decrease in the 
survival of Acanthamoeba and Acanthamoeba with intracellular bacteria by 16 % and 11 %, respectively. 
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  Chapter 5.
Effects of Eugenols on the survival 
 of Acanthamoeba and internalised bacteria 
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5.1. Background 
 
The antimicrobial effect of spices was first described by Anthony Van Leeuwenhoek. He described 
a reduction in the number and activity of animalcules in a sample of well water after addition of pepper in 
a letter dated 9 October 1676. In the 1980s, preservative agents were commonly being used but progress 
in the usage of spice derived components was very slow. The antimicrobial activity of spice oil has been 
found in a number of other aromatic molecules, one of those being eugenol. 
Eugenol is a natural phenolic component of clove oil but it is also found in several other spices like 
basil, cinnamon, and bay leaves. It is the foremost active phenylpropanoid constituent of the essential oil 
among various aromatic plant (De Vincenzi et al., 2000). Eugenol being a major component of clove oil 
is used primarily as a flavouring agent in food and cosmetic products. According to studies, eugenol 
possesses various biological abilities, including antimicrobial, antioxidant, anti-inflammatory, 
anticarminative, and antispasmodic activities (Hashimoto et al., 1988; Nagababu and Lakshmaiah, 1997; 
Gill and Holley, 2004; Mohammed and Al-Bayati, 2009). In traditional Chinese medicine, eugenol has 
been used due to its analgesic, antiseptic, and antibacterial properties (Zheng et al., 1992). Eugenol has 
antitumor properties causing destruction of various cancer cells.  According to a number of researchers, 
the anti-Candida biofilm activity has potential of plant-derived chemicals such as flavonoids (Cao et al., 
2008), and essential oils (Khan and Ahmad, 2012). Moreover, eugenol also has anti-tumor potential 
related with apoptosis in different cancer cells. It has induced apoptosis in RBL-2H3 mast cells (Park et 
al., 2005) and HL-60 human promyelocytic leukemia cells (Yoo et al., 2005). Furthermore, eugenol has 
therapeutical application as an adjuvant in the management of neuropathy in rat brain.   
As claimed by two studies, eugenol affects Ca
2+
 homeostasis in three cell types. Eugenol increased 
cytosolic free Ca
2+
 concentrations ([Ca
2+
]) in neonatal rat cardiac myocytes (Choudhary et al., 2006),  
Jurkat T-cells and monocytic THP-1 cells (Chan et al., 2005). Although, whether eugenol alters Ca
2
+ 
movement and viability in cultured human glioblastoma cells is unclear. The decrease in levels of Ca
2
+ in 
the endoplasmic reticulum would lead to activation of stress signals, which in turn switches on the genes 
associated with apoptosis (Nicotera & Orrenius 1998). 
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Certain antibiotics can influence the expression of staphylococcal exotoxins, and eugenol, an 
essential oil component in plants, has been reported to have activity against both Gram-positive and 
Gram-negative bacteria. This study aimed to determine the influence which sub-inhibitory concentrations 
of eugenol may have on the expression of the major exotoxins produced by MSSA, MRSA and 
Acanthamoeba (De Vincenzi et al., 2000). Four novel eugenols were kindly provided by Professor Mark 
S. Baird from Bangor University. In this current project these eugenols were tested for their ability to 
inactivate a variety of Acanthamoeba and bacteria. By a differential concentration of eugenols, 
Acanthamoeba and bacteria inactivation can be achieved. 
The experiments described were done to determine the effect of eugenols on the survival of 
Acanthamoeba and internalised bacteria. Structures of all eugenols used in the course of this study are 
shown (Figure 5.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
135 
 
 
     
 
      
 
 
 
      
 
     
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EN1: EN-1-(5-allyl-2-
hydroxy-3-
methoxybenzaldehyde) 
EN2: EN-2-  4-allyl-2-
(hydroxyl methyl)-6-
methoxyphenol 
EN3: EN-3-  6,6’-
methylenebis(4-allyl-2-
methoxyphenol)     
EN4: EN-4 -  6,6’-
(oxybis(methylene))bis(4-
ally-2-
methoxyphenol)methoxyph
enol)     
Figure 5.1. Structures of all eugenols used in the course of the study. 
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5.2. Materials and Methods  
 
5.2.1. The antimicrobial effects of eugenols on Acanthamoeba 
Acanthamoeba belonging to T4 genotype was grown in PYG medium (5 mL) in T-25 tissue 
culture flasks until confluency. Before each experiment, 5 mL of PYG was added and the flasks were 
placed on ice for 20 – 30 min. The flasks were checked under the microscope to ensure that 
Acanthamoeba were floating and not adhered to the flask. The media containing the Acanthamoeba was 
then collected and placed in 50 mL Falcon tubes to be spun down for a count using a haemocytometer. 
After counting, 5 x 10
5 
Acanthamoeba were placed into each well of a 24-well plate and left overnight in 
30 
o
C incubator. The following day, PYG medium was removed and wells were washed with PBS three 
times. Eugenols at volumes of 40, 30, 20 and 10 µg/mL were then added to specific wells and incubated 
overnight at 30 
o
C. Each well was then treated with 100 µl of Trypan Blue (0.4 %) and left for 20 min 
following which medium was discarded and dead Acanthamoeba were counted. Same experiments were 
repeated to study the effect of eugenols on intracellular bacteria after doing the invasion assays. Dose 
response curves were generated using the Levenberg-Marquardt algorithm and the concentrations that 
resulted in 50% inhibition of growth were determined (IC50) for every type of eugenol. 
5.2.2. The antimicrobial effects of eugenols on intracellular bacteria 
Invasion assays were performed to determine the ability of MRSA and MSSA to invade or be 
taken up by Acanthamoeba. Acanthamoeba was grown in 24-well plates to confluence followed by 
addition of bacteria. After 1 h of incubation, wells were washed once with PBS after which vancomycin 
(100 µg/mL, final concentration) was then added and incubated for 45 min to eradicate the extracellular 
bacteria. Wells were then washed once with PBS following which eugenols were added and incubated 
overnight at 37 
o
C. Acanthamoeba was lysed by 0.05 % SDS, and number of bacteria released from lysed 
Acanthamoeba was enumerated using nutrient CLED agar plates. 
5.2.3. Zymographic assays 
To study the effect of eugenols on the production of proteases by Acanthamoeba, zymography 
assays were performed as described in section 3.2.6. 
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5.3. Results 
5.3.1. Effects of eugenol derivatives on Acanthamoeba T4 
Effects of four types of EN (EN1, EN2, EN3 and EN4) on Acanthamoeba T4 trophozoites were 
analysed by performing the survival assays. The survival assays showed dose dependent effects of EN on 
Acanthamoeba T4 survival (Figure 5.2). The doses of EN used for these assays were between 10 μg/mL - 
64 μg/mL. Dead Acanthamoeba were confirmed by Trypan blue staining. At 40 μg/mL, EN1 and EN3 
were seen to be more effective at inhibiting Acanthamoeba than EN2 and EN4. This is because 22.7 % 
and 23 % of Acanthamoeba remained viable after 24 h treatment with EN1 and EN3 respectively while 
37 % and 27.7 % of Acanthamoeba remained viable after 24 h treatment with EN2 and EN4 respectively. 
Furthermore, at a higher concentration of 64 μg/mL, EN3 totally inhibited the growth of Acanthamoeba 
after 24 h while there were still 1.33 % of viable Acanthamoeba following treatment with EN1 after 24 h 
(Figure 5.3).  In addition dose response curves were generated using the Levenberg-Marquardt algorithm 
and the concentrations that resulted in 50% inhibition of growth were determined (IC50). For EN1, EN2, 
EN3 and EN4 IC50 was found at 30, 35, 29 and 31 μg/mL respectively. 
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Figure 5.2. The effects of Eugenols on Acanthamoeba T4 trophozoite after 24 h of exposure at 30 oC. A. 
Effect of EN1 B. Effect of EN2 C. Effect of EN3 D. Effect of EN4. Acanthamoeba T4 was grown until confluency. 
After counting, 5 x 10
5
  Acanthamoeba were inoculated into each well of a 24-well plate and incubated at 30 
o
C. 
The following day, medium was removed and wells were washed. Eugenols at volumes of 40, 30, 20 and 10 µg/mL 
were then added to specific wells and incubated overnight at 30 
o
C. The next day each well was then treated with 
100 µl of Trypan Blue (0.4 %) and left for 20 min following which, medium was discarded and dead Acanthamoeba 
were counted using haemocytometer. IC50 (orange line) is point at which growth is inhibited by 50%. These results 
represent selected data of three independent experiments in triplicates. Error bars represent standard error, (P<0.05 
using paired t-test, one-tail distribution). 
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Figure 5.3. Morphology of Acanthamoeba T4 trophozoite (A) after 24 h: a) control, non-treated; b) 10 
μg/mL EN; c) 20 μg/mL EN; d) 30 μg/mL EN with Trypan Blue. Acanthamoeba T4 was grown until 
confluence. After counting, 5 x 10
5
  Acanthamoeba were inoculated into each well of a 24-well plate and 
incubated at 30 
o
C. The following day, medium was removed and wells were washed. Eugenols at 
volumes of 30, 20 and 10 µg/mL were then added to specific wells and incubated overnight at 30 
o
C. The 
next day each well was then treated with 100 µl of Trypan Blue (0.4 %) and left for 20 min following 
which, medium was discarded and live/dead Acanthamoeba were photographed using bright field 
microscope. 
 
 
 
 
 
 
 
 
 
 
 
a b c d 
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5.3.2. Effects of eugenol derivatives on Acanthamoeba with intracellular bacteria  
 
        In these assays the effects of eugenols EN (1, 2, 3 and 4) on Acanthamoeba T4 trophozoites with 
invaded bacteria were studied. Treatments with all the ENs were for 24 h at 37 
o
C. The bacteria used 
were MRSA and MSSA; death of Acanthamoeba with MSSA and MRSA was confirmed by trypan blue 
staining (Figure 5.4). At 40 μg/mL, 18 %, 33 %, 20 % and 20 % of Acanthamoeba with internalised 
MSSA survived following 24 h treatment with EN1, EN2, EN3 and EN4 respectively. On the other hand, 
15 %, 9 %, 18 % and 4 % of Acanthamoeba with internalised MRSA survived after 24 h treatment with 
40 μg/mL of EN1, EN2, EN3 and EN4 respectively. At 64 μg/mL, 8 % and 3 % of Acanthamoeba with 
internalised MSSA survived after treatment with EN1 and EN3 respectively. Moreover, EN3 was seen to 
totally inhibit the growth of Acanthamoeba with internalised MRSA at 64 μg/mL while 1 % of 
Acanthamoeba with internalised MRSA survived after treatment with EN1 at the same concentration. 
The effects of all ENs on Acanthamoeba with internalised MSSA and MRSA were determined after 24 
h of exposure at 37 
o
C (Figure 5.5). 
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Figure 5.4. The effects of ENs on Acanthamoeba T4 trophozoites with invaded MSSA and 
MRSA after 24 h of exposure at 37 
o
C. A. Effect of EN1 B. Effect of EN2 C. Effect of EN3 D. 
Effect of EN4. Acanthamoeba T4 was grown until confluence. After counting, 5 x 105  Acanthamoeba 
were inoculated into each well of a 24-well plate and incubated at 30 
o
C. The following day, medium was 
removed and wells were washed. Eugenols at volumes of 40, 30, 20 and 10 µg/mL were then added to 
specific wells and incubated overnight at 30 
o
C. The next day each well was then treated with 100 µl of 
Trypan Blue (0.4 %) and left for 20 min following which, medium was discarded and dead Acanthamoeba 
were counted using haemocytometer. These results represent selected data of three independent 
experiments in triplicates. Error bars represent standard error, (P<0.05 using paired t-test, one-tail 
distribution). 
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Figure 5.5. Acanthamoeba T4 trophozoites with intracellular bacteria (A+B) after 24 h: a) control, non-
treated; b) 10 μg/mL EN; c) 20 μg/mL EN; d) 30 μg/mL EN; e) 40 μg/mL EN with Trypan Blue. 
Acanthamoeba T4 was grown until confluence. After counting, 5 x 10
5
  Acanthamoeba were inoculated 
into each well of a 24-well plate and incubated at 30 
o
C. The following day, medium was removed and 
wells were washed. Eugenols at volumes of 40, 30, 20 and 10 µg/mL were then added to specific wells 
and incubated overnight at 30 
o
C. The next day each well was then treated with 100 µl of Trypan Blue 
(0.4 %) and left for 20 min following which, medium was discarded and live/dead Acanthamoeba were 
photographed using bright field microscope. 
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5.3.3. Effects of eugenol derivatives on bacteria MRSA and MSSA 
 
          These assays were performed to investigate the effects of eugenols on survival of bacterial strains, 
MRSA and MSSA. EN1 was seen to be more effective than the other ENs at inhibiting MRSA and 
MSSA at 40 μg/mL. This is because only 12 x 104 CFU/mL of MRSA and 3.5 x 104 CFU/mL of MSSA 
survived after treatment with EN1 unlike in the case of the other ENs where it was seen that >15 % of 
MRSA and MSSA survived after 24 h treatment. At 64 μg/mL, only 6 x 104 CFU/mL MRSA and 1.4 x 
10
4
 CFU/mL of MSSA survived following 24 h treatment with EN1 while 14 x 10
4
 CFU/mL MRSA and 
2 x 10
4
 CFU/mL MSSA survived following treatment with EN3. The effect of all the EN used in this 
study on MRSA and MSSA (Figure 5.6). 
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Figure 5.6. The effects of ENs on MSSA and MRSA after 24 h of exposure at 37 
o
C. a) Effect of 
EN1 b) Effect of EN2 c) Effect of EN3 d) Effect of EN4. Various concentrations of Eugenols were 
inoculated with bacteria (x 10
6
) overnight. The next day media were diluted and cultured into CLED agar 
plates. Plates were incubated overnight and colonies were counted. Percentage of bacterial viability was 
calculated. These results represent selected data of three independent experiments in triplicates. Error bars 
represent standard error, (P<0.05 using paired t-test, one-tail distribution). 
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5.3.4. Effects of eugenol derivatives on internalized bacteria inside Acanthamoeba 
 
          These assays were performed to investigate the effects of ENs on bacteria internalized by 
Acanthamoeba. EN3 was seen to be more effective than the other ENs at inhibiting MRSA and MSSA 
inside Acanthamoeba. < 20 % of both MRSA and MSSA inside Acanthamoeba survived after treatment 
with EN3 unlike in the case of other ENs where the surviving MRSA and MSSA were seen to be > 20 %.  
The effects of all ENs on MRSA and MSSA internalized by Acanthamoeba were determined after 24 h 
(Figure 5.7). 
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Figure 5.7. The effects of ENs on MRSA and MSSA internalized Acanthamoeba after 24 h of 
exposure at 37 
o
C. a) Effect of EN1 b) Effect of EN2 c) Effect of EN3 d) Effect of EN4. 
Acanthamoeba was grown in 24-well plates to confluence followed by addition of bacteria. After 1 h of 
incubation, wells were washed once with PBS after which vancomycin (100 µg/mL, final concentration) 
was then added and incubated for 45 min to eradicate the extracellular bacteria. Wells were then washed 
once with PBS following which eugenols were added and incubated overnight at 37 oC. Acanthamoeba 
was lysed by 0.05 % SDS, and number of bacteria released from lysed Acanthamoeba was enumerated 
using nutrient CLED agar plates.These results represent selected data of three independent experiments in 
triplicates. Error bars represent standard error, (P<0.05 using paired t-test, one-tail distribution). 
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5.3.5. Zymographic assays 
 
          Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) allows separating 
biological molecules such as proteins according to their molecular weight. Addition of SDS allows 
linearization and distribution of proteins according to their molecular weights/sizes. Zymography detects 
hydrolytic enzymes using a suitable substrate such as gelatin, which will be degraded when the enzyme is 
present. 
          This study was done to ascertain the effect of the ENs (EN1, EN2, EN3, and EN4) on the 
expression extracellular proteases by Acanthamoeba. At a concentration 40 μg/mL, EN1 and EN3 were 
seen to reduce the production of extracellular proteases when compared with the control and the effect of 
EN2 and EN4 (Figure 5.8). These results support outcomes obtained in section 5.3.1 where it was seen 
that EN1 and EN3 were more effective at inhibiting growth of Acanthamoeba at 40 μg/mL compared to 
EN2 and EN4.  
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Figure 5.8. Effects of ENs (EN1, EN2, EN3, and EN4) on the expression of extracellular 
proteases in Acanthamoeba T4 Conditioned Media. Acanthamoeba CM (only) and other 
samples (CM) with different concentrations of eugenols were blended (1:1) with the sample 
buffer and electrophoresed on SDS-PAGE containing fish gelatine (4% w/v). After 
electrophoresis, the gels were soaked in 2% Triton solution for 60 mins, incubated in a 
developing buffer at 37 °C overnight, then washed and stained with Comassie Brilliant Blue. 
Samples were treated with eugenols (EN1, EN2 EN3 and EN4), which was found to be the most 
effective in inhibiting Acanthamoeba extracellular proteases. At a concentration 40 μg/mL, EN1 
and EN3 were seen to reduce the production of extracellular proteases when compared with the 
control and the effects of EN2 and EN4. 
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5.4. Discussion 
 
          Acanthamoeba is widely present in the environment (Khan, 2009) and can cause infections in 
humans. Common infections such as keratitis affect the cornea and can cause blindness. Another 
infection caused by Acanthamoeba is GAE, a rare serious infection that can end up fatal. Current 
treatments for Acanthamoeba keratitis include antibiotics and use of topical steroids, however the 
treatment for encephalitis, such as antimicrobial drugs, does not help as the diagnosis is made late 
(Siddiqui and Khan, 2012). The need for new treatments with broader anti-amoebic activities is driving 
the research into synthesis of new monoclonal antibodies and development of new drugs.   
          Eugenols are chemicals manufactured by plants, which possess numerous functions in plants. 
Researches have revealed that eugenol has various biological capabilities, including antimicrobial, 
antioxidant, anti-inflammatory, carminative, and antispasmodic activities (Qiu et al., 2010). 
          It is broadly acknowledged that essential oils have antimicrobial activities, and recent 
investigations have revealed that these characteristics are attributable to the existence of various 
substituted aromatic molecules. These molecules comprise eugenol, cinnamaldehyde, and carvacrol (Jay 
and Rivers, 1984; Moleyar and Narasimham, 1992; Juven et al., 1994). Eugenol, the main phenolic 
compound and antimicrobial constituent of clove oil, has been registered by the European Commission 
for use as a flavouring ingredient in foodstuffs and is identified to carry no risk to consumer health (Burt, 
2004). Recent study specifies that eugenol (IC50 101 µg/mL) was identified to have antiprotozoal 
properties. The trophozoites adherence was decreased within the first hr of incubation. The major 
phenotypical changes were in the cell morphology, internalisation of flagella and ventral discs, 
membrane blends, and intracellular and nuclear clearing. (Machado et al., 2011). 
        To investigate the possible anti-proliferative effects of eugenol derivatives as a first step on the way 
to the development of novel antimicrobial agents, we studied four types of eugenol derivatives (EN1, 2, 3 
and 4) for their anti-amoebic potential to inhibit growth and viability of Acanthamoeba T4 trophozoites. 
This is the first study to investigate the effect of eugenol derivatives on the survival of Acanthamoeba 
castellanii T4 trophozoites, and its biological properties. 
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          The outcomes of survival assays showed dose-dependent effects of EN3 and EN1 on 
Acanthamoeba castellanii T4 genotype trophozoites survival. The value of MIC for the most effective 
compound (EN3) on Acanthamoeba was found to be 64μg/mL. This concentration achieved total 
eradication of Acanthamoeba after 24 h. EN2 and EN4 had lower antimicrobial potencies. Additionally 
the 50 % growth inhibition was found (IC50). The value IC50 for eugenols EN1, EN2 EN3 and EN4 
against Acanthamoeba trophozoites were 30, 35, 29 and 31 µg/mL respectively. Research study by  
Jaganathan et al., (2011) showed that eugenols have both anti-proliferative and apoptosis-inducing 
ability. In our study we investigated the phenotypic changes in Acanthamoeba trophozoites. The trypan 
blue staining assays showed that the non-treated control trophozoites were evenly distributed throughout 
the cell culture well and they were growing next to each other. Treatment with EN caused a significant 
decrease in the number of visible trophozoites present in the well. Furthermore, their structure changed to 
irregular shapes and there was some debris around them, which could be the trophozoites that underwent 
destruction after their membrane lysed, which could be because of the cellular stress caused by eugenols. 
This shows that the effect is not only on the limitation of the trophozoites metabolism, but it actually 
causes decrease in proliferation and increase in apoptosis by the possible lysis of trophozoites.  
          In parallel to this, effects of eugenol derivatives were investigated against Acanthamoeba with 
invaded bacteria in it. The expactations were to observe negative effects of intracellular bacteria on 
resistance of Acanthamoeba against eugenols. MRSA presence in Acanthamoeba was expected to have 
more negative results than when MSSA due to its greater virulence. Even though the MIC of eugenol 
against trophozoites alone was similar to that when it has bacteria inside, it was detected that the 
behaviour of Acanthamoeba has been changed. The lowest effective concentrations of eugenols were 
found to stimulate trophozoites to turn to cysts. This event was not seen when Acanthamoeba without 
intracellular bacteria was exposed to eugenols.  
          Eugenol has been documented to reduce the proliferation of Escherichia coli, Listeria 
monocytogenes, and S. aureus (Blaszyk and Holley, 1998; Ben Arfa et al., 2006). In addition to 
antibacterial potencies, eugenol also has antifungal and antiviral potencies (Sissons et al., 2006; 
154 
 
 
Schnitzler et al., 2011). As of its antimicrobial characteristics, eugenol is the one of the primary 
candidates to be recognised as an antimicrobial agent. 
          To verify the antibacterial potential of eugenol derivatives, we tested eugenol compounds for their 
ability to inhibit growth and viability of bacteria such as MRSA and MSSA in intracellular and 
extracellular conditions.  
          Our results demonstrate significant inhibitory activity of eugenol derivatives on MRSA and MSSA 
in extracellular conditions. Eugenol predominantly damages the cell membrane and causes the leakage of 
the cell contents (Yadav et al., 2015). EN1 and EN3 had the most antibacterial potent.  
          When eugenol derivatives were tested against MRSA and MSSA in intracellular conditions inside 
Acanthamoeba, it was expected to have less antimicrobial effect due to barriers of passing through 
Acanthamoeba membrane. Surprisingly, intracellular bacteria had lower MIC than that when they are in 
extracellular conditions. We hypothesize this is due to the less number of bacteria (less than x 10
6
) inside 
Acanthamoeba. 
          Previous studies showed that the mechanisms of tissue damage and invasion by amoeba involve the 
release of proteases, including cysteine proteases and serine proteases (Alfieri et al., 2000; Alsam et al., 
2003). It was found that protease activity is much higher in pathogenic Acanthamoeba species as 
compared to non-pathogenic ones. The proteases from pathogenic Acanthamoeba were shown to cause 
cytotoxicity to endothelial cells by forming holes in their membranes (Hurt et al., 2003). When 
Zymography was done on the extracellular proteases, it showed that the main protease released is a serine 
protease with a molecular weight of 107 kDa and inhibition potential by 1 mM aprotonin or 1 mM PMSF 
(Alsam et al., 2003). In our study SDS-PAGE zymography was used to assess the effect of eugenol 
derivatives on proteases released from Acanthamoeba castellanii T4 (trophozoites). Our results displayed 
that when doses of EN were increased, the release of proteases from trophozoites was decreased. This 
indicates that EN can be potentially used in protecting against tissue damage. These proteases found were 
at a size band around 60 and 70 kDa, pointing out it was serine protease (Kim et al., 2003). 
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6.1. Discussion 
 
Staphylococcus aureus is one of the commonest human bacterial pathogens which cause both 
healthcare- and community acquired infections. In 1962, two years after the introduction of methicillin 
antibiotic for management of penicillin-resistant S. aureus infections, the first case of MRSA was 
detected.  Despite use of control measures, methicillin resistance among S. aureus has gradually become 
greater than before. Approximately 30 % of the population carry S. aureus in the nares or on the skin 
(Wertheim et al., 2005). Community-acquired MRSA (CA-MRSA) is more likely to cause soft tissue and 
skin infections in contrast with healthcare-acquired MRSA (HA-MRSA). The gene encoding methicillin 
resistance, mecA, is located on mobile chromosomal element called the staphylococcal cassette 
chromosome (SCCmec) (Ma et al., 2002; O’Brien et al., 2005; Tenover et al., 2006). MRSA is the reason 
for a number of hospital-acquired infections, notably boils and abscesses, pneumonia, food poisoning, 
toxic shock syndrome and causes huge problems in diabetic patients. 
One of the advantageous strategies to overcome treatments and cause reinfections for pathogenic 
bacteria such as S. aureus can be being able to survive in Acanthamoeba (Cardas et al., 2012). 
Acanthamoeba is a free living protozoan which is greatly distributed in the environment. It was isolated 
from nasal cavities and pharynx of healthy humans. It is reported that on average every human inhales 
one Acanthamoeba cyst a day (Kingston and Warhurst, 1969). Generally, Acanthamoeba feeds on 
bacteria. Some of the phagocytized bacteria are digested but some bacteria are able to survive and 
multiply intracellularly, leading to new bacterial characteristics. The growth of bacteria inside 
Acanthamoeba has been related to enhanced environmental survival of bacteria, increased virulence and 
increased resistance to antimicrobial agents. This is of great importance from both clinical and 
environmental aspects.  
The aims of this project were, to investigate Acanthamoeba  castellanii (a keratitis isolate 
belonging to the T4 genotype) interactions with MRSA and MSSA; and factors affecting the molecular 
mechanisms involved in Acanthamoeba interaction with bacteria. 
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In this study, Acanthamoeba contact-dependent engulfment mechanism, phagocytosis, was 
studied. Phagocytosis plays an important role in the pathogenesis of Acanthamoeba. Nevertheless, 
knowledge of the detailed molecular mechanisms related to Acanthamoeba phagocytosis remain vague. 
FITC-, and rose Bengal labelled MRSA and MSSA were used to study processes involved in the 
phagocytosis of Acanthamoeba. Several lines of evidence suggest that PI3K plays an important role in 
host cell cytoskeletal remodelling processes, such as phagocytosis, pseudopod formation and trafficking 
(Wymann and Pirola, 1998; Cox et al., 1999). Here it was observed that LY294002, a specific PI3K 
inhibitor, reduced the likelihood of Acanthamoeba invasion by MRSA and MSSA. This is in line with the 
findings of  Alsam, et al (2006) who found that PI3K played an important role in Acanthamoeba 
interaction with E. coli. The use of this inhibitor led to a reduction of the bacterial invasion of 
Acanthamoeba. Another PI3K inhibitor, wortmannin, exhibited a similar effect on phagocytosis, 
suggesting that Acanthamoeba phagocytosis is dependent on PI3K-mediated intracellular signalling 
pathways. Na-orthovanadate was used to inhibit protein tyrosine phosophatase. Previous studies indicated 
that sodium orthovanadate causes an increase in the Acanthamoeba uptake of E. coli (Alsam et al., 2005; 
Sissons et al., 2006b). However, in our study, uptake of MRSA and MSSA was reduced unlike Alsam et 
al., (2005). Overall our data suggests that all enzymes investigated here play roles in phagocytosis, 
proposing that particle uptake in Acanthamoeba is a multifarious process that could play a substantial 
role, both in food uptake as well as the pathogenesis of this protozoan.  
Binding of Acanthamoeba leads to another virulence factor such as production of extracellular 
proteases, one of the contact-independent mechanisms. The role of extracellular proteases in 
Acanthamoeba – bacteria interactions remains incompletely understood. To this end, inhibition of 
extracellular serine proteases was performed by PMSF inhibitor. Analysis of proteases from keratitis-
causing Acanthamoeba shows that the presence of a 130 kDa protease was inhibited by PMSF. PMSF has 
a role in permeabilising the blood-brain barrier (Sissons et al., 2006b). It is thought-provoking that 
inhibition of serine proteases increased MRSA and MSSA uptake by Acanthamoeba. In addition to that, 
zymography assays showed 130 kDa band representing serine proteases were not expressed, indicating 
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inhibition of these serine proteases. The similar results of 130 kDa band inhibition was confirmed by 
performing 2D gel electrophoresis. These data support work by Alsam et al, (2005b). 
In an effort to investigate the expression of novel proteins, treated and untreated Acanthamoeba 
CM was investigated by two-dimensional gel electrophoresis. The results of our proteomic analysis 
revealed the resolution of a number of polypeptide spots. Forty three protein spots resolved at a given pI 
and molecular weights were identified. More analysis by mass spectrometry is needed to identify the 
sequence and identity of differentially regulated polypeptides observed. This could validate the findings 
and correlates with existing proteins identified in databases. 
Bacterial infections have always been a persistent threat to human health. As a result of the 
unending rise of drug-resistant bacteria, both in healthcare and in the community, there is a necessity for 
novel strategies for antimicrobial therapy. PDT has recently been utilised to efficiently eradicate 
microorganisms. PDT turned out to be an effective strategy to kill multi- drug resistance microorganisms 
and there is no reported evidence for PDT resistant mechanisms as compared with antimicrobials. In vitro 
PDT experiments have demonstrated that m-THPC may be used as PS against S. aureus and MRSA 
(Sperandio et al., 2013). According to these results, the effectivity of m-THPC mediated PDT was 
determined on internalized MRSA, MSSA and Acanthamoeba trophozoites. m-THPC mediated PDT was 
capable of eliminating 100 % the viability of internalised MRSA, MSSA and A. castellanii trophozoites 
proportionate to the increase of the PS concentration. Psoralen mediated phototoxic effect on 
Acanthamoeba, MRSA and MSSA was established as dose dependent, supporting several studies 
regarding PDT and different bacteria using a variety of PS (Wainwright, 2009). One of the goals was to 
investigate whether Acanthamoeba might protect the bacteria inside them against phototoxicity. Solheim 
et al. (2006) concluded Acanthamoeba keratitis and bacteria were affected when psoralen was used. The 
results of this study showed that psoralen is capable of eradicating even intracellular bacteria such as 
MRSA and MSSA inside Acanthamoeba.  
            Another set of experiments were carried out using natural product as antimicrobial agent. It has 
been revealed that eugenol has various biological capabilities, including antimicrobial, antioxidant, anti-
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inflammatory, carminative, and antispasmodic activities (Qiu et al., 2010). Recent study specifies that 
eugenol was identified to have antiprotozoal properties (Machado et al., 2011). Four types of eugenol 
derivatives for their anti-amoebic potential to inhibit growth and viability of Acanthamoeba were studied. 
The outcomes of survival assays displayed dose-dependent effects. Treatment with eugenol derivatives 
caused a significant decrease in the number of visible trophozoites present in the well. Furthermore, their 
structure changed to irregular shapes and there was some debris around them, which could be the 
trophozoites that underwent destruction after their membrane lysed, which could be because of the 
cellular stress caused by eugenols. This shows that the effect is not only on the limitation of the 
trophozoites metabolism, but it actually causes decrease in proliferation and increase in cell death by the 
possible lysis of trophozoites. Our results demonstrate significant inhibitory activity of eugenol 
derivatives on MRSA and MSSA in intracellular as well as extracellular conditions. Eugenol 
predominantly damages the cell membrane and causes the leakage of the cell contents (Yadav et al., 
2015).  
          Previous studies showed that the mechanisms of tissue damage and invasion by amoeba involve the 
release of proteases (Alfieri et al., 2000; Alsam et al., 2003). The proteases from pathogenic 
Acanthamoeba were shown to cause cytotoxicity to endothelial cells by forming holes in their 
membranes (Hurt et al., 2003). In our study SDS-PAGE zymography was used to assess the effect of 
eugenol derivatives on proteases released from Acanthamoeba castellanii T4 (trophozoites). Our results 
displayed that when doses of EN were increased, trophozoites released less proteases into environment. 
This indicates that EN can be potentially used in protecting against tissue damage.  
In conclusion, this study has shown: MRSA and MSSA were able to invade, survive and multiply 
within Acanthamoeba; Inhibition of PI3K, tyrosine protein kinase and tyrosine protein phosphatase 
decreased bacterial uptake by Acanthamoeba. In contrast, inhibition of serine proteases resulted in greater 
uptake than control samples; It was detected that in the phagocytosis process some bacteria actively 
invade  through the cell membrane while some of them are being taken up by Acanthamoeba. The 
number of internalised bacteria were mainly actively phagocytosed  ones; PMSF was able to inhibit 130 
kDa extracellular serine protease; Protein spot analyses indicated inhibition of 43 proteins on treated gel 
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which were expressed in untreated control gel; m-THPC and psoralen mediated PDT was effective 
against Acanthamoeba and bacteria both in intracellular and extracellular conditions; Among four types 
of eugenol, natural product derivatives utilised, two of them (EN1 and EN3) had higher antimicrobial 
effect than others.      
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6.2. Recommendations for future work  
 
The findings derived from the work described in this thesis enlighten some aspects of S. aureus 
virulence, but also posed more questions that  need to be answered.  The focus of this study was on the 
ability of MRSA and MSSA to interact with Acanthamoeba. Also, it will be sensible to exploit the PDT 
approach and several antimicrobial agents against Acanthamoeba, MRSA and MSSA in intracellular and 
extracellular conditions for therapeutic use. 
1. Understanding of metabolic pathways playing role in Acanthamoeba-bacteria interactions;  
2. As keratitis is the most common infection caused by Acanthamoeba, it would be interesting to use in 
future human corneal epithelial cell line; 
3. Identification of the gene products important for binding and intracellular survival of MRSA and 
MSSA within amoebae. One interesting method would be preparing mutants lacking the genes 
responsible for the expression of the corresponding virulence factors; 
4. It is desirable to investigate drugs used against amoeba infections due to an increase in number of 
contact lens wearers. Most of the drugs given are mixed together which allow for an additive and 
synergistic effect but can also cause unwanted side effects and drug toxicity. A mixture of drugs is used 
because none of the available drugs is 100 % efficient; 
5. The use of natural products, including eugenol derivatives as antimicrobial agents may have the 
potential to be one of the therapeutic protocols against Acanthamoeba and bacterial infections;  
6. The use of PDT application as an alternative treatment for bacterial infection could overcome 
antibiotic drug resistance.  
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 Appendices Chapter 7.
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7.1. Appendix one: Acanthamoeba storage, counting and viability 
7.1.1. Acanthamoeba storage 
Acanthamoeba trophozoites can be stored as axenic cultures for long term. Briefly, exponentially 
growing amoebae were re-suspended at a density of 5 x 10
6
 cells per mL in the PYG medium and placed 
into a cryotube. The cryotube was quickly placed in a box with ice and transferred to -20 °C for 1 h, 
followed by their storage at -80 °C overnight before permanent storage in liquid nitrogen. 
7.1.2. Preparation of Acanthamoeba culture  
Thawing and recovery of Acanthamoeba from liquid nitrogen was done quickly. Pre-warmed 
PYG medium was prepared in advance. The cryotubes were taken out from liquid nitrogen in dry ice and 
immediately placed in 37 °C incubator until 80 % has thawed. Acanthamoeba were transferred into a tube 
with pre-warmed medium and centrifuged at 1100 rpm for 3 min. After centrifugation the amoebae were 
gently re-suspended in growth medium (PYG) followed by their immediate transfer in a T-25 tissue 
flasks. Next, flasks with Acanthamoeba were incubated at 30 °C until they become confluent. 
7.1.3. Counting Acanthamoeba  
The number of Acanthamoeba was determined by using the haemocytometer. After the 
haemocytometer and the coverslip were cleaned using 70 % ethanol, 7 µl of cell suspension were placed 
on haemocytometer and the average number of Acanthamoeba in 1mL was calculated. The 
Acanthamoeba were diluted to the required number using appropriate medium and plated in flasks or 
plates as required by experimental design. 
7.1.4. Determination of the viability of Acanthamoeba  
To determine the viability of Acanthamoeba trophozoites, trypan blue exclusion test was used. 
Acanthamoeba was incubated at room temperature with 0.2 % trypan blue for 20 min and counted by 
using the haemocytometer. 
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7.2. Appendix two: Bacterial cell culture techniques, storage and counting 
7.2.1. Bacterial strains 
Clinical isolates of MRSA, MSSA were generously provided by Dr Tony Elston from Colchester 
hospital. 
7.2.2. Media and growth conditions 
For interaction assays, all staphylococcal strains were grown in Luria-Bertani (LB) broth at 37 °C 
and used at the logarithmic growth phase. All bacterial strains were cultured on nutrient agar plates and 
sub-cultured weekly. 
7.2.3. Storage of bacterial cultures 
Using a sterile loop roughly 20-30 isolated colonies of bacteria were picked up from the agar 
plate and inoculated in a 10 mL LB broth containing 30 % glycerol. Aliquots of 1 mL bacterial mixture 
were transferred in cryotubes and placed in a -20 °C freezer for permanent storage. To activate bacteria, a 
loop was dipped in the frozen cryotube and the streaking protocol was followed. The streaked agar plate 
was incubated in a 37 °C incubator overnight resting on its lid to prevent water condensation from falling 
onto the agar. After the incubation the plate was carefully examined if the colonies have similar 
morphologies such as textures, colours and border shapes and stored at 4 °C for up to a month. 
7.2.4. Counting bacteria 
The number of MRSA and MSSA before their incubation with Acanthamoeba was determined 
by spectrophotometric analysis, followed by serial dilution with PBS and plated on nutrient agar plates. 
After 48 h of incubation the number of colonies from a dilution plate showing isolated colonies was 
counted and according to the sample inoculated on each plate, the number of bacteria/mL was calculated. 
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7.3. Appendix three: Reagents and Inhibitors used in chapter two 
7.3.1. Inhibitors used in phagocytosis assays 
 
Genistein (G6649): 0.0027 g in one mL 
DMSO: Concentrations used are 10, 50 and l00 µM. 
Sodium orthovanadate (S6508): 50 mM stock was prepared by dissolving 
0.0092 g in one mL distilled water. Concentrations used are 10, 50 and l00 µM. 
3.5 mM LY294002 (0012): 3.5 mM stock was prepared by dissolving 5 mg in 5 mL of DMSO. Effective 
concentration is 50 µM. 
Phenylmethanesulfonyl fluoride (PMSF) (P7626-250 MG): 0.017 dissolved in one mL methanol. For 
1 mM final concentration, add 10 µl of 10 mM to 990 µl methanol. 
7.3.2. Buffers used in phagocytosis assays 
Carbonate-bicarbonate buffer:  (9.5 mL 0.2 M Na2C03 mixed with 41.5 mL 0.2 M NaHC03, solution 
made up to 200 mL, pH 9.4) 
7.4. Appendix four: Reagents and Inhibitors used in chapter three 
7.4.1. Reagents and buffers for Zymographic assays 
 
1.5M Triethylamine hydrochloride (Tris) pH 7.4: (T8521) 18.1 g dissolved in 100 mL distilled 
water, adjust pH to 7.4 using hydrochloric acid (HCl). 0.5 M Tris pH 6.8: 6.057 g in 100 mL distilled 
water, adjust pH to 6.8 using HCL 10 % (w/v) SDS: (L3771) 10 g  SDS make up to l00 mL with distilled 
water 30 %  (v/v) Bis/ acrylamide  solution for electrophoresis:  (A3574) 4 % (w/v) gelatin:  (9000-70-8) 
4 g make up to 100 mL with distilled water. Running buffer for SDS-PAGE (stock solution SX): Tris 15 
g, glycine (G8898) 72 g, SDS 5 g, make up to 1000 mL with distilled water. Adjust pH to 8.3 with HCI. 
Dilute to 1X with distilled water prior to use. 
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Sample buffer (2X): distilled water 4.0 mL; 0.5M Tris pH 6.8, 1.0 mL; glycerol 0.8 mL; 10 % SDS (w/v 
in distilled water) l.6 mL; 0.05 % (w/v in distilled water) bromophenol blue (B6131). To analyse protein 
samples using SDS-PAGE, 1:10 2-mercaptoethanol (M6250) to sample buffer is added, samples with 
sample buffer (1:1) are mixed, and heat at 95 °C for 5 min prior to electrophoresis. For zymography, no 
2-mercaptoethanol was added to the sample buffer and the sample was not heated. 
Coomassie brilliant  blue stain: 0.5 % (w/v) Coomassie brilliant blue (B0149), 40 % methanol (v/v), 10 
% acetic acid (v/v), 50 % distilled water (v/v). De-stain:  40 % methanol (v/v), 10 % acetic acid (v/v), 50 
% distilled water (v/v). Temed solution: (T9281).  Ammonium   persulphate: (Sigma A3678), 4 % (w/v 
dissolved in distilled water) Tris buffer used  to prepare triton and developing buffer: 50 mM Tris (6.057 
g), adjust pH to 7.5. 
Triton: 2 % Triton X-100 (v/v in Tris buffer) (X-100). 
Developing buffer: 10 mM CaCl (1.4 g/l C1016). 
10 % SDS-PAGE zymography running gels: 
 
Distilled water 4.2 mL 31.89 % 
Bis/acrylamide solution 3.33 mL 34.7 % 
SDS 10 % 100 µ1 0.1 % 
Tris 1.5 M pH 7.4 2 mL 20.8 % 
Ammonium persulphate 400 µ1 0.4 % 
Temed solution 6 µ1 0.06 % 
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4 % Stacking gel 
Distilled water 4.3 mL 6.9.77 % 
Bis/acrylamide solution 0.8 mL 13 % 
SDS 10 % 0.75 mL 12.16 % 
Tris 0.5 M pH 6.8 60 µ1 0.97 % 
Ammonium persulphate 250 µ1 4.0 % 
Temed solution 3 µ1 0.048 % 
 
7.4.2. Zymographic assays protocol 
The Biorads mini-protein electrophoresis unit (67512533, Biorad, Hemel Hempstead, UK) is 
assembled according to the manufacturers' instructions. The running gel reagents were mixed and loaded 
into the sealed gel caster (overlaid with 70 % ethanol to exclude oxygen), this is a vertical SDS-PAGE 
system that cast gels of 0.75 mm thickness. After polymerisation, the ethanol was decanted and the 
stacking gel was mixed and layered on top of the running gel. Plastic 10-well combs (holds up to 20  
µl/well) were inserted into the stacking gel and polymerisation allowed to occur (~30 min). The combs 
were then removed and gels were assembled into the electrophoresis tank (Biorad 165-2949) and the tank 
filled with 1X running buffer as mentioned above. Samples mixed with sample buffer (1:1) were added to 
the wells and electrophoresed for ~2 hrs, 115V. After that gels were washed with 50 mL 2 % Triton X-
100 in Tris buffer for 1 h, with gentle shaking to remove SDS and re-nature proteases. Then incubated 
overnight in 50 mL developing buffer at 37 °C without shaking. Next day, gels were stained with 50 mL 
coomassie blue stain for 1 h, followed by de-staining with 50 mL de-stain and the proteolytic activity was 
visualized as unstained regions. For SDS- PAGE only, gels were stained with 50 mL coomassie blue 
stain, with gentle shaking and then de-stained for ~30 min with gentle shaking to visualise protein bands 
on the same day. 
 
168 
 
 
7.4.3. Buffer Recipes for 2 DE   
 Rehydration solution preparation  7.4.3.1.
 
Just prior to use, the appropriate volume of stock solution is slowly thawed. Add the appropriate 
amount of IPG Buffer, if it is not already included in the rehydration stock solution. Add sample. The 
rehydration stock can be diluted no more than 1/8 by sample addition [eg. 62 ul of sample for each 0.5 
mL rehydration stock]. The amount of protein that can be added is dependent upon the length of strip, the 
pH range and the detection method to be used. Up to 1 mg can be added to a wide pH range 17 cm strip. 
Note: DTT and the sample must be added fresh, just prior to use. 
   Strip length (cm) total volume per strip
1
 (ul) [min; max]
2
 
7 125; 200 
11 200; 280 
13 250; 350 
18 350; 500 
 
1
 this volume includes the sample 
2
 The minimum volume rehydrates the strip to a gel thickness of 0.5 mm and a gel composition of 4 % T/ 
3 % C. The maximum volume allows for larger protein sample loads, facilitates entry of larger proteins 
and minimizes protein solubility problems. 
For most samples it is recommended to stay as close to the lower volume limit as possible. 
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 SDS equilibration buffer 7.4.3.2.
 
 Component Final concentration Amount 
1.5 M Tris-Cl, pH 8.8 50 mM 6.7 mL 
Urea (FW 60.06) 6 M 72.07 g 
Glycerol (87 % v/v) 30 % (v/v) 69 mL 
SDS (FW 288.38) 2 % (w/v) 4.0 g 
Bromophenol blue trace (a few grains) 
Double distilled H2O  to 200 mL 
 
 (50 mM Tris-Cl pH 8.8, 6 M urea, 30 % glycerol, 2 % SDS, bromophenol blue, 200 mL) 
Store in 40 mL aliquots at –20 °C. 
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7.5. Appendix five: Preparation of Eugenol Derivatives 
7.5.1. Preparation of 5-allyl-2-hydroxy-3-methoxy-benzaldehyde AM2 (C11H12O3) 
 
        4-allyl-2-methoxy-phenol (AM1, 10.66 g, 65 mmol) in glacial acetic acid (75 mL, 1312 mmol) was 
treated with hexamine (40 g, 285.7 mmol). The mixture was heated and stirred until a clear solution was 
obtained. After that, the reaction mixture was heated on oil bath at 105 ºC for 7 h. The dark brown-red 
solution was treated while hot with a boiling mixture of concentrated hydrochloric acid (50 mL) and 
water (100 mL). The reaction mixture was heated for another 5 min, then cooled slowly. The product was 
extracted with ether (3 x100 mL) .The combined organic layers were washed with water (3 x100 mL). 
The clear ether solution was then shaken with sodium hydroxide 30 mL (20 %). The lower aqueous layer 
was colourless showing that only acetic acid had been extracted. The organic layer was dried with 
magnesium carbonate, filtered and evaporated, to give a brown oil residue. Purified by column 
chromatography on silica gel and eluted with petroleum spirit: ether (1: 1) ( Rf = 0.57), to give 5-allyl-2-
hydroxy-3-methoxy-benzaldehyde (AM2, 3.3 g, 30.9 % ), a yellow crystal. m.p.48-50. (Scheme: 1) (The 
Indian Academy of Sciences, 1949). 
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Scheme (1): Preparation of AM2 from AM1 
 
 
 
 
 
 
 
 
 
 
172 
 
 
7.5.2. Preparation of 4-allyl-6-hydroxy methyl-2-methoxy-phenol AM3 (C11H14O3) 
 
       4-allyl-2-methoxy-phenol (AM1, 14.76 g, 0.09 mol) and formaldehyde (8.1 mL, 0.1 mol) (37 % 
solution of formalin) are mixed in a round bottom flask at pH = 9-10 by adding 5 % NaOH solution, then 
stirred and refluxed at 100 ºC for 2.5 h. As a result, this yellow mixture was separated into two layers, the 
viscous yellow – brown liquid was dissolved in ethanol and neutralized with 5 % HCl solution, then 
diluted with water (100 mL). The hydroxy methyl eugenol was extracted with ether (2 x 100 mL), dried, 
evaporated to give a brown oil residue which was purified by column chromatography on silica gel eluted 
with petroleum spirit/ ether ( 1:1 )( Rf = 0.22), to give a 4-allyl-6-hydroxy methyl-2-methoxy-phenol 
(AM3, 3.7 g , 25.1 % ), as a yellow oil(Scheme :2) (The Indian Academy of Sciences, 1949). 
 
 
 
 
 
 
 
 
 
 
 
 
173 
 
 
OMe
HO
AM1 AM3
OMe
HO
HO
10 % NaOH
PH 9-10
C
O
+HH
 
  
 
 
 
 
                                    
Scheme (2): Preparation of AM3 from AM1 
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